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Abstract 
Traditional Chinese Medicine (TCM) is becoming one of the most potential scientific 
fields and an exciting trend of research on TCM is obvious, due to its long history, good 
therapeutic effects and abundant botanical resources. However, TCM is based on an 
unique theory which is different from western scientific thinking. Thus, much work has 
been dedicated to translate or to modernize the TCM system to western medical system 
nowadays. Many botanical resources which are declared effective in TCM are directly 
tested through the western scientific methods to discover and to prove the functionality, 
the active compounds and to clarify the pharmacodynamic and pharmacokinetic mode 
of action.  
Wounding healing is an important issue for life quality in the world. In this work skin 
active herbal drugs from TCM have to be identified from the botanical resources and 
further to be investigated concerning in vitro functionality on human skin cells and 
phytochemical aspects. 
A broad screening for wound healing effective plants was performed according to 
Pharmacopoeia of People's Republic of China (2005 Version) and 160 herbal drugs have 
been described as effective species for this medical use.  Further literature research was 
performed to identify plant species from this group which have not been investigated for 
wound healing or detailed phytochemistry until now in detail. Angelicae sinensis radix, 
Archyranthis bidentatae rhizoma, Cimicifugae rhizoma, Corydalis rhizoma, Gardeniae 
fructus, Houttuyniae herba, Lonicerae japonicae caulis, Lonicerae japonicae flos, Moutan 
cortex, Notoginseng radix et rhizoma, Paeoniae rubrae radix and Rehmanniae radix  were 
finally selected for detailed investigations. 
Standardized water and ethanol-water extracts were tested on primary normal human 
dermal fibroblasts (pNHDF) and HaCaT keratinocytes on influence on dehydrogenase 
activity (MTT, XTT tests), cell vitality (neutral red assay), cellular proliferation (BrdU 
incorporation ELISA) and necrosis-inducing activity (LDH test). 
Extracts from Notoginseng radix et rhizoma, Angelicae sinensis radix and Lonicerae 
japonicae flos turned out to be moderate active; extracts from Moutan cortex (MC) had 
significant stimulating activities, while extracts from all other herbal drug materials 
turned out to be inactive.  
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Detailed investigations were performed on water extract and ethanol-water (6:4) 
extract from Moutan cortex (MC), enhancing the cell viability of keratinocytes and 
pNHDF in a dose-dependent manner with about 20 to 40 % increased cell viability at 
100 µg/mL. Bioassay-guided fractionation led to a EtOAc soluble part (fraction 10) and a 
water soluble part (fraction 12). Both fractions stimulated the cell viability on both cell 
types about 10 to 30 % at 0.1 to 10 µg/mL. Also cell proliferation was increased for both 
cell types.  
Bioassay-guided fractionation of fractions 10 and 12 by chromatography on Sephadex® 
LH-20 and MCI gel yielded the flavan-3-ols (+)-catechin, (-)-epicatechin-3-O-gallate and 
the oligomeric proanthocyanidins (-)-epicatechin-ȋͶȾĺ8)-catechin and epicatechin-3-
O-gallate-(4ĺ8)-catechin. Additionally trigalloyl-glucose and 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose (PGG) were isolated. From a lipophilic fraction paeonol was isolated.    
The proanthocyanidin-containing fractions as well as PGG were shown to contribute 
substantially to the stimulating influence on skin cell physiology. Especially PGG 
enhanced cell viability and cellular proliferation of HaCaT keratinocytes at concentration 
of 1.1×10-4 mol/L. 
In this work, Moutan cortex has been proven to be a potential TCM herbal drug for 
wound healing. By the clearly structured biossay guided research, the in vitro cell 
investigations showed clearly the skin cell viability/proliferation stimulating effects of 
Moutan cortex which can be correlated to the tannin-like polyphenol compounds. These 
results strongly suggest that Moutan cortex is a potential TCM plant for wound healing 
by promoting the proliferation of pNHDF and HaCaT keratinocytes. 
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1 Introduction 
1.1 Traditional Chinese Medicine (TCM)                
1.1.1 General introduction of TCM 
Traditional Chinese Medicine is one of the oldest folk medicine in the world with a 
history of more than 2000 years. It is the fortune from the wisdom of people in the early 
times. It has been used to cure diseases and to improve the health conditions in order to 
resist diseases in China till now. With amazing effects, TCM is nowadays also very 
popular in the world. It is frequently utilized in western countries as the complementary 
and alternative medicine (CAM) (Eisenberg, et al., 1998).  
With the development of the western medicine, the modernization of TCM is required 
and some new changes have occurred in this old medical system. Besides, as one great 
database of abundant herbal drugs, TCM plants have been investigated for obtaining the 
functional components with western medical methods in labs all over the world.  
To study TCM, historical factors and some understanding of Chinese ancient philosophy 
are necessary. Thus, the main history and some important conceptions of TCM are 
explained as the basement for getting into this work.  
1.1.2 Brief history of TCM 
Grounding of TCM theoretical system 
TCM is the only ancient natural medical system in the world with the unique theoretical 
system. The initiation of theoretical system of Chinese medicine can date back to 
Warring States (about from 475 BC to 221 BC) and the Qin and Han dynasties. For the 
initiation, there were several important conditions as the basis of this theoretical system 
(Chai, K., et al., 2007): 
1. The long-term accumulation of medical experience; 
2. The affection of philosophical thoughts from ancient China; 
3. The interaction with other natural sciences, such as astronomy, calendar, 
meteorology, geopgraphy, phenology, acoustics, agronomy, mathematics etc. 
Ancient people found out some medical uses of plants, animals etc. accidently in the 
process of searching and using them as food. With the accumulation of medical 
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experience against diseases, many were recorded and went down from generation to 
generation. They made the great and rich content of TCM. At that time, the development 
of philosophy in China gave one strong structural supporting to the sorting of the 
contents.  Moreover, the interaction with other natural sciences gave more space and 
new directions for the growth of TCM and made the theory complete. 
 
The marks of the formation of theoretical system of TCM 
The coming out of several remarkable TCM classics indicated the formation of the 
theoretical system of TCM (Li, D. et al., Zhongyijichulilun, 2006; Chai, K. et al., 2007): 
1. Innen Canon of Yellow Emperor:  
It consists of two parts- Plain Question and Miraculous Pivot. This classic started 
around Spring and Autumn Period and Warring States Period. It was finished 
around the Han Dynasty. It is the earliest medical classic extent in China. The 
content of this classic was collected, sorted and integrated by many medical 
scientists at that time. In this book, medical contents are taken as the center, 
applying philosophical theory and scientific knowledge and taking the holism as 
the guiding line, to expound the life regularity and the integrity of man with its 
external surrounding, and to study the theories of human morphological 
structure, physiology and pathology, as well as the diagnosis, prevention and 
treatment of diseases. The monism, yin-yang and the five elements theories are 
as the guidance running through the whole book. The accomplishment of this 
book indicated that the development of TCM had gone to a new phase of 
theoretical summarizing from pure accumulation of experience. 
2. Eighty-One Medical Problems: 
The written time of this book is estimated to be about in Western Han period. The 
Author is unknown. It interpreted the knowledge and the understanding of 
meridians, vital gate and tri-Jiao based on the theoretical ground of Inner 
Canon of Yellow Emperor.  
3. Treatise on Cold Pathogenic and Miscellaneous Diseases: 
This book was written by Zhongjing Zhang at late East Han dynasty (ca. 200-210 
A.D.). After the resorting by other people, it was divided into two parts as 
Treastise on Cold Pathogenic diseases and Synopsis of Golden Chamber. In this 
book the rich experiences on prevention and treatment of diseases before East 
Han dynasty are summed up, and diagnosis and treatment of cold pathogenic and 
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miscellaneous diseases are dealt with respectively differentiation. In the book, 
the theory, principle, formula and medicinals are all given, laying a basis for the 
development of clinical medicine in later ages. This outstanding work is well 
known in later ages as the ancestor of formula. 
4. Shennong's Classic of Medicinal Herbs: 
The time of coming out of this book is unclear. The most popular version is that 
this classic was written in Han dynasty. In the book, 365 kinds of medicinals are 
recorded, and divided into three grades of upper, middle and lower agents. The 
medicinals of the upper grade are mainly used for strengthening physical health 
to correspond with the heaven, the ones of middle grade for culturing mental 
health to correspond with man, and the ones of lower grade for treating diseases 
to correspond with the earth, which is the first classification of medicinals in 
China. In the book, the briefly generalized pharmaceutical theories are also four 
natures (cold, hot, warm and cool), five flavors (sour, bitter, sweet, acrid and 
salty), and seven conditions of ingredients in prescription (single effect, 
mutual accentuation, mutual enhancement, mutual counteraction, mutual 
antagonism, mutual suppression and mutual incompatibility). The coming out of 
this book is the important mark of establishment of theoretical system of Chinese 
pharmacy, laying a basis for development of TCM. It is the earliest monography 
of materia medica extant in China. 
Development of TCM theoretical system 
There are 4 important phases for the developing of the TCM theoretical system (Li, D. et 
al., 2006; Chai, K. et al., 2007): 
1. Period of the Jin, Sui and Tang dynasties (Time: 265 -907): 
During this period, the medicine and pharmacy had been developed 
comprehensively. Especially, there came many suming-up monographs in 
diagnostics, etiology, acu-moxibustion and prescription. For example, the Pulse 
Classic written during the Jin dynasty by an imperial medical official Shuhe Wang, 
in which the conditions of 24 pulses and their indication syndromes are 
expounded, is the earliest monograph of pulse lore extant in China; A-B Classic of 
Acupuncture and Maxibustion compiled by well known scholar Pumi Huang 
through sorting out the expounding of meridians, points and acupuncture 
methods in Plain Questions and Miraculous Pivot, is the earliest monograph of 
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acupuncture; Handbook of Prescriptions for Emergency was written by Hong Ge, 
some infectious diseases such as smallpox and measles can be diagnosed 
according to their pathogenic features and clinical manifestations. In the Sui 
dynasty, General Treatise on Causes and Manifestations of All Diseases compiled by 
an imperial physician Yuanfang Cao and his coworkers, is a representative work 
of studying pathogens and manifestations of diseases. The monumental works on 
medicinals and prescriptions coming out in the Tang dynasty are the focus of 
attention. Among them, Essential Recipes for Emergent Use Worth a Thousand 
Gold and A Supplement to Recipes to Worth a Thousand Library are all the handed 
down prescription books that record the effective formulas of well-known 
physicians and their various therapeutic measures. 
2. Period of the Song, Ji and Yuan dynasties: 
In this period an active atmosphere called ''a hundred schools of thought 
content'' began, various schools by using their unique academic views had greatly 
enriched the medical theories and practice. 
During the Song dynasty, Wuze Chen in his work of Treatise on Three Categories 
of Pathogenic Factors and Prescriptions put forth the well known ''theory of three 
categories of disease causes''. He completely summarized the disease causes  as 
three respects: Endogenous cause is endogenous injury by the seven affects; 
exogenous cause is exogenous contraction by six climatic pathogens; and non-
endo-exogenous causes are improper died, injury of qi by loudly crying, wounds 
by insects and animals, poisonings, incised wounds, injuries from falls and heavy 
load, drowning, etc.. Besides, Yi Qian in Song dynasty wrote the book Key to 
Therapeutics of Children's Diseases and was thus called ''the father of 
pediatrics'' in China. 
Many medical schools with their own features in the Jin and Yuan dynasties came 
out, among them the most representative physicians are Wansu Liu, Congzheng 
Zhang, Dongyuan Li and Danxi Zhu. They were honored later as ''four great 
physicians in the Jin and Yuan dynasties''. 
3. Period of the Ming and Qing dynasties: 
In this period, chinese medicine had gone into a new stage in investigations of 
infectious diseases. Treatise on Pestilence written by Youke Wu came out in Ming 
dynasty. He set forth the theory of ''pestilential qi'', holding that the pathogens of 
''pestilence'' are ''a noxious qi rather than wind, cold, summer-heat and 
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dampness''. The way of infection is through the mouth and nose. This is a great 
breakthrough in etiology of warm diseases (especially pestilential diseases) and 
this book set up the basis for the development of pestilence. 
In the Qing dynasty, the famous physicians of warm disease Tianshi Yie, Shengbai 
Xue, Jutong Wu and Mengying Wang summarized the relative research 
achievements gained formerly, broken through the traditional viewpoint of 
''warm diseases are not beyond the category of cold pathogenic diseases''.  
Besides, Qingren Wang of Qing dynasty advocated the theory of pathogenesis of 
stagnant blood and created a series of formulas with acting of activating blood to 
resolve stasis. 
A great classic about herbal drugs came out in Ming dynasty- Compendium of 
Materia Medica, written by Shizhen Li. In this notable classic, 1892 medicinals 
are recorded, 374 are first time reported; 11096 prescriptions are collected. 
Additionally, the author made 1160 precise drawings to describe the drugs. 
Among all medicinals, there are in total 1095 herbal drugs described in this book. 
It is the summary of the traditional chinese medicinals of thousands years. It 
made a great dedication to the development of TCM. 
According to all above, many innovative views and breakthroughs came up to 
TCM system during this period, and the clinical practices were rapidly developed. 
Many medical books came out after the summarization of theories and clinical 
experiences. 
4. Modern times: 
From 1840 to 1949 
From the period of Opium War to the founding of The People's Republic of China, 
with the introduction and rapid spreading of western thoughts and medicine in 
China, there was the time that the ''new things and thoughts'' and ''the old things 
and thoughts'' coexisted in China, and they stayed at the contradictory with each 
other. At that time, the development of TCM has been slowed down to a great 
extent. However, the new thought of coexistence of two different medical systems 
and scientization of TCM also started at that time.  
Several famous physicians in China, such as Zonghai Tang, Peiwen Zhu and 
Xichun Zhang have seen different advantages from both medical systems. They 
advocated to study the advances from the western medicine and at the same time 
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to insist the good from TCM. They created the school of integration of traditional 
Chinese and Western medicine. Many efforts have been made by using western 
medicine to explain TCM. Although no great breakthrough came out on this way, 
the experience did help the modernization of TCM and help people to accept both 
medical systems at the same time and to have right views about them. 
Nowadays  
With the popularity of western medicine in China, at the end of the 19th century, 
western medical universities with the introduction of Western medicine into 
China were established by Europeans, mostly missionaries. Nowadays, most of 
them are the leading medical universities in China and the educational 
programmes of those universities are based on those of western universities. 
According to this situation in China, TCM was once largely ignored (Zhu Y., et al., 
1995).  
Thus, the Chinese government paid great attention on protecting and developing 
TCM. TCM is one of the most valuable fortune with the thousands years' 
accumulation of experiences. Thus, it can't be discarded and it is placed the same 
important as the Western medicine by the government.  ''To develop the modern 
medicine and the traditional medicine'' and ''to accomplish the modernization of 
TCM'' are even written in the constitution of China. Besides, TCM medicinals are  
as one important part written in Pharmacopoeia of People's Republic of China. 
Nowadays, Chinese government has established many TCM universities and 
colleges in China to offer the professional education of TCM. All of them have TCM 
hospitals or have cooperation with TCM hospitals to offer the practices for the 
students. Even in the most western medical hospitals in China, there are mostly 
TCM departments existent. In 95% of the hospitals practising Western medicine 
there are departments of traditional Chinese medicine, most with inpatient beds; 
when patients arrive at the outpatient department, they can opt for Chinese or 
Western medicine treatment. In Jiangsu province, one of the rich, more 
sophisticated eastern provinces, one quarter of all outpatients in one year (10 
million) had opted for traditional treatment (Hesketh, T., et al., 1997). Some 
hospitals make integration of both medical methods to develop some new 
methods for curing diseases, some of which have gained good efforts (Xu, J. et al., 
2009).   
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Since TCM offered abundant resources from the nature, it has become one of the 
most interesting research areas in the world and it is drawing more attentions 
from research centers and pharmaceutical companies etc.. Until now,  still, 
nobody could tell the right future of TCM and how it could be finally explained 
and accepted in the world. But for sure, it exists on its own special way and it 
gives further benefits to people's health. 
1.1.3 Understanding  TCM 
Comparison of Western medicine and TCM 
To realize the differences between the two medical systems is essential for the 
understanding of TCM. Thus, comparisons of Western Medicine and TCM are performed. 
Modern medicine is trying to get the specificity of the cause, pathology and location, and 
as a result, the therapeutic approach is targeting on the specificity. New drugs in modern 
medicine are developed from strictly designed scientific pharmacological tests and work 
directly on the targets (Lu, A.P. et al., 2004). The medicines and therapies work fast and 
the effect could be seen or be measured usually immediately after the uptaking of the 
medicines or the therapies. That is also the reason, why Western medicine in China is 
often regarded as more effective in acute situations or where the etiology is known  
(Hesketh, T., et al., 1997).  
Modern drugs are good at curing those diseases with clarified cause and pathology, it is 
normal that the function of one modern drug was described to be anti-bacterial or anti-
viral which is very specific to one pathological symptom. However, they are not good at 
curing those diseases due to multiple factors in the pathogenesis, which have become 
more common in medical science (Lu, A.P. et al., 2004).  
TCM works differently from the Western medicine. One of its most important view is the 
integrity of life. The integrity includes the human itself and its social and natural 
environment. The therapeutic mechanism can be achieved by activating systems, 
improving system connection and enhancing human resistance. The mechanism in TCM 
is not like Western medicine that seeks the mechanism from cellular or molecular level 
(Lu, A.P. et al., 2004). Four diagnostic methods (inspection, auscultation-olfaction, 
interrogation and palpation) are used in TCM for the doctors to diagnose a disease. 
There was no exact standards for the diagnoses and the procedure is also without any 
help of modern medical instruments, for example, the blood pressure won't be 
measured. Thus, the conclusion from the TCM doctor relies much from the learned and 
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accumulated experience. According to the individual diagnosing results, different 
patients will be given individual prescriptions due to one's health condition. And after 
some time taking the TCM medicines, the patient could be diagnosed again and 
according to the reaction and changing of the body to the first prescription, the 
prescription could be altered accordingly. The individuality of TCM makes the 
prescription more precise for every patient, especially for those who have the same 
symptoms but with different causes or under very different healthy conditions. But in 
Western medicine, the patients with the same symptoms will be treated in the same way. 
TCM, based on the syndrome (Zheng) which is taken as an outcome of differentiation of 
symptoms and signs, targets to the non-specificity and parts of the specificity. The effect 
of Chinese herbal medicine is not so good in curing a disease with specific signs, which 
can be only obtained by modern diagnostic instruments since Zheng does not refer to 
those signs. However, the effect of herbal medicine is better in treating some cases when 
the non-specificity decides the process of a disease (Lu, A.P. et al., 2004). Thus, it is 
normal in China that many patients which are not cured by Western medicine turn to 
TCM.  
Another very important aspect in both Western medicine and TCM is about herbal 
medicines. Medical herbs also play an important role in Western medicine. 
Pharmaceuticals from plants are gaining more attention in the Western world and 
people are becoming aware that the plant kingdom has a great potential for the 
development of new drugs. Plants are also being included in large screening 
programmes, for example, by the National Cancer Institute in the United States (Zhu, Y. 
et al., 1995). But working differently, the medical herbs in Western are used singly and 
for some scientifically approved functions. For example, Calendulae flos (Asteraceae) 
contains flavonoids, volatile oil and triterpenoids etc., it has been proved to have the 
antiphlogistic function and is usually used for the wound healing.  
In TCM, firstly, the medical herbal plants are sorted by the four natures, five flavors etc.. 
Secondly, single plants are rare used in TCM prescription. A prescription containing over 
10 plants is very common. A typical prescription is composed of the principal drug, the 
associate drug, the adjuvant drug, and the messenger drug. These drugs are often 
described as emperor, minister, assistant and envoy, respectively. A principal drug is 
directed against and has the most effect on the causes or the main symptoms of the 
disease and is indispensable to the formula of the prescription. An associate drug either 
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aids the principal drug in treating the cause or the main symptoms or serves as the main 
ingredient directed against coexisting symptoms. An adjuvant drug has one of the 
following three different functions. First, it reinforces the effect of the principal drug or 
the associate drug, or directly treats a less important aspect of the disease. In this 
capacity, it is known as a helpful adjuvant. Second, it moderates or eliminates the 
toxicity or harsh property of the principal or associate drug. In this capacity, it is known 
as a corrective adjuvant. Third, it has an opposite effect to that of the principal drug but 
it produces a supplementary effect in the treatment and is used in very serious and 
complex disorders. In this capacity, it is known as an opposing adjuvant. A messenger 
drug can either focus the actions of the formula on a certain area of the body or 
harmonize and integrate the actions of the other ingredients of the formula (Zhu, Y. et al., 
1995).  
Not all formulas contain the full hierarchy of ingredients. In fact, it would be quite 
unusual for a formula to include all the various types of associate, adjuvant , and 
messenger ingredients. Many formulas consist of only a principal and one or two 
associate ingredients. If the principal and the associate ingredients are not toxic, there is 
no need for corrective adjuvants. Sometimes the principal ingredient focuses on the 
level and location of the disorder, obviating the need for a messenger. However, a 
formula may sometimes contains more than one principal drug targeted at the main 
symptoms of the disease (Zhu, Y. et al., 1995). 
TCM in the world 
According to the aforementioned differences between TCM and Western medicine, it's 
obvious that it is difficult to translate ancient interpretations of disease from TCM into 
those used in modern medicine (Qiu, J. 2007). But still with thousands of years of 
experience in treating diseases with natural materials, TCM still plays an important role 
in the health-care system of modern China and is also officially recognized in Japan and 
in some other eastern and south-eastern Asian countries which have the similar cultural 
traditions (Zhu, Y. et al., 1995). Besides, traditional Chinese herbal medicine has been 
gaining acceptance in many western countries. According to one report, an estimated 1.5 
billion people now use these preparations from TCM worldwide (Dobos et al., 2005).  
TCM products have been exported to about 163 countries in the world. Based on the 
report from China Chamber of Commerce for Import & Export of Medicines & Health 
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products, the TCM herbal medicine export is almost US$ 1.2 billion in 2007, which 
increased 8% from 2006. Depending on differetions and calculation, Chinese herbal 
medicine represents 20-50% of the herbal medicine market share worldwide (Xu, J. et 
al., 2008).  
The education of TCM is open for the world. In 2006, among 400,000 enrolled students, 
there are almost 4000 foreign students enrolled. 90% of them are from Asia followed by 
4% from North America and 4% from Europe (Xu, J. et al., 2008).  
The USA could be one of the western countries which pay great attention on TCM. In the 
USA, preparation of traditional Chinese herbal medicine (TCHM) generally comes within 
the legal classification of ''dietary supplements'' rather than conventional medical 
''drugs''. TCHM is sold in the form of individual recipes, often as decoctions and as 
ready-made formulas produced in either the U.S. or China. In recognition of vast 
consumer usage of dietary supplements, the U.S. congress in 1994 passed the dietary 
Supplement Health and Education Act (DSHEA). Any statements or claims on product 
labels must conform do DSHEA requirements (Dobos et al., 2005). In June 2004, the US 
Food and Drug Administration (FDA) issued new guidelines that permit the approval of 
herbal mixtures if they can be shown to be safe and effective, even if the active 
constitutions are not know. The new regulations have helped to renew industry's 
interest in the complex formula (Qiu, J. 2007). This step indubitably gave more space for 
the further development of TCHM in the USA. Moreover, the academy exchanges 
between China and the USA about TCM are frequent. TCM doctors in China are often 
invited for the lectures in the USA.  Many modern researches about TCM are also 
undertaking in many labs in the USA. Besides, more and more Americans go to China for 
taking the traditional education of TCM. 
In Germany, TCM is also very popular. Up to 40,000 M.D.s are practicing acupuncture 
and 2/3 of the population are in favor of TCM. All Chinese herbs which are considered as 
drugs have to be sold by pharmacies and thus are subject to strict regulations. The 
quality of these herbal drugs is highly required, so these quality-assuring regulations 
increase the price of TCHM in Germany. In 1991, the first TCM hospital has been 
established in Germany (Kötzting), which evaluates the efficiency and safety of TCHM 
and which has also started to establish a quality control system for Chinese herbs. 
Federal Agency for Drugs and Medicinal products (BfArM) takes the governmental 
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executive of TCHM in Germany. However, TCHM is prescribed only by medical 
physicians and non-medical practitioners of alternative medicine (Heilpraktiker). To 
date, no official standards have been defined for their education in this field. Any 
medical physician or practitioner of alternative medicine can recommend and prescribe 
TCHM, irrespective of their education in TCHM (Dobos et al., 2005). 
For meeting these requirements for higher qualities from TCM herbal drugs from other 
countries, the identification and production standards have to be raised up in China. 
This reason gives a good pushing for the development of TCM in China. 
Modern investigations of TCM and the achievements 
In TCM, the herbal medicine is the most interesting part for all the scientists in the world. 
Many efforts have been made for investigating the active compounds from the natural 
medical herbs. In TCM, formulas are frequently used and the components are often 
changed according to the individuality of the patient. But they are different for the 
scientific research because of the complication of the components and mutual reactions 
between plants. So the investigations of single plants are preferred. Until now, many 
investigations of the active compounds from the TCM herbal medicine have been 
performed and some of very positive results have been obtained. 
The most illustrative example is the discovery of the sympathomimetic effect of 
Ephedrae herba (Ma Huang), which has been used in the treatment of asthmatic 
conditions for thousands years. It was firstly recorded in Shennong‘s Classic of Medicinal 
Herbs. Its active constituent epheǡȽ- and ß-
adrenergic receptors, was identified in the late 1920s by Dr K. K. Chen, then the head of 
the Peking Union Medical College. Another popular example, Yingzhaosu A is one 
sesquiterpene endoperoxide compound with antimalarial activity. It was isolated from 
the roots of Artabotrys uncinatus (L.) Merr. (Annonaceae), a traditional herbal medicine 
used in southern China for malaria (Zhu, Y., et al., 1995).  
Until now, several modern investigations on TCHM have obtained outstanding results. 
Even some clinical researches have been performed. For example, one double-blind with 
placebo-controlled clinical investigation in England with oral taken decoction from the 
TCHM formula against atopic dermatitis was performed and showed very good efficacy 
(Koo, J. et al., 2003). During the epidemic of Severe Acute Respiratory Syndrome (SARS) 
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in 2003, the death rate was only 4% after the TCM integration of TCM started with the 
patients. In Beijing, the death rate decreased 80% after integrating TCM treatments (Xu, 
J. et al., 2008). 
In a word, with more and more approval positive efficacies from TCM, especially from 
TCHM, the value of TCM has been more realized and the direction of modernizing TCM 
with Western medicine has been assured. With more investments and the insistence, we 
believe that more achievements will be obtained in the future.  
Main problems existing in TCM 
Side effect is one problem should be noticed in TCM. It is believed widely that TCM has 
no side effects because it uses ''natural'' substances. This view, held by some clinicians 
and many patients, can lead to unnecessary complications and even fatalities if 
appropriate measures are not taken quickly enough. Many experienced practitioners of 
TCM are well aware of the possible side effects that can occur with various TCM drugs 
and drug combinations, and exercise great caution in their use. Dr. Li states that 
''hypersensitivity, hepatic toxicity and renal damage have all been reported in China, 
some of which have been fetal'' (Koo, et al., 2003). Survey was once carried out in Hong 
Kong about TCM use in pharmacy students. 74% reported that they had not been told of 
any side effects of TCM (Hon, et al., 2004). According to all these, the side effect from 
TCM should be paid great attention in the future, the promotion of this knowledge 
should be included in the education and the TCM doctors shall also mention the possible 
side effects to their patients. Beside, in the  procedure of investigating of TCM medicines, 
the toxicity tests should also be considered and performed to assure the safety of the 
application. 
Another very important problem is the quality of the TCM drugs. With the opening 
policy of TCM from China government, TCM is not only used in China, but also become 
popular in the world. The State Administration of TCM People's Republic of China has 
reported that in 1995, around 1020 pharmaceutical factories for TCHM produced about 
400,000 tons of Chinese medicinal materials valued at 17.9 billion Yuan (about $ 2 
billion). There are general tendencies in the Chinese pharmaceutical market, especially 
by several factories, to manufacture TCHM products according to international quality 
criteria like GMP, but up to now pharmaceutical manufacturers have not been legally 
required to meet these standards (Dobos, G.J. et al., 2005). Thus, several products from 
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China have attracted negative attention. For example, the wrong identified plants, or 
other residues like metal-containing were found in the herbal drugs; although labeled as 
herbal remedies, examples are known of preparations containing strongly acting 
synthetic drugs such as corticosteroids, non-steroidal anti-inflammatory agents, and 
benzodiazepines, without this being mentioned on the leaflet or on the package. Besides, 
the quality of single medicinal herbs draws more attention as well. In the ancient times, 
people described all plants only be drawings, texts and experiences. Now with the 
modern methods, the fingerprint of each traditional Chinese herbal drug should be made 
in order to prove the quality and to avoid any medical accidents happening. Chinese 
government have actually realized this problem and is working on it. In order to ensure 
safety and efficacy, quality assurance procedure must be used to standardize herbal 
drugs. Chemical tests and assays procedures are required to supplement the standards 
which are described in the Pharmacopeia of People's Republic of China (Zhu, Y. et al., 
1995). However, the truth is, there are more herbal drugs which are not chemically 
described. So further work is required for the quality control of the herbal drugs which 
matters the health of people and the development of TCM. Also, the strict control of all 
pharmaceutical companies should be put into process urgently.    
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1.2 Wound healing  
1.2.1 Skin, skin function and the structure 
Skin envelops the entire body, is the chief means of identifying individual human beings, 
and is the major organ of sexual attraction. Functionally, skin is a most extraordinary 
organ (Montagna, W. et al., 1974).  
Skin has very important functions, such as it works like a barrier to protect our body. 
Besides, it has the function of sensation, it helps the metabolism and skin can regulate 
the body temperature. Skin has the structure for excretion and itself has also the 
function of absorption.  
Among its numerous functions, none are more important than preventing the organism 
from desiccating and protecting it from its environment even while maintaining it in 
uninterrupted communication with the environment (Montagna, W. et al., 1974). As well 
acting as a physical barrier, skin also plays an important immunological role. It normally 
contains all the elements of cellular immunity, with the exception of B cells. So it is an 
impenetrable barrier to most external organisms and has anti-microbial function 
(Bensouilah, J. et al., 2006).   
Melanocytes are located in the basal layer of the skin. Melanin inside has an important 
role in the skin's barrier function by preventing damage by UV radiation. Moreover, 
vitamin D, which mediates the absorption of calcium from the intestine and the 
deposition of inorganic minerals in growing bone, is produced in the skin (Loomis, 
1967).  
There are three structural layers to the skin: the epidermis, the dermis and subcutis. 
Hair, nails, sebaceous, sweat and apocrine glands are regarded as derivatives of skin. 
Epidermis is the external layer mainly composed of layers of keratinocytes but also 
containing melanocytes, Langerhans cells and Merkel cells. The area of supportive 
connective tissue between the epidermis and the underlying subcutis contains sweat 
glands, hair roots, nervous cells and fibres, blood and lymph vessels. Under the dermis, 
the subcutis layer contains loose connective tissue and fat. The skin structure is shown 
in Fig. 1.1.  
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Fig. 1.1 The structure of skin (hairless skin and hairy skin). (Source: 
http://en.wikipedia.org/wiki/Skin, 05.01.2012) 
As shown in Fig 1.1, the epidermis is stratified squamous epithelimum. The main cells of 
the epidermis are the keratinocytes, which synthesise the marker protein keratin. 
Protein bridges called desmosomes connect the keratinocytes, which are in a constant 
state of transition from the deeper layers to the superficial. Moving from the lower 
layers upwards to the surface, the four layers of the epidermis are: stratum basale (basal 
or germinativum cell layer), stratum spinosum (spinous or prickle cell layer), stratum 
granulosum (granular cell layer) and stratum corneum (hory layer) (Bensouilah, J. et al., 
2006). 
1.2.2 Wound and wound healing  
A wound (injury) is described as a break in the continuity of tissue from violence or 
trauma and is regarded as healed if there is a restoration of the wound site or inflamed 
tissue to normal condition (Esimone, C.O. et al., 2005). Knowing the importance of skin 
for us, the avoidance of wound happening and the wound treating should be taken 
seriously. Many data show that the happening of wounds (injuries) is one of the leading 
causes which threaten people’s lives. For example, in the injuries to Massachusetts (MA) 
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residents 2007 data book, after the analyses, they found out injures were the leading 
cause of death to Massachusetts residents between the ages of 1 and 44 and the third 
leading cause of death among all ages. In 2007, an average of 8 residents died every day 
from injuries. The total charges for all injury-related cases treated within an acute care 
hospital (includes inpatient hospital discharges, emergency department discharges, and 
observation stays) in 2007 exceeded $2.4 billion. There are many causes leading to the 
injuries in the daily life, some are showed in Table 1.1. 
Table 1.1 Number of Injury-related Cases by Cause, MA Residents, 2007 (partial). 
(Patrick, D. L. et al. 2010) 
Cause of Injury Total Injuries 
(Number) Cause of Injury 
Total Injuries 
(Number) 
Cut  or pierce 74,913 Dog bites 6,556 
Fire/Burn 10,941 Transport injuries 90,371 
Struck by/against 116,132 Fall 206,280 
 
As shown in the Table 1.1, things happen every day which would lead to wounds. Only 
from the report from one state in the USA, the numbers of people who suffered under 
the wounds in one year are already surprisingly big. Thus, for the people’s health in the 
world and for a better living standard, great attention should be paid to wound healing. 
Until now, many researches have been carried out and the process of wound healing has 
been better understood.  
Wound can range from a simple break in the epithelial integrity of skin or it can be 
deeper, extending into subcutaneous tissue with damage to other structures such as 
tendons, muscles, vessels, nerves, parenchymal organs and even bones. Normal wound 
healing is a dynamic and complex process involving a series of coordinated events, 
including bleeding, coagulation, initiation of an acute inflammatory response to the 
initial injury, regeneration, migration and proliferation of connective tissue and 
parenchyma cells, as well as synthesis of extracellular matrix proteins, remodeling of 
new parenchyma and connective tissue and collagen deposition. Finally, increasing the 
Introduction  27 
 
 
 
wound strength takes place in an ordered manner and culminates in the repair of 
severed tissues (Velnar, T. et al., 2009).  
There are many different classifications of wounds (Robson, M.C. et al., 2001). The most 
usual criteria divided the wounds into acute wounds, chronic wounds and complicated 
wounds.  
Acute wounds  
Acute wounds normally heal in a very orderly and efficient manner characterized by 
four distinct, but overlapping phases: hemostasis, inflammation, proliferation and 
remodeling (Velnar, T. et al., 2009).  
Chronic wounds 
According to the present definition, wounds are considered chronic when healing time 
does not follow the expected course or fall within the range of what is considered a 
normal healing trajectory. The entire process is prolonged, and wounds diagnosed or 
categorized as chronic often resist attempts at treatment. In addition, the quality of 
tissue may be poor, and a functional closure is not achieved so the wounds may reoccur. 
In terms of the healing trajectory, the curve is shifted away from normal, indicating the 
delay in healing that typifies chronic wounds (Whitney, J.D. et al., 2005).  Besides, 
disrupted vasculature and high energy-demand by regenerating tissue results in wound 
hypoxia, which leads to the chronic wounds mostly (Sen, C.K. et al., 2002).  
As described in the conception of acute wounds, there are four important phases during 
the normal wound healing procedure. 
Hemostasis phase 
Immediately after injury, coagulation and hemostasis take place in the wound. The 
principal aim of these mechanisms is to prevent exsanguination. A second aim is a long-
term one, which is to provide a matrix for invading cells that are needed in the later 
phases of healing. Together with hemostatic events, the coagulation cascade is activated 
through extrinsic and intrinsic pathways, leading to platelet aggregation and clot 
formation in order to limit blood loss (Velnar, T. et al., 2009). 
Inflammatory phase 
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Inflammatory phase consists of early inflammatory phase and late inflammatory phase. 
Starting during the late phase of coagulation and shortly thereafter, the early 
inflammatory response has many functions. It activates the complement cascade and 
initiates molecular events, leading to infiltration of the wound site by neutrophils, whose 
main function is to prevent infection.  The neutrophils begin to be attracted to the 
wound site within 24-36 h of injury by various chemoattractive agents (Velnar, T. et al., 
2009). Infiltrating neutrophils cleanse the wounded area of foreign particles and 
bacteria and which are then extruded with the eschar or phagocytosed by macrophages 
(Singer, A.J. et al., 1999). 48 hours after injury, fixed tissue monocytes become activated 
to become wound macrophage. Theses specialized wound macrophages are perhaps the 
most essential inflammatory cells involved in the normal healing response. The presence 
of wound macrophages is a marker that the inflammatory phase is nearing an end and 
that the proliferative phase is beginning. Lymphocytes come into the wound area at a 
later stage but are not considered to be major inflammatory cells involved in the healing 
response (Diegelmann, Robert F. et al., 2004).  
Proliferative phase 
The proliferative phase starts on about the third day after wounding and lasts for about 
2 weeks thereafter. It is characterized by fibroblast migration and deposition of newly 
synthesized extracellular matrix, acting as a replacement for the provisional network 
composed of fibrin and fibronectin (Velnar, T. et al., 2009). In this phase, the TGF-Ⱦ
released by the platelets, macrophages and T-lymphocytes becomes a critical signal. As 
healing progresses several other important biological responses are activated. The 
process of epithelization is stimulated by the presence of EGF (epidermal growth factor)  
	Ƚ ȋ   Ȍ      
macrophages, platelets and keratinocytes. Angiogenesis is stimulated by vascular 
endothelial cell growth factor (VEGF), basic fibroblast growth factor (bFGF) and TGF-Ⱦ
to offer the increasing demand for oxygen and nutrients in this phase. The collagen 
synthesis is greatly activated in this phase and abundant type 1 and type 3 collagens are 
synthesized. The cross-links of collagen are then formed. As the collagen matures and 
becomes older, more and more of these intramolecular and intermolecular cross-links 
are placed in the molecules. This important cross-linking step gives collagen its strength 
and stability (Diegelmann, R. F. et al., 2004). Besides, migration of epithelial cells starts 
from the wound edges within a few hours of wounding. A single layer of cells initially 
Introduction  29 
 
 
 
forms over the defect, accompanied by a marked increase in epithelial cell mitotic 
activity around the wound edges. Cells migrating across them attach to the provisional 
matrix below. When the advancing epithelial cells meet, migration stops and the 
basement membrane starts to form (Velnar, T. et al., 2009). 
Remodeling phase 
As the final phase of wound healing , the remodeling phase is responsible for the 
development of new epithelium and final scar tissue formation. This phase may last up 
to 1 or 2 years, or sometimes for an even more prolonged period of time. The 
remodeling of an acute wound is tightly controlled by regulatory mechanisms with the 
aim of maintaining a delicate balance between degradation and synthesis, leading to 
normal healing (Velnar, T. et al., 2009). In the process of collagen remodeling, collagen 
degradation also occurs (Diegelmann, R. F. et al., 2004). In this phase, the new collagen 
matrix becomes more oriented and cross-linked over time. Its subsequently 
organization is achieved during the final stages of the remodeling phase. The underlying 
connective tissue shrinks in size and brings the wound margins closer together, owing  
to fibroblast interactions with the extracellular matrix. The process is regulated by a 
number of factors, with PDGF, TGF-ß and FGF being the most important. As the wound 
heals, the density of fibroblasts and macrophages is further reduced by apoptosis. The 
end result is a fully matured scar with a decreased number of cells and blood vessels and 
a high tensile strength (Velnar, T. et al., 2009).   
Methods for wound healing 
Understanding of the different phases of wound healing helps to give a right treatment 
to the wounds, in order to complete the phases in the right order and to reach good 
healing effect. In clinic, one very important method leading to the good wound healing is 
the debridement. It is essential as it accelerates wound healing and different techniques 
exist. Even in chronic wounds, correct debridement helps to convert a chronic wound 
into an acute one, which can then progress through the normal stages of healing (Velnar, 
T. et al., 2009).  Against the hypoxia, oxygen therapy is also commonly used to facilitate 
wound healing (Sen, C.K. et al., 2002). Recently, the low level laser therapy and vacuum 
assisted closure have drawn great attentions and have been tested gradually in the clinic 
trial to help the wound healing, However, the effects are still controversial and more 
clinical data are required (Samson, D. et al., 2004). 
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Until now, for investigating a better way to shorten the time of wound healing and to 
reduce the pains of the patients from the wounds, medications are also utilized for the 
healing procedure. The ones usually used are zinc and panthenol. With the deeper 
investigation of natural products, some plants are proven to have the functions of anti-
bacterial, antiphlogistic entities or cell-stimulating effect. They are used to help during 
the wound healing procedure. Typical medical herbs are, for example, Calendulae flos, 
Matricariae flos and Arnicae flos etc., which are typical anti-inflammatory herbs.  
1.2.3 Wound healing in China 
China is the largest developing country in the world, in which wounds are one of the 
principal killers. Written records in China concerning wound care and management can 
be traced back more than one thousand years. Many different things from the nature 
were used for the wounds in the ancient time, such as stone mines, herbs. For example, 
in the Shang dynasty (17th century B.C.), not only bronze instruments were used but also 
wine was employed in taking care of wounds. In the Zhou dynasty (11th century B.C.), 
there emerged so called ''ulcer doctors,'' who were specialized in treating ulcers. In 
Hunan province, from a Han (dynasty) tomb at Ma Wang Dui, there were records of 
injuries caused by knives and weapons, and descriptions of treating fresh wounds by 
washing and applying herbs. China has a long history fighting against wounds (Fu, X.B. et 
al., 2001).   
Among all of them, herbs are often used for medications for the wounds in the ancient 
China. The people in the ancient times leave us abundant herbal resources and records 
about wound healing. However, the wound healing in the modern time in China, with the 
integration of the Western medicine, has been ignored to a great extent. No systematic 
innovations for wound healing have been made from the natural plants. There are some 
TCM formula medicine which are still existing and which are popular to Chinese for the 
wound healing, but no explanation has been given and no scientific research has been 
performed. Some formulas are even protected as patents, for example, the very famous 
medication: Yunnanbaiyao. Thus, there must be great space for the investigation of the 
wound healing herbs in TCM.  
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1.3 Aims of the research 
This view that TCM may have great potential for finding out active plants for wound 
healing brings us the interest for investigating some skin-active TCM plants for wound 
healing. With modern cell-based functional assays, the TCM plants had to be screened 
for the function of wound healing, and followed by phytochemical analyses of the active 
compounds. With all these thoughts, the research: Bioassays guided Research on Skin-
active Plants in Traditional Chinese Medicine has started and the aims of this research 
are: 
1. To pick out all the recorded skin-active TCM plants from Pharmacopeia of 
People's Republic of China and to sort them according to the classification of skin 
disorders and wound healing. 
2. To perform a systematic literature survey of selected TCM wound healing plants, 
in order to select the ones which have not been not fully investigated both 
functionally and structurally.  
3. To screen the selected plants by bio-assays on skin cells to prove the skin-active 
effect and to identify a potential plant for further investigations. 
4. To perform phytochemical investigations by bioassay guided fractionation, and 
some single compounds are expected to be isolated and identified.  
5. To review and evaluate the bio-assay guided testing system for the wound 
healing investigations of TCM plants 
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2 Materials and methods 
2.1 Materials 
2.1.1 Plant materials 
Angelicae sinensis radix 
Chinese name: Dang Gui, plant species: Angelica sinensis (Oliv.) Diels, family: Apiaceae. 
The herb material (100 g) was purchased from CHINA MEDICA GmbH, D-83684 
Tegernsee, batch No.: 780019. Identification has been done both in P. R. China and in 
Germany according to the PPRC2000/2005, Arzneibuch der Chinesischen Medizin (ACM, 
10/2001) and Zhongguo yixue kexueyuan yaowu yanjiusuo (ZYZ I/417). The plant 
material has been dried and stored under dry condition. No additional processing has 
been performed.  
Archyranthis bidentatae rhizoma 
Chinese name: Niu Xi, plant species: Achyranthes bidentata Bl., family: Amaranthoceae. 
The herb material was purchased from Caesar & Loretz GmbH, D-40721 Hilden, 
Germany, Art. No.: 40050-100g, batch No.:50269428. Identification has been done both 
in P. R. China and in Germany according to the PPRC 2000, Arzneibuch der Chinesischen 
Medizin (ACM. 10/2001), Zhongguo yixue kexueyuan yaowu yanjiusuo (ZYZ I/121) and 
Zhongyao jiandingxue (JDX 55). The harvest place was Henan Province in P. R. China. 
The plant material has been dried and stored under dry and ventilative conditions. No 
additional processing has been performed. 
 Cimicifugae rhizoma 
Chinese name: Sheng Ma, plant species: Cimicifuga foetida L., family: Ranunuculaceae. 
The herb material was purchased from Caesar & Loretz GmbH, D-40721 Hilden, 
Germany, Art. No.: 41040-100g, batch No.: 5027145. Identification has been done both 
in P. R. China and in Germany according to the PPRC 2000. The harvest place was Hebei 
Province in P. R. China. The plant material has been dried and stored under dry and 
ventilative conditions. No additional processing has been performed. 
Corydalis rhizoma 
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Chinese name: Yan Hu Suo, plant species: Corydalis yanhusuo W.T. Wang, family: 
Papaveraceae. The herb material was purchased from Caesar & Loretz GmbH, D-40721 
Hilden, Germany, Art. No.: 41280-100g, batch No.: 50811239. Identification has been 
done both in P. R. China and in Germany according to the PPRC 2000, Pharmacopoeia of 
Chinese medicine (ACM, 10/2001, german language), Zhongyaozhi yixue kexue 
kexuanyuan yaowu yanjiusuo (ZYZ I/6), Zhongyao jiandingxue (JDX 94) and the 
Pharmacopoeia of Japan (PJ86, 1183). The harvest place was Zhejiang Province in P. R. 
China. The plant material has been produced with vinegar processing (vinegar was 
added to this plant material until it was all absorbed) and stored under dry and 
ventilative conditions.  
Gardeniae fructus 
Chinese name: Zhi Zi, plant species: Gardeniae jasminoides Ellis, family: Rubiaceae. This 
herb material was purchased from Caesar & Loretz GmbH, D-40721 Hilden, Germany, 
Art. Nr.: 41820-100 g, batch No.:50351408. Identification has been done both in P. R. 
China and in Germany according to the PPRC 2000. The harvest place was Guangxi 
Province in P. R. China. The plant material has been dried and stored under dry and 
ventilative conditions. No additional processing has been performed. 
Houttuyniae herba 
Chinese name: Yu Xing Cao, plant species: Houttuynia cordata Thunb., family: 
Saururaceae. The herb material was purchased from Caesar & Loretz GmbH, D-40721 
Hilden, Germany, Art. No.: 42090-100g, batch No.: 50185265. Identification has been 
done both in P. R. China and in Germany according to the PPRC 2000. The harvest place 
was Zhejiang province in P. R. China. The plant material has been dried and stored under 
dry condition. No additional processing has been performed. 
Lonicerae japonicae caulis 
Chinese name: Ren Dong Teng, Plant species: Lonicera japonica Thunb., family: 
Caprifoliaceae. The herb material was purchased from Caesar & Loretz GmbH, D-40721 
Hilden, Germany, Art. No.: 42370-100g, batch No.: 50816038. Identification has been 
done both in P. R. China and in Germany according to the PPRC 2000. The harvest place 
was Hunan Province in P. R. China. The plant material has been dried and stored under 
dry and ventilative conditions. No additional processing has been performed. 
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Lonicerae japonicae flos 
Chinese name: Jin Yin Hua, plant species: Lonicera japonica Thunb., family: 
Caprifoliaceae. The herb material was purchased firstly from CHINA MEDICA GmbH, D-
83684 Tegernsee, Germany, batch No.: 780681. Identification has been done both in P. R. 
China and in Germany according to the PPRC 2000. This plant material has been dried 
and no additional processing has been done.  Then the big amount material was ordered 
from Caesar & Loretz GmbH, D-40721 Hilden, Art. No.: 42380, batch No.: 81995099. 
Identification has been done both in P. R. China and in Germany according to the PPRC 
2000/2005, Pharmacopeia of Chinese medicine (ACM, 10/2001, german language), 
Nihon Yakkyokuhogai Shoyaku Kikakushu (NIJ 16) and Zhongyao jiandingxue (JDX 351). 
The harvest place was Henan Province in P. R. China. The plant material has been dried 
and stored under dry and ventilative conditions. No additional processing has been 
performed.  
Moutan cortex 
Chinese name: Mu Dan Pi, plant species: Peaonia suffruticosa Andr., family: 
Ranunculaceae. This herb material was purchased from Caesar & Loretz GmbH, D-40721 
Hilden, Germany, 100 g material purchase. Art. No.: 42710, batch No.:50247249, 1kg 
material purchase: Art. No.: 42710-1kg, batch No.: 05024701. Identification of the two 
batches has been done both in P. R. China and in Germany according to the PPRC 2000 
and Pharmacopoeia of Chinese medicine (ACM, 10/2001, german edition). The harvest 
place was Anhui Province in P. R. China. The plant material has been dried and stored 
under dry and ventilative conditions. No additional processing has been performed. 
Notoginseng radix et rhizoma 
Chinese name: San Qi, plant species: Panax notoginseng (Burk.) F. H., family: Araliaceae. 
This herb material (100 g) was purchased from CHINA MEDICA GmbH, D-83684 
Tegernsee, Germany, batch No.: 751115. Identification has been done both in China and 
also in Germany according to the PPRC 2000/2005, Pharmacopoeia of Chinese medicine 
(ACM, 10/2001, german edition), Zhongyaozhi (ZYZ I/11) and Zhongyao jiandingxue 
(JDX 126). The plant material has been dried and stored under dry condition. No 
additional processing has been performed.  
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Paeoniae rubrae radix 
Chinese name: Chi Shao, plant species: Paeonia veitchii Lynch, family: Ranunculaceae. 
The herb material was purchased from Caesar & Loretz GmbH, D-40721 Hilden, 
Germany, Art. No.: 42950-100g, Batch No.:50578507. Identification has been done both 
in P. R. China and in Germany according to the PPRC 2000. The harvest place was 
Sichuan Province in P. R. China. The plant material has been dried and stored under dry 
and ventilative conditions. No additional processing has been performed. 
Rehmanniae radix 
Chinese name: Di Huang, plant species: Rehmannia glutinosa Libosch., family: 
Scrophulariaceae. The herb material was purchased from Caesar & Loretz GmbH, D-
40721 Hilden, Germany, Art. No.: 43530-100g, batch No.: 50582386. Identification has 
been done both in P. R. China and in Germany according to the PPRC 2000. The harvest 
place was Henan Province in P. R. China. The plant material has been dried and stored 
under dry condition. No additional processing has been performed.  
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2.1.2 Chemical materials and equipments 
2.1.2.1 General solvents and chemicals  
Solvents and chemicals Manufacturers 
Methanol, ethyl acetate, acetone 
(analytical grade, Ph. Eur) 
VWR, Darmstadt, Germany 
Methanol (HPLC) VWR, Darmstadt 
Folin-Ciocalteu’s phenol reagent Merck, Darmstadt 
Trifluoroacetic acid (TFA) Merck, Darmstadt 
Hide powder for determination of tannic 
acid 
Slightly chromated  
Merck, Darmstadt 
(+)-Catechin, Rotichrom®~CHR Carl Roth GmbH, Karlsruhe 
 Chlorogenic acid Carl Roth GmbH, Karlsruhe   
Caffeic acid, ~97.0% (HPLC )  Fluka Chemie AG, Buchs, Switzerland 
Quercetin dihydrate, ~99% (HPLC)  Fluka Chemie AG, Buchs, Switzerland 
Hyperoside, η95%  Phytoplan GmbH, Heidelberg 
Rutin   Carl Roth GmbH, Karlsruhe 
Chloroform-D1 (degree of deuteration: 
99.8%) , methanol-D4 (degree of 
deuteration: 99.8%), acetone-D6 (degree 
of deuteration: 99.9%) 
 Merck, Darmstadt 
Pyridine GR dried  Merck, Darmstadt 
Sulfuric acid 95-97%  Merck, Darmstadt 
Hydrochloric acid fuming 37%  Merck, Darmstadt 
(-)-Epicatechin Sigma-Aldirich GmbH 
Natural product reagent A, η98%, 25 g Carl Roth GmbH, Karlsruhe 
(+)-Epicatechin from green tea, η98% 
(HPLC) 
Sigma-Aldrich, St. Louis, USA 
Ethanol Berkel AHK Alkoholhandel GmbH & Co. KG, 
Lippstadt 
 Note: ethanol used in this work is 96% (v/v).  
2.1.2.2 Laboratory equipment 
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Note: All equipments and analytic consumables are from german suppliers, if not stated 
otherwise. 
Balances  
Kern 770 Kern & Sohn, Balingen 
BL2105 Sartorius, Goettingen 
Sartorius BL 610 Sartorius, Goettingen 
 
Heating devices  
Heating mantle type U 2/2  Heraeus, Heiderberg 
Magnetic stirrer with Heating  IKA, Staufen in Breisgau 
Heating plate LHG  Harry Gestigheit, Duesseldorf 
Thermomix 1420  B. Braun, Melsungen 
  
Rotor stator fractionor  
Ultra-Turrax T25 IKA, Staufen in Breisgau 
  
Drying oven (dry box)  
Kelvitront Heraeus, Hanau 
Vacuum dryer VT 5042 EK  Heraeus, Hanau 
  
Ultrasonic bath  
Sonorex Super RK 106 Bandelin, Berlin 
  
Rotary evaporators  
Rotavapor BUECHI R-200 with heating 
bath B-490 
Buechi, Flawil, Switzerland 
Membrane pumps Vacuubrand, Wertheim 
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Mill  
Mill M20 IKA, Staufen in Breisgau 
  
pH Meter  
pH 526 WTW, Weilheim 
  
Millipore water purification system  
Simplicity 185 Millipore, Billerica, USA 
  
Freeze dryers  
Alpha 1-4  Christ, Osterode 
Alpha 1-4 LD Plus  Christ, Osterode 
 
Centrifuges  
Mikro 120 Hettich Zentrigugen, Tuttlingen  
Labofuge 400 Heraeus, Osterode 
Avanti J-E Centrifuge with Rotor JA-18 Beckman Coulter, Hamburg, USA 
Sigma 2K20 Sigma, Osterode 
  
Fraction collector  
LKB SuperFrac   Pharmacia, Uppsala, Sweden 
  
Ice maker  
Icematic F80C  Castel Mac SpA, Castelfranco Vento, Italy 
 
Camera equipment  
DMIL microscope with DFC300 FX camera  Leica, Wetzlar 
Las-1000 with Intelligent Darkbox  Fujifilm, Tokyo, Japan 
Reprostar 3  Camag, Muttenz, Switzerland 
Microscopecamera VHX-600  Keyence, Osaka, Japan 
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Media bottles  
Media bottles 100mL, 250 mL and 500 mL SCHOTT DURAN, New York, USA 
 
 
Laminar flow cabinet  
Steril GARD® The Baker Company, USA 
  
Safety benches  
Envirco Ceag Schirp Reinraumtechnik, Bork 
SterilGARD The Baker Company, Sanford, USA 
Microtiter plate readers  
Sunrise Tecan, Groedig, Austria 
EL 800 Bio Tek, Bad Friedrichshall  
 
Autoclave 
 
V-65 Systec, Wettenberg 
 
 
 
 
 
 
Cell counting equipment 
 
CASY Model TT Schaerfe-System, Reutlingen 
 
 
 
 
 
 
 
 
 
Pipettes 
 
Graduated pepettes (glass) Brand, Wertheim 
Volumetric pipettes Brand, Wertheim 
Piston-driven air displacement pipettes 
(single-channel) 
Eppendorf, Hamburg 
Piston-driven air displacement pipettes 
(multi-channel) 
Eppendorf, Hamburg & Brand, Wertheim 
Pipetting aid  
Accu-Jet Brand, Wertheim 
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Incubators  
HERACELL 150i CO2 incubator Thermo Scientific, Germany 
WTB BINDER CB150 incubator Binder GmbH,  Tuttlingen 
 
Spectrophotometer 
 
UV-vis Spectrophotometer  Thermo Fischer Scientific, Madison, USA 
UV Spectrophotometer  Novaspec®II, Amersham Pharmacia 
Biotech 
  
Liquid chromatography system  
SPOT Liquid chromatography flash Armen Instrument, Saint-Avé, France 
 
Shakers  
Yellow line OS 5 basic Sysmex Diatana AG, Hargen, Switzerland 
GFL Type 3018 Gesellschaft für Labotechnik GmbH, 
Burgwedel 
  
Electrophoresis equipment  
Mini protean II BioRad, Muenchen 
Power Pak 300 Powersupply BioRad, Muenchen 
 
2.1.2.3 Lab consumables 
Microtiter plates (F-form), 12 wells, sterile Greiner Bio-one, Frickenhausen 
Microtiter plates (F-form), 24/96 wells, 
sterile 
Sarstedt, Nuembrecht 
Petri dishes (3.5 cm and 9.6 cm), sterile Sarstedt, Nuembrecht 
Glas pasteur pipettes (15 and 20 cm) Brand, Wertheim 
Pipette tips (10, 200 and 1000 µL) Sarstedt, Nuembrecht 
Biosphere Filter Tips (100 and 100 µL) Sarstedt, Nuembrecht 
Tissue culture flasks (25 and 75 cm2), 
sterile 
Sarstedt, Nuembrecht 
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Centrifuge tubes, 15 and 50 mL, sterile Greiner Bio-one, Frickenhausen 
Half micro cuvettes (disposable, 
polystyrene), 10×10×45 mm 
Greiner Bio-one, Frickenhausen 
Syringe filter 0.2µm (15 and 28 mm), 
sterile  
Corning, USA 
Cell scrapers (25cm) Sarstedt, Nuembrecht 
Syringes (2.5, 5 and 10 mL) BD, Franklin Lakes, USA 
PVDF membranes BiotransTM, 0.2 µm pore 
size 
MP Biomedicals, Hamburg 
TLC plates, silica gel 20×20 cm Merck, Darmstadt 
Autoclave bags, 300×500mm Greiner Bio-one, Frickenhausen 
Autoclave tapes Carl Roth, Karlsruhe 
Cryotubes, 1.8 mL, sterile Nunc, Wiesbaden 
Qualitative filter paper 413 (< 20 µm) VWR International, Leuven, Franch 
HPLC vials VWR, Darmstadt 
 
2.1.2.4 Reagents, solution and kits for cell culture 
Thiazolyl blue tetrazolium bromide (MTT-
Reagent) 
AppliChem GmbH, Darmstadt 
Dimethyl sulfoxide, dried p.A. (DMSO) AppliChem GmbH, Darmstadt 
WST-1 reagent Roche, Penzberg 
RC/DC-Protein Assay BioRad Labotories GmbH, Muenchen 
Bio-Rad Protein Assay (Bradford), dye 
reagent concentrated 
Bio-Rad Labotories GmbH, Muenchen 
Fetal Bovine Serum (FBS) Invitrogen, Karlsruhe 
Chemiluminescent substrates A&B MP Biomedicals,  IIIkirche, France 
Gentamicin stock solution (10 mg/mL) PAA Laboratories GmbH, Pasching, Austria 
L-Glutamine 200 mM PAA Labotories GmbH, Pasching, Austria 
Amino Acids (100X) Non Essential PAA Labotories GmbH, Pasching, Austria 
Trypsin-EDTA (1X), 0.05%/0.02% in PBS) PAA Labotories GmbH, Pasching, Austria 
Tween®20 Carl Roth GmbH, Karlsruhe 
4’, 6-Diamidino-2-phenylindole Merck KGaA, Darmstadt 
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dihydrochloride (DAPI) 
Neutral Red AppliChem GmbH, Darmstadt 
Bovine Serum Albumin pH 7.0 PAA Labotories GmbH, Pasching, Austria 
Triton®X-100 AppliChem GmbH, Darmstadt 
Glycine (buffer substance for 
electrophoresis) 
Merck KGaA, Darmastadt 
SDS AppliChem GmbH, Darmstadt 
Penicillin/Streptomycin soltuion (1×) PAA Labotories GmbH, Pasching, Austria 
Tris (hydroxymethyl)-aminomethane Merck KGaA, Darmastadt 
EDTA disodium salt dihydrate AppliChem GmbH, Darstadt 
Trypan blue solution (0.4% in 0.81% NaCl 
and 0.06% KH2PO4) 
Fluka, Buchs, Switzerland 
Cell Proliferation Kit II (XTT), Colorimetric Roche Diagnostics GmbH, Mannheim 
Cell Proliferation ELISA (5-bromo-2’-
deoxyuridine, BrdU) Test Kit 
Roche Diagnostics GmbH, Mannheim 
Cytotoxicity Detection Kit (LDH), 
Colorimetric 
Roche Diagnostics GmbH, Mannheim 
 
2.1.2.5 Materials for cell culture 
Cells used: 
Cell type Origin 
Primary Normal human dermal fibroblasts 
(pNHDF) 
Self-isolated from fresh skin, University 
Hospital Münster 
Human adult low calcium high  
temperature keratinocytes (HaCaT- 
keratinocytes) 
from Prof. Dr. Norbert Fusenig, Germany 
Cancer Research Center (DKFZ), 
Heidelberg 
 
All media used were purchased from PAA Laboratories GmbH, Pasching, Austria; 
Exceptions are additionally noted.  
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HaCaT-Keratinocyte Medium (HM)                                        
500 mL D-MEM high glucose with L-glutamine                        
50 mL FCS 
 5 mL Non essential amino acids 
 5 mL Penicillin/Streptomycin solution or 1.5 mL Gentamicin solution 
 
 Fibroblast Medium (FM) 
 500 mL D-MEM high glucose without glutamine 
 50 mL FCS 
  5 mL Penicillin/Streptomycin solution or 1.5 mL Gentamicin solution 
 
  Normal Human Keratinocyte Medium (NHK)  
  500 mL Keratinocyte Cell Basal Medium/Quantum 286 Medium 
  500 mL MCDB Complete Medium 
 
   Cell testing media: 
   MCDB Complete Medium (Bochrom AG, Berlin) 
    500 mL MCDB basal medium 
    2.5 µL rhEGF 
    250 µL bovin insulin 
    250 µL ethanolamine 
    250 µL hydrocortisone 
    250 µL phosphoethanolamine 
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    15.5 mL L-glutamine solution (200 mg/mL) 
    Fibroblast Test Medium + Ser Ex® (FMserEx) 
    500 mL D-MEM high glucose without glutamine 
    50 mL Ser Ex® 
     5 mL L-Glutamine 
      
     Neutral red medium (fresh made) 
     Neutral red stock solution (see following) was diluted at 1: 100 in pre-warmed cell 
     test medium (serum-free). The NR medium was filtered with sterile cellulose acetate  
     membrane-filter (0.2  µm) and maintained at 37°C. It should be used within 30 min  
     after preparation and within 15 min after removed from 37°C water bath. 
     
    Buffers: 
     Cell lysis buffer in LDH test 
     10% Triton (m/v) (×100) in PBS  
      
    Phosphate Buffered Saline Buffer (PBS) 
     8 g NaCl 
     0.2 g KCl 
     1.44 g Na2HPO4 
       0.2 g KH2PO4 
     Aqua Millipore, diluted to 1 L 
     Solutions 
      NR (neutral red) stock solution 
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      0.33 g NR dye powder dissolves in 100 mL PBS, stored at RT up to 2 months 
      
     NR (neutral red) desorb solution (100mL) 
      1 mL glacial acetic acid 
      49 mL Millipore water 
      50 mL EtOH  
     
2.1.2.6 Chemical analytic equipments  
 Gas Chromatography-Mass Spectrometry (GC-MS) 
Instrument: 6890N Network GC System, Agilent Technologies, Boeblingen; Detector:  
5973 Network Mass Seletive Detector, Quadropol Mass Filter (-70 eV), Agilent 
Technologies, Boeblingen; Column: HP5-MS, i.D. 0.25 mm, film thickness 0.25 µm, length 
30 m; Software: Agilent MSD Productivity, ChemStation for GC and GC-MS systems, Data 
Analysis Application, Agilent Technologies, Boeblingen. 
Column chromatography 
Table 2.1 The used column types and the producers: 
Materials of 
stationary phases 
Manufacturers 
Materials of the 
Column 
Inner Dimension 
(cm) 
Sephadex®LH-20 Pharmacia Biotech AB, Uppsala, Sweden Glass 
24 × 3 
65 × 3 
MCI-Gel®CHP-20P 
Mitsubishi Kasei 
Corporation, Tokyo, 
Japan 
Glass 50 × 2.5 
Silica A-80G 
(Puriflash Column- 
Uptiprep 50U) 
INTERCHIM, Montluçon, 
France 
 
UHMW clear 
Polypropylene 17 × 3 
 
Note: MCI-Gel column was connected to a HPLC pump (Waters 510, HPLC). 
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Analytical High Performance Liquid Chromatography                                                                  
WatersTM 600 Controller, WatersTM  996 Photodiode Array detector, Waters 717 plus  
WatersTM 474 Scanning Fluorescence Detector; Autosampler, Waters In-Line Degasser  
AF, software: Millennium32® (3.05.01), Milford, Masachusetts, the USA; Column:   
Phenemonex® Luna 5 µm C18, 100Å, 250 × 3.00 mm, Aschaffenburg, Germany. 
 Preparative High Performance Liquid Chromatography  
 Waters Pump Control Module, Waters 515 HPLC pumps (A&B), KNAUER K2500/A4080  
UV Detector, Berlin; Waters busSAT/IN Module; Software: Empower Pro, Empower 2  
(Waters); Column:  Eurospher100, C18 RP, 7 µm, 250 × 20 mm, VDS Optilab. 
Ultra Performance Liquid Chromatography (UPLC) 
WatersTM Acquity Ultra Performance Liquid Chromatography® (UPLC), Milford, U.S.A.;  
PDA eɉ Detector, Sample Manager, Binary Solvent System; Software: Empower 2;  
Column: Acquity UPLC BEH shield RP 18 1.7 µm, 2.1 x 100 mm. 
FCPC 
Instrument: CPC Kromaton®, Kromaton Technologies, Angers, France; Pump: Knauer 
HPLC Pump; Injector: max. 10 mL, Rheodyne, Rohnert Park, the U.S.A.; Rotor: volume  
200 mL. 
NMR 
Instrument: Varian AS 400 Mercuryplus, 400 Hz, Institute for Pharmaceutical and  
Medicinal Chemistry, WWU Muenster. 
Polarimeter 
Instrument: Polarimeter 341, PERKIN ELMER, Waltham, USA 
Circular dichroism 
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Instrument: Jasco J-815 CD Spectrometer, Jasco, Tokyo, Japan; Software: Spectra  
Manager for Windows 95/NT, SpectraAnalysis Version 1.53.04, copyright@1995-2002,  
JASCO Corporation 
LC-MS 
Instrument:  UHPLC System Dionex Ultimate 3000 RS (Solvent Rack SRD-3600; Pump:  
DGP-3600; Autosampler: WPS-300 TSL; Column heater: TCC-3000 RS, Dionex:  
Sunnyvale, the U.S.A.); Column: Dionex Acclaim RSLC120, C18, 2.2×100 mm i. d., Dionex,  
Sunnyvale, the U.S.A; Injection volume: 2 µL; UV detector: DAD-3000 RS (Dionex,  
Sunnyvale, the U.S.A.); Sample injector: Bruker Apollo ESI-Quelle (Bruker, Billerica, the  
U.S.A.); Column temperature: 40°C; UV-Detector: MS-Spectrometer: Bruker micrOTOF- 
QII (Bruker, Billerica, the U.S.A.); Software: ChromPass.  
2.1.2.7 Working software 
      
 
 
 
 
 
 
 
ChemDraw, level: Ultra, Version: 12.0 ©1989-2009, Cambridge Soft.  
MestReNova, Version: 6.2.1-7569 ©2010, Mestrelab Research S. L. 
SciFinder, web version ©2011, American Chemical Society 
RefWorks ©2011, ProQuest LLC 
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2.2 Methods 
2.2.1 Definitions of skin disorders and concerning conceptions 
Definitions of following skin disorders and conceptions were defined according to 
various literatures: ulcer, skin regeneration, swelling (edema), trauma (physical and 
chemical), aphthae (oral ulcer), eczema, gastric ulcer, haemorhoids, bites, burns, 
heamatoma and sores. 
2.2.2 Literature Survey of Traditional Chinese Medicinal wound healing plants 
(Pharmacopoeia) 
First volume of Pharmacopoeia of People's Republic of China (PPRC) 2005 has been 
used as the standard reference. Over 1000 single TCM plants and Chinese patent 
medicines have been screened and the range has been condensed to 160 plants which 
may have effects during wound healing.  
For this screening, Table 2.2 was designed to clarify potential plants for wound healing 
from TCM.  
Table 2.2 TCM survey of wound healing plants: 
TCM Plant No.  
Chinese Name: 
Drug / Plant Part: 
Plant (s): 
Family: 
Types of 
Skin 
Disorders 
Bites Burns Ulcer Trauma Aphthae 
Eczema Stomach 
Eczema Itch Ulcer Pain 
If 
Effective          
Types of 
Skin 
Disorders 
Swelling 
and 
Edema 
Skin 
Regene- 
ration 
Sores Hemorr- oids 
Heama- 
toma Skin Infection 
Remarks: 
If 
Effective       
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2.2.3 Literature survey of selected TCM wound healing plants                                                       
The research of published primary literature on wound healing activity of all selected 
160 plants was performed by Scifinder® web version (American Chemical Society). 
Again, a survey table was designed (Table 2.3). 
Table 2.3 Evaluation sheet literature survey of selected TCM wound healing plants. The 
corresponding numbers of search results for each TCM plant should be filled into the 
blank. 
Plant No.____________ 
Plant Name: 
Key Words In Total Non-Patent 
Plant Name   
Plant Name, Wound Healing   
Plant Name, Skin   
Plant Name, Keratinocytes   
Plant Name, Fibroblasts   
Plant Name, Antimicrobial   
Plant Name, Inflammation   
Plant Name, Phytochemistry   
 
2.2.4. Final decision of experimental TCM plants                                                                                
After the evaluation of the literature survey and under the consideration of the 
commercial availability of selected plants, 12 species: Niu Xi (Archyranthis bidentatae 
rhizoma), Dang Gui (Angelicae sinensis radix), Sheng Ma (Cimicifugae rhizoma), Yan Hu 
Suo (Corydalis rhizoma), Zhi Zi (Gadeniae fructus), Yu Xing Cao (Houttuyniae herba), Ren 
Dong Teng (Lonicerae japonicae caulis), Jin Yin Hua (Lonicerae japonicae flos), Mu Dan Pi 
(Moutan cortex), San Qi (Notoginseng radix et rhizoma), Chi Shao (Paeoniae rubrae 
radix), Di Huang (Rehmanniae radix), were selected for the final experimental evaluation. 
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2.2.5 Preparation of fractions for in vitro screening 
Angelicae sinensis radix (Dang Gui) 
EtOH-water (6:4, v/v) extraction: 
5.0 g milled powder of ASR (Angelicae sinensis rhizoma) were added to a mixture of 150 
mL EtOH-water (6:4, v/v). performed by using rotor stator homogenizer (4 rounds, 
5min/round, 5min’s breaks were made in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the fraction (supernatant from the 
centrifugation), which still contained floating particles, was filtered again over filter 
paper (see 2.1.2.3) and the filtrate was evaporated below 40°C under reduced pressure 
to remove solvent. Finally, lyophilization was done to get the dry fraction which was 
named as fraction As. 
Archyranthis bidentatae rhizoma (Niu Xi) 
EtOH-water (6:4, v/v) extraction: 
A mixture of 100 mL from EtOH-purified water (6:4, v/v) was added to the 5.0 g of 
milled ABR and the fractionion was performed by using rotor stator homogenizer (3 
times, 5 min/time, 5 min’s breaks were made in between, after each fractioning, the 
fraction was collected and the fresh solution was added to the herbal material). The 
mixture was centrifuged for 5 min at RCF 1852 [RCF=1.12 × 10-5 × RPM2 ×radius (cm), 
RPM=3500]. Additionally, the fraction (supernatant from the centrifugation), which still 
contained floating particles, was filtered over filter paper (see 2.1.2.3) and the filtrate 
was evaporated at a temperature below 40°C under reduced pressure to remove 
solvent. Finally, lyophilization was done to obtain the dry fraction which was named as 
fraction 3. 
Purified water extraction: 
300 mL purified water were added to 5.0 g of milled ABR and the fractionion was 
performed by using rotor stator homogenizer (3 times, 5min/time, 5min’s breaks were 
made in between). The mixture was centrifuged for 5 min at RCF 1852. Additionally, the 
fraction (supernatant from the centrifugation), which still contained floating particles, 
was filtered over filter paper (see 2.1.2.3) and the filtrate was evaporated below 40°C 
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under reduced pressure to remove solvent. Finally, lyophilization was done to obtain the 
dry extract which was named as extract 2. 
 
Cimicifugae rhizoma (Sheng Ma) 
EtOH-water extraction (6:4, v/v): 
5.0 g of milled CR powder were added to a mixture of 300 mL from EtOH-purified water 
(6: 4, v/v). The extraction was performed by using rotor-stator homogenizer in an ice 
bath (4 rounds, 5 min/round, 5 min’s breaks in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant from the 
centrifugation), which still contained floating particles, was filtered over filter paper 
(see 2.1.2.3) and the filtrate was evaporated below 40°C under reduced pressure to 
remove solvent. Finally, lyophilization was performed to obtain the dry extract which 
was named as extract Ci. 
Corydalis rhizoma (Yan Hu Suo) 
EtOH-water extraction (6:4, v/v): 
100 mL of a mixture from EtOH-purified water (6:4, v/v) were added to 5.0 g of milled 
CDR. The extraction was performed by using rotor-stator homogenizer (3 rounds, 
5min/round, 5min’s breaks were made in between, after each extraction, the extract 
was collected and the fresh solution was added to the herbal material). After that, the 
mixture was centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant 
from the centrifugation), which still contained floating particles, was filtered over filter 
paper (see 2.1.2.3) and the filtrate was evaporated below 40°C under reduced pressure 
to remove solvent. Finally, lyophilization was performed to obtain the dry fraction which 
was named as extract 0. 
Purified water extraction: 
300 mL of purified water were added to 5.0 g of milled CDR powder and it was 
vigorously stirred for 3 times, 5 min/round. 5 min’s breaks in between. The supernatant 
was collected and centrifuged by 3500 RPM for 5 min. After that, the supernatant was 
filtrated over filter paper and the ethanol was removed by rotary evaporator below 40 
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°C under reduced pressure. Lyophilization was performed finally to obtain the extract 
which was named as extract 1. 
Gardeniae fructus (Zhi Zi) 
EtOH-water extraction: 
100 mL of a mixture from EtOH-purified water (1:1, v/v) was added to 5.0 g of milled GF. 
The extraction was performed by using rotor-stator homogenizer (3 rounds, 5 
min/round, 5min’s breaks were made in between, after each ectracting, the extract was 
collected and the fresh solution was added to the herbal material). After that, the 
mixture was centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant 
from the centrifugation), which still contained floating particles, was filtered over filter 
paper (see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under 
reduced pressure to remove solvent. Finally, lyophilization was performed to obtain the 
dry extract which was named as extract 4. 
Water extraction: 
300 mL of purified water were added to 5.0 g of milled GF and the extract was 
performed by using rotor-stator homogenizer (3 rounds, 5min/round, 5min’s breaks 
were made in between). After that, the mixture was centrifuged for 5 min at RCF 1852. 
Additionally, the extract (supernatant from the centrifugation), which still contained 
floating particles, was filtered over filter paper (see 2.1.2.3) and the filtrate was 
evaporated at a temperature below 40°C under reduced pressure to remove solvent. 
Finally, lyophilization was performed to obtain the dry extract which was named as 
extract 5. 
Houttuyniae herba (Yu Xing Cao) 
EtOH-water extraction: 
5.0 g of milled HH were added to 300mL of a mixture from EtOH-purified water (6: 4, 
v/v). The extraction was performed by using rotor-stator homogenizer (4 rounds, 
5min/round, 5min’s breaks were made in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant from the 
centrifugation), which still contained floating particles, was filtered over filter paper 
(see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under reduced 
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pressure to remove solvent. Finally, lyophilization was performed to obtain the dry 
extract which was named as extract Hu. 
Lonicerae japonicae caulis (Ren Dong Teng) 
EtOH-water extraction: 
5.0 g of milled PRR powder were added to 300 mL of a mixture from EtOH-purified 
water (6: 4, v/v). The extraction was performed by using rotor-stator homogenizer (4 
rounds, 5min/round, 5min’s breaks were made in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant from the 
centrifugation), which still contained floating particles, was filtered over filter paper 
(see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under reduced 
pressure to remove solvent. Finally, lyophilization was performed to obtain the dry 
extract which was named as extract Lc. 
Lonicerae japonicae flos (Jin Yin Hua) 
extracts of LJF from China Medica GmbH: 
EtOH-water extraction: 
5.0 g of milled LJF powder were added to 300 mL of a mixture from EtOH-purified water 
(6: 4, v/v).  The extraction was performed by using rotor-stator homogenizer (4 rounds, 
5min/round, 5min’s breaks were made in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant from the 
centrifugation), which still contained floating particles, was filtered over filter paper 
(see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under reduced 
pressure to remove solvent. Finally, lyophilization was performed  to obtain the dry 
extract which was named as extract 6. 
Water extraction / EtOH-water extraction (1:1, v/v) / EtOH extraction / ethyl acetate 
extraction: 
100 mL of purified water / EtOH-purified water (1:1, v/v) / EtOH / ethyl acetate were 
separately added to 5.0 g of milled powder of LJF. Each extraction was performed by 
using rotor-stator homogenizer (3 rounds, 5min/round, 5min’s breaks were made in 
between, after each extracting, the extract was collected and the fresh solution was 
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added to the herbal material). The mixtures were centrifuged for 5 min at RCF 1852. 
Additionally, the extracts (supernatants from the centrifugation), which still contained 
floating particles, were filtered over filter papers (see 2.1.2.3) and the filtrates were 
evaporated at a temperature below 40°C under reduced pressure to remove solvents. 
Finally, lyophilization was performed to obtain the dry extracts which were named as 
extract V for purified water extraction, extract S for EtOH-purified water extraction (1:1, 
v/v), extract T for EtOH extraction and extract K for ethyl acetate extraction. 
Extractions of LJF from Caesar & Loretz GmbH: 
EtOH-water (6:4, v/v) and Ethyl acetate extractions: 
100 mL of a mixture from EtOH-purified water (6:4, v/v)/ethyl acetate were added 
separately to 5.0 g of milled LJF powder. Each extraction was performed by using rotor-
stator homogenizer (3 rounds, 5 min/round, 5 min’s breaks were made in between, after 
each extracting, the extract was collected and the fresh solution was added to the herbal 
material). After that, the mixture was centrifuged for 5 min at RCF 1852. Additionally, 
the extract (supernatant from the centrifugation), which still contained floating 
particles, was filtered again over filter paper (see 2.1.2.3) and the filtrate was 
evaporated at a temperature below 40°C under reduced pressure to remove solvent. 
Finally, lyophilization was performed to obtain the dry extracts which were named as 
extract 6c for purified water-EtOH (4:6) and extract Kc for ethyl acetate. 
Purified water and purified EtOH-water (1:1, v/v) extractions: 
300 mL of purified water / purified EtOH-water (1:1, v/v) were added separately to 5.0 
g of milled LJF  and the extractions were performed by using rotor-stator homogenizer 
(3 rounds, 5 min/round, 5 min’s breaks were made in between). The mixtures were then 
centrifuged for 5 min at RCF 1852. Additionally, the extracts (supernatants from the 
centrifugation), which still contained floating particles, were filtered over filter paper 
(see 2.1.2.3) and the filtrates were evaporated at a temperature below 40°C under 
reduced pressure to remove solvents. Finally, lyophilization was performed to obtain 
the dry extracts which were named as extract Vc for purified water extract, extract Sc 
for purified water-EtOH (1:1, v/v) extract. 
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Moutan cortex (Mu Dan Pi) 
EtOH-water extraction (6:4, v/v): 
100 mL of a mixture from EtOH-purified water (6:4, v/v) were added to 5.0 g of milled 
MC and the extraction was performed by using rotor-stator homogenizer (3 rounds, 
5min/round, 5min’s breaks were made in between, after each extraction, the extract 
was collected and the fresh solution was added to the herbal material). After that, the 
mixture was centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant 
from the centrifugation), which still contained floating particles, was filtered over filter 
paper (see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under 
reduced pressure to remove solvent. Finally, lyophilization was performed to obtain the 
dry extract which was name as extract 7. 
Purified water extraction: 
300 mL of purified water were added to 5.0 g of milled MC and and the extraction was 
performed by using rotor-stator homogenizer (3 rounds, 5min/round, 5min’s breaks 
were made in between). After that, the mixture was centrifuged for 5 min at RCF 1852. 
Additionally, the extract (supernatant from the centrifugation), which still contained 
floating particles, was filtered over filter paper (see 2.1.2.3) and the filtrate was 
evaporated at a temperature below 40°C under reduced pressure to remove solvent. 
Finally, lyophilization was performed to obtain the dry extract which was name as 
extract 8. 
Notoginseng radix et rhizoma (San Qi) 
EtOH-water extraction (6: 4, v/v): 
5.1 g of  milled NRR were added to 300 mL of a  mixture from EtOH-purified water (6: 4, 
v/v). The extraction was performed by using rotor-stator homogenizer (4 times, 5 
min/round, 5 min’s breaks were made in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant from the 
centrifugation), which still contained floating particles, was filtered over filter paper 
(see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under reduced 
pressure to remove solvent. Finally, lyophilization was performed to obtain the dry 
extract which was name as extract No. 
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Paeoniae rubrae radix (Chi Shao) 
EtOH-water extraction: 
5.0 g of milled PRR were given to 300 mL of a  mixture from EtOH-purified water (6: 4, 
v/v). The extraction was performed by using rotor-stator homogenizer (4 times, 5 
min/round, 5 min’s breaks were made in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant from the 
centrifugation), which still contained floating particles, was filtered over filter paper 
(see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under reduced 
pressure to remove solvent. Finally, lyophilization was performed to obtain the dry 
extract which was name as extract Pa. 
Rehmanniae radix (Di Huang) 
EtOH-water extraction: 
5.0 g of milled RR were added to 300 mL of a mixture from EtOH-purified water (6: 4, 
v/v). and the extraction was performed by using rotor-stator homogenizer (3 rounds, 5 
min/round, 5 min’s breaks were made in between). After that, the mixture was 
centrifuged for 5 min at RCF 1852. Additionally, the extract (supernatant from the 
centrifugation), which still contained floating particles, was filtered over a filter paper 
(see 2.1.2.3) and the filtrate was evaporated at a temperature below 40°C under reduced 
pressure to remove solvent. Finally, lyophilization was performed to obtain the dry 
extract which was name as extract Re. 
2.2.6 Morphological and microscopic identification of tested TCM plants  
All selected TCM herbal drugs for in vitro cell assays have been identified 
morphologically according to the descriptions from PPRC 2005. There are also 
characteristic microscopic identifications for some herbal drugs (not to all) in PPRC 
2005. The microscopic identifications were thus performed with these herbal drugs 
according to PPRC 2005. 
Methods: Microscope camera VHX-600 was used to take microscopic images. The plants 
were milled to a fine powder prior to microscopic observation. The histological sections 
were made with chloral hydrate solution with heating. For the observation of starch, two 
drops of iodine solution were added; for the observation of lignified cell walls, the 
Materials and Methods  57 
 
 
 
phloroglucinol solution (from 1 to 2 drops) were added, then 1 drop hydrochloric acid 
was added to the histological section. 
 
2.2.7 Phytochemical methods 
2.2.7.1 Thin Layer Chromatography (TLC) 
Silica gel 60 F254 aluminum sheets (10 × 20 cm) were used as standard plates for all TLC 
separations. The developing distance was in general 8 cm and the distance from the 
bottom of the plate to sample application line was 1.5 cm.  
The volume of sample applied was normally around 5 to20 µL per spot. The sample was 
applied as a 1 cm long strip. After each time sample applying on the plate, the applied 
wet area was dried immediately with the hair drier. A filter paper at the proper size was 
moistened with mobile phase and was put sticking on the inner side of the chamber for 
the purpose of chamber saturation.  
The plate was dried by a hair dryer or heating oven and put into the fume hood, sprayed 
with relevant spray reagent (s).  Photos were taken under day light, 254 nm or 366 nm 
with Reprostar 3 (Camag, Muttenz, Switzerland).  
Mobile phase system: 
I: Ethyl acetate: formic acid: purified water = 90: 5: 5 (v/v/v);  
II: Cyclohexane: ethyl acetate= 3: 1 (v/v); 
 III: Ethyl acetate: formic acid: purified water = 9: 2: 2 (v/v/v) 
Spray reagents: 
1. Natural product reagent A: 1% (m/v) Diphenylboryloxyethylamin dissolved in 
methanol;  
2. Vanillin-HCl reagent: 1% vanillin (m/v), dissolved in MeOH, after the plate was 
sprayed with vanillin solution and dried, concentrated HCl was then sprayed onto the 
plate;  
3. FeCl3 reagent: 1% FeCl3 (m/v) was dissolved in methanol;  
4. Anisaldehyde-H2SO4 reagent: 5 mL sulphuric aicd, 0.5 mL anisaldehyde, 85 mL MeOH 
and 10 mL acetic acid mixed together;  
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5. Vanillin-H2SO4 reagent: 1% vanillin (m/v), dissolved in MeOH, after the plate was 
sprayed with vanillin solution and dried, concentrated H2SO4 was then sprayed evenly 
on the plate. 
 
2.2.7.2 Quantitative determination of tannin content 
The tannin content in plant material was determined according to the method of 
European Pharmacopoeia (Ph. Eur. 6.0, Monograph "Bestimmung des Gerbstoffgehaltes 
pflanzlicher Drogen", 2008) and Glasl, 1983.  
About 750 mg of the milled plant powder were weighed into a round bottom flask. 150 
mL of boiling purified water was added and the mixture was put into a water bath 
between 80 to 90oC for 30 min. Then it was cooled down to RT. The aqueous extract was 
transferred into a 250 mL narrow necked volumetric flask and the volume was filled up 
to 250 mL with purified water. 30 mL of the extract were centrifuged (RCF: 1852). The 
supernatant was marked as the stock solution and stored in the darkness. 5 mL of the 
stock solution were pipetted into a 25 mL volumetric flask and then diluted with 
purified water to 25 mL. It was then labeled as Total Phenol Solution (TPS). 100 mg of 
hide powder was added to 10 mL stock solution. It was shaken for 60 min and then 
filtered over filter paper. 5 mL of the filtrate were diluted with purified water to 25 mL 
and noted as Remaining Phenol Solution (RPS). 1 mL Folin-Ciocalteus-Phenol reagent 
was added both to 2 mL RPS and to 2 mL TPS into the 25 mL volumetric flasks. Then 
10.6 % (m/v) sodium carbonate fresh made solution were added to both flasks till 25 
mL and laid for 15 min. After that, both absorptions of solutions TPS and RPS were 
measured  spectrophotometrically at 691 nm against purified water as blank reference. 
The results were calculated as follows: 
Tannins [%] = (࡭்௉ௌି࡭ோ௉ௌ)×ଵହ଺ଶହଵ଴଴଴×௠  
A: Absorption value; m: the weight of the milled plant powder 
2.2.7.3 Detection of flavonoids by TLC                                                                                                  
Sample solution: 1 g of milled drug was mixed with 10 mL MeOH. The solution was 
shaken in a water bath at around 65°C for 5 min. After cooling down and filtration over 
filter paper, the sample solution was used for TLC;                                                                                                         
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Reference standards: 0.25 mg/mL hyperoside in MeOH, 0.25 mg/mL quercetin MeOH.                  
Developing distance on TLC plate: 8 cm;                                                                                               
Applying amount: 10 µL;                                                                                                                                 
Mobile phase: EtOAc: formic acid: purified water = 90: 5: 5 (v/v/v);        
Spray reagent: Natural product reagent;                                                                                               
Detection: The TLC plate was dried immediately after developed with mobile phase, 1% 
natural product reagent A (see 2.5.8.1) was sprayed on the plate. After drying of the 
plate, photos of the plate were made at 366 nm. 
2.2.7.4 Fast centrifugal partition chromatography (FCPC)                                                       
Principal of the method: Using high speed rotation of two phases which don't mix with 
each other; the extract is partitionated between the two phases. 
Extract K                                                                                                                                                                      
To optimize the solvent system for extract K (EtOAc extract of Lonicerae japonicae flos, 
China Medica GmbH), TLC of the extract was performed with different phases from the 
Arizona system (Berthod et al., 2005) or according to experience made within prior 
investigations (see table 2.1). EtOAc as mobile phase and purified water phase as 
stationary phase (1:1, v/v) were chosen. Both phases were mixed well firstly for mutual 
saturation and then kept still until both phases were clear. The two phases were 
separated. The inner part of FCPC instrument was washed with MeOH before and then 
filled up with the stationary phase (purified water phase). The FCPC ascending mode 
was turned on and the mobile phase was applied to the system. A cylinder was used to 
collect the elute from FCPC. After some stationary phase came out, the system was in a 
balance with the two phases. 1 g of extract K was dissolved in 10 mL of the mobile phase 
and was filtrated over filter paper. The filtrate was injected into the instrument and the 
automatic fraction collector was run immediately at the speed of 2 min/tube to collect 
all fractions eluting from FCPC. TLC was performed with all extracts in order to combine 
fractions with similar compositions.                                                                                                                                                        
After the isolation, the instrument was washed with MeOH in the descending mode to 
get out the stationary phase. Fractions obtained were dried and stored at -20°C.                                              
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Table 2.4 FCPC system I optimisation: The listed A to E systems were mixed. 10 mg of 
extract K were given to the different systems. The different phases were investigated by 
TLC (mobile phase: EtOAc- purified water- formic acid= 90- 5- 5; spray reagent: natural 
product reagent A). 
System I Stationary phase Mobile phase Additive (v/v) 
A Purified water 2 mL EtOAc 2 mL ------ 
B Purified water 2 mL EtOAc 2 mL 1% n-propanol 
C Purified water 2 mL EtOAc 2 mL 2% n-propanol 
D Purified water 2 mL EtOAc 2 mL 5% n-propanol 
E Purified water 2 mL EtOAc 2 mL 10% n-propanol 
 
Table 2.5 FCPC system II according to Arizona optimisation system (Berthod et al., 
2005): The listed F to J systems were mixed. 10 mg extract K were given to the different 
systems. The different phases were investigated by TLC (mobile phase: EtOAc-purified 
water- formic acid= 90- 5- 5; spray reagent: natural product reagent A). 
System II Heptane EtOAc Methanol Purified water 
F 1 19 1 19 
G 1 3 1 3 
H 1 1 1 1 
I 3 1 3 1 
J 9 1 9 1 
 
Compared with TCL results from both systems, A from system I was chosen as the 
optimal FCPC system to fractionate extract K. It was shown by TLC that one single 
compound could be fractionated by the water phase. 
Extract 9 with FCPC                                                                                                                                         
Extract 9 was the 60 % EtOH extract from defatted Moutan cortex (see 2.2.7.15). The 
same isolating solution system (EtOAc-purified water) was chosen as for extract K but 
without the previous test. For FCPC 1.0 g of extract 9 was dissolved in 7 mL purified 
water + 3 mL EtOAc. The solution was well dissolved after the ultrasonic bath. All other 
procedures were identical with the description of extract K.  
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2.2.7.5 Defatting of the plant material                                                                                                       
The plant material was extracted by Soxhlet apparatus with petroleum benzine (boiling 
point: 40-60°C) to remove lipophilic compounds. This method was performed with 
Moutan cortex.                            
Used materials: Mantle heater for 2000 mL round bottom flask; 2000 mL round bottom 
flask with zeolites inside; 1000 mL soxhlet fractionor; condenser; fraction thimble.                         
Procedure: around 400 g milled Moutan cortex was put to the fraction thimble and the 
thimble was put into the glass Soxhlet. 1500 mL petroleum benzine were added to round 
bottom flask with zeolites. The condenser was fixed onto the Soxhlet and let the cold 
water running through. The round bottom flask was heated by mantle heater. Defatting 
was performed for 40 h. The defatted plant material was dried and stored at -20°C. The 
petroleum bezine extract was named of extract PE. 
2.2.7.6 Column Chromatography (CC) 
Silica column: PF-50SI/80G, PURIFLASH COLUMN-UPTIPREP 50U SILICA -80G                                
The column was connected to SPOT Liquid Chromatography Flash (Armen Instrument, 
Saint-Avé, France). Extract K (EtOAc extract from Lonicerae japonicae flos) was 
fractionated using this chromatographic system. The column was washed with MeOH at 
10 mL/min for 30 min. Then it was conditioned with hexane 30 min for the initial 
condition. 
Table 2.6 Gradient system for fractionation of extract K on flash chromatography: 
Time (min) Mobile phases 
0-30 Gradient linear from Hexane 100 % to EtOAc 100 % 
31-60 Gradient lienear from EtOAc 100 % to MeOH 100 % 
61-90 MeOH 100 % 
                                                                                                                                                                                        
3.8 g of extract K were dissolved in 20 mL hexane as sample solution. Sample solution 
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was applied to the column system for two runs (10 mL each run, 190 mg/mL). The flow 
rate was 10 mL/min. The fractions were collected by automatic fraction collector at the 
speed of 1 min/tube. Fractions were detected by TLC with natural product reagent A 
solution (detected at 366 nm). Fractions with similar compositions were combined. 
Combined fractions were concentrated with rotary evaporators at 36°C and lyophilized. 
The column was then washed with 20 % MeOH (in Aqua Millipore) for 30 min, the 
solution was collected and detected by TLC. At the end, the column washed with MeOH 
for 30 min. 
Sephadex® LH-20 column chromatography                                                                                            
Sephadex® LH-20 can be used both for isolation of lipophilic and hydrophilic 
compounds. Extracts 10 and 12 from Moutan Cortex were fractionated using this 
stationary material. 
Fractionation of fraction 10 (EtOAc phase extract from defatted Moutan cortex) 
Column size: 65 cm × 3 cm (see 2.1.2.6); Mobile phases: linear gradient from EtOH (96 %) 
to MeOH (100 %), then to 70 % Acetone (in Aqua Millipore). The column was washed 
and conditioned with EtOH (96 %). 6 g of fraction 10 were dissolved in 15 mL of a 
mixture of 13 mL EtOH and 2 mL MeOH and the mixture was applied to the column. The 
fraction collector was set to 15 min/tube and the flow rate was around 16.5 mL/ 15 min. 
EtOH was firstly used to elute the column. Then MeOH was used as mobile phase and at 
the end the mixture of acetone-water (7:3, v/v) was used. Both MeOH and acetone 
fractions were collected batchwise directly with round bottom flasks instead of using 
fraction collector. The column was reconditioned with MeOH. All EtOH fractions were 
investigated by TLC (mobile phase: EtOAc: purified water: formic acid= 90: 5: 5; spray 
reagent: vanillin-HCl reagent, FeCl3 reagent), fractions with similar compositions were 
combined together, concentrated by use of  rotary evaporator  at  temperature < 40°C 
and stored at -20°C. Also the fractions from MeOH and acetone-water (7:3, v/v) were 
concentrated by a rotary evaporator at temperature <40°C and lyophilized.                                                                                                                             
Column size: 24 × 3 cm (see 2.1.2.6); mobile phase: EtOH / MeOH / acetone-water (7:3, 
v/v, Aqua Millipore); The column was preconditioned with EtOH. 1.5 g of fraction 10 
were dissolved in 6 mL of a mixture of 5 mL EtOH and 1 mL MeOH and the mixture was 
applied to the column. EtOH was firstly used as mobile phase to elute the column. Then 
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MeOH was used as mobile phase and at the end acetone-water (7:3, v/v) was used. The 
three fractions were concentrated by use of a rotary evaporator and then lyophilized. 
The column was reconditioned with MeOH.  
Fractionation of fraction 12 
Column size: 24 × 3 cm (see 2.1.2.6); mobile phase:  MeOH-water (1:1, v/v) / acetone-
water (7:3, v/v). The column was firstly washed by 100 % MeOH and then conditioned 
by the mixture of MeOH-water (1:1, v/v). 1.4 g of fraction 12 were dissolved in 3 mL of 
Auqa Millipore and were applied to the column. A mixture of MeOH-water (1:1, v/v) was 
used as mobile phase to elute the column. After that a mixture of acetone-water (7:3, v/v) 
was used as mobile phase to the column. Both fractions were collected and concentrated 
by using a rotary evaporator at temperature < 40°C, lyophilized and stored at -20°C. The 
Sephadex® LH-20 column was reconditioned with 100 % MeOH in the end.                                                                                                                                       
MCI gel® CHP-20P column   
The subfractions 10C, 10D, 10E, 10F, 10G, 10I, 10J, 10K from EtOH fraction of fraction 10 
were further fractionated by MCI gel® column. A mobile phase gradient was used for 
elution of the column:  gradient linear of MeOH-water (1:4, v/v) to MeOH-water (7:3, 
v/v).                                                                                 
The MCI® gel column was preconditioned with MeOH-water (1:4, v/v). For gradient 
formation, two connected beakers were used. 1 L of a mixture of MeOH-water (1:4, v/v) 
and 1 L of a mixture of MeOH (7:3) were added to the beakers at the same time and 
magnetic stir bars were used in both beakers for mixing. The solution was pumped from 
beaker contained mixture of MeOH-water (1:4, v/v) to the column. The flow rate of the 
column: 2 mL/min. The collecting time for each tube of automatic fraction collector was 
set for 10-15 mL elute per tube. All fractions were investigated by TLC (mobile phase: 
EtOAc: purified water: formic acid= 90: 5: 5; spray reagent: vanillin-HCl reagent, FeCl3 
reagent) and fractions which had similar TLC compositions were combined together and 
concentrated by rotary evaporator  (< 40°C) and stored at -20°C.  
2.2.7.7 High Performance Liquid Chromatography (HPLC) 
Analytical HPLC                                                                                                                                           
Analytical HPLC was used to analyze the purity of fractions or isolated substances.  
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The subfractions 10B to 10K and also the subsequently obtained compounds and 
fractions were analyzed by HPLC.                                                                                                                                                  
The instrument: WatersTM600 Controller, WatersTM996 Photodiode Array Detector 
(waters, Milford, USA), WatersTM 474 Scanning Fluorescence Detector; stationary phase 
column: Luna® 5u C18(2) 100 Å, 5 µm, 250 × 3.00 mm; samples were dissolved in MeOH 
(HPLC quality); column temperature: 40°C; injection volume: 10 µL; flow rate: 0.5 
mL/min; software: Millennium32 Version 3.05.01(Waters, Milford, USA). Mobile phase 
system is shown in Table 2.7.          
Table 2.7 Gradient systems for HPLC mobile phase. 
Time (min) MeOH (%) 
TFA in Aqua millipore 
(0.1 %) 
0 5 95 
45 95 5 
50 95 5 
60 5 95 
65 5 95 
 
The HPLC system was washed prior analysis without the column by MeOH and was 
purged to make sure there was no air inside. When the pressure of the system was 
stable, the column was connected to the system and washed with MeOH. After that, the 
column was preconditioned through the initial condition of the binary flow system. The 
HPLC column was washed again after all runs with MeOH and was then properly 
restored. 
Preparative HPLC 
The Sephadex® LH-20 fractions from fraction 10: 10D2, 10E, 10F1, 10F2 and 101 were 
further fractionated by preparative HPLC. Analytical HPLC was done with all fractions 
before the isolation with preparative HPLC.                                                                                                                        
All instruments except the controlling computer were turned on. Both HPLC pumps 
were set as Mode REM. Detector was calibrated by 'Auto Zero' before each round.  
Software: Empower.  Mobile phase: gradient of MeOH and Aqua Millipore. Stationary 
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phase: Eurospher® 100, C18, 7 µm, 250 × 20 mm (VDS Optilab). All samples were 
dissolved in MeOH at a maximal concentration of 15 mg/ mL. Flow rate: 3 to 7 mL/min. 
The column was always preconditioned and reconditioned after the use.  The sample 
injector was washed every time before the sample applied to the column.  
2.2.7.8 UPLC 
Instruments please see 2.1.2.6. Run parameters: column temperature: 45°C; sample 
temperature: 25°C; binary solvent system: A = TFA (0.1%) in Aqua Millipore, B = MeOH; 
sample concentration: 1 mg/mL; UPLC gradient program is shown below. 
Table 2.8: UPLC gradient program 
Time (min) 
Flow rate 
(mL/min) 
TFA (1%) in 
Aqua Millipore 
MeOH 
0 0.145 90 10 
0.10 0.145 90 10 
0.50 0.145 80 20 
6.40 0.145 55 45 
7.90 0.145 40 60 
8.90 0.145 90 10 
15.00 0.145 90 10 
 
2.2.7.9 Gas chromatography-mass spectrometry (GC-MS) 
Instrument for GC-MS see 2.1.2.6. GC parameters:  oven (linear temperature, gradient): 
initial temperature: 100°C, end temperature: 320°C, run time: 58.33 min; sample 
injection volume: 1 µL; sample concentration: 1 mg/mL; split ratio: 10:1; flow: 1 
mL/min. Carrier gas: Helium.                                                                
MS parameters: fragmenting mode: EI; Ionization energy: -70 eV; detection: Quadrupol-
Massfilter; data evaluation: NIST data base. Samples (fraction PE and crystals from PE) 
were dissolved in 1 mg/mL (fraction PE in petroleum benzine, crystals in hexane).                                                                                                                              
2.2.7.10 Liquid chromatography-mass spectrometry (LC-MS) 
Instruments please see 2.1.2.6.  
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Method 1 (for fraction 10C1, 10 and 10J1): sample preparation: 1 mg/mL in MeOH; 
+ESI-MS/MS short method for HPLC-MS: Nebulizer gas, dry gas and collision gas: 
nitrogen; Mass Range: 50-3000 m/z; Ion polarity: positive; sampling rate: 5 Hz = 1000 
summations/spectrum; Capillary voltage: 4500 V; end plate offset : -500 V; nebulizer 
pressure: 5 bar; dry gas flow: 9.0 L/min; dry gas heater: 220°C; Ion energy: 3.0 eV; Low 
mass: 100 m/z; Auto-MS/MS range: 50-3000 m/z; HPLC method: autosampler 
temperature: 10°C; column oven temperature: 40°C; sample concentration: 1 mg/mL in 
MeOH; sample injection volume: 2 µL; flowing system: A = formic acid (0.1%) in Aqua 
Millipore, B = 0.1% formic acid in acetonitrile; gradient program see Table 2.9. 
Method 2 [for the comparision between Lonicerae japonicae flos purchased from China 
Medica GmbH and Caesar& Loretz GmbH (3.6.6)]: sample preparation: 50 mg/mL in 
MeOH-water (6:4); nebulizer gas, dry gas andcollision gas: nitrogen; mass range: 50-
3000 m/z; ion polarity: positive; sampling rate: 2 Hz = 2500summations/spectrum. 
Source parameter: capillary voltage: 4500V; endplate offset: -500V; nebulizer pressure: 
4.0 bar; dry gas flow: 9.0 L/min; dry gas heater: 200°C. Ion energy: 3.0 eV; low mass: 
100.00 m/z; Transfer time: 70.0 µs; prepulse storage time: 5.0 µs; auto-MS/MS range: 
50-3000 m/z; calibration mode: HPC (High Precision Calibration); Calibrant: 10 mM 
natriumformiat in 50% isopropanol. HPLC method: autosampler temperature: 10°C; 
column temperature: 40°C; sample injection volume: 2 µL; flowing rage: 0.4 mL/min; ǣʹǤͳέͳͲͲǡʹǤʹɊǡ
͵έͷͳͺǡͳǤͺɊǢgradient 
program see Table 2.9. 
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Table 2.9 Gradient program for LC-MS: A is formic acid (0.1%) in Aqua Millipore; B is 
formic acid (0.1%) in acetonitrile.  
Time (min) Flow rate (mL/min) 
A% C% Method 
1 
Method 
2 
Method 
1 
Method2 
0 0 0.8 0.4 95 5 
9.5 5.0 0.8 0.4 0 100 
12.5 37.0 0.8 0.4 0 100 
12.6 47.0 0.8 0.4 95 5 
15.0 48.0 0.8 0.4 95 5 
-- 55 -- 0.4 95 5 
 
2.2.7.11 Peracetylation of proanthocyanidins 
The selected fraction for peracetylation was put into a small round bottom flask. 1 mL of 
pyridine and 1 mL acetic anhydride were added and the mixture was kept at RT for 24 
hours avoiding any light. After that, Aqua Millipore at 0°C was added to the mixture, 
resulting in immediate precipitations. The flask was kept in an ice bath over night. Then 
the mixture was filtered through a glass sintered filter P4 and Aqua Millipore at 0°C was 
used to wash the filter until no more pyridine could be smelled. The filtrate was 
discarded and acetone was used to wash out the acetylated fraction. Solvents were 
removed by rotary evaporator and the material obtained was put to vacuum drying oven 
over night to obtain the dry peracetylated fraction. 
2.2.7.12 NMR 
Samples were measured by 1H- and 13C-NMR. Samples were dried and stored in the 
vacuum drying oven at least for 12 hours. Suitable NMR solvents as chloroform-D1, 
methanol-D4 and acetone-D6 were used to dissolve the samples. The solution was 
centrifuged and the clarified solution was given to NMR tube till the length of the 
solution reached 5 cm. The samples were measured on Varian AS 400 Mercuryplus 
spectrometer in the Institute for Pharmaceutical and Medicinal Chemistry, WWU ǡ
ǤȋɁȌignals were measured without inner 
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reference (TMS etc.) in ppm and coupling constants (J) in Hz. For the respective chemical 
shifts of NMR solvents see Table 2.10. 
Table 2.10 Typical chemical shifts of NMR solvents and the use of solvents for analyzing 
natural compounds. 
NMR solvents 
Chemical shifts (1H/13C-
NMR) 
Substance classes 
Methanol-D4 ɁͶǤͺ7 ȀɁͶͻ.16 Phenolic substances 
Chloroform-D1 Ɂ͹Ǥʹ͸Ȁ- Acetylated(oligomeric/polymeric) proanthocyanidins 
Acetone-D6 Ɂ2.05 / - Polymeric proanthocyanidins 
 
2.2.7.13 Polarimetry                                                                                                                                            
A minimum of 2 mg substance were dissolved in MeOH (HPLC). Measurement 
conditions: wavelength: sodium D-line (589 nm); temperature: 20.0 °C. The 
measurements were performed for 20 times to obtain the average values. The degree of 
the optical rotation was then calculated by the following formula (Hart, H. et al. 1999): 
[ߙ] 20ܦ = ߙܿ × ݈ ȽαǢα concentration (g/mL); l = length of the cuvette (dm) 
2.2.7.14 Circular dichroism (CD) 
Circular dichroism refers to the differential absorption of left and right circularly 
polarized light. It is used for studying the stereochemical information of small organic 
molecules (Atkins et al., 2005). The isolated substances were dissolved in HPLC-quality 
MeOH to the exact concentration of 0.1 mg/mL. Each solution was measured in a 0.1 cm 
cuvette by Jasco J-815 CD Spectrometer (Jasco, Tokyo, Japan) at the wavelength of 200 
to 300 nm. The blank control only with MeOH in cuvette was also measured at the same 
conditions. The final sample spectrums were obtained by substraction of the blank 
control spectrum. 
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2.2.7.15 Extraction and fractionation of Moutan cortex 
Extract 9 
5 L of EtOH-water (6:4, v/v) and 1 kg of defatted MC were mixed and were put into one 
big glass bottle sealed. The bottle was fixed on a shaker and fractioned for 18 h at the 
speed of 120 round/min. After the supernatant was taken, another 5 L of EtOH-water 
(6:4, v/v) were added to the herbal material and the extraction was repeated. The 
fractions of two times were combined and centrifuged at RCF 1852 for 5 min. Then 
filtration was performed with filter paper to clear the extract completely. After EtOH 
removal and lyophilization, extract was obtained and named as extract 9. 
Fraction 10 and fraction 12 
Ethyl acetate and water were used as two phases for fractionation. 2.0 L of each solvent 
were pre-mixed and saturated. They were then separated from each other. 50.0 g of 
extract 9 were mixed with 300 mL of water phase. 300 mL of EtOAc phase were then 
added to the water phase and the mixture was shaked by hand violently for 5 min. EtOAc 
phase was collected and another 300 mL of EtOAc phase were added. The same 
fractionation procedure was repeated 4 times. In total, 50.0 g of extract 9 were 
fractionated by 300 mL of water phase with 1500 mL of EtOAc phase. Two phases were 
combined separately and filtered with filter paper. The EtOAc phase fraction was named 
as fraction 10 and the water phase fraction was named as fraction 12. 
2.2.8 Cell culture and in vitro testing methods 
2.2.8.1 Cell culture methods 
2.2.8.1.1 Isolation of primary normal human dermal fibroblasts (pNHDF) 
Human skin was gained from dermatology department of university clinic Münster. The 
isolation method was according to the method from Deters et al. (2005). 2 Petri dishes 
(9.6 cm) were filled with 20 mL of fibroblast growth media (FM) each. 50 µL 
gentamincin solution were added to one Petri dish (dish 1), 100 µL were added to the 
other one (dish 2). The fresh skin was put into a new Petri dish (9.6 cm) and it was fixed 
and cut into small pieces with sterile tweezers and knife. The pieces were put into dish 1 
for ca. 2 min. After that, they were taken out to a new Petri dish and cut into smaller 
pieces. The pieces were put to dish 2 and washed for ca. 2 min. Then the skin pieces 
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were transferred to a 3.5 cm Petri dish with the epidermal side was upwards. The rest 
media was cleared and dispase was pipetted into the Petri dish till the skin pieces were 
covered. The Petri dish was stored at 4°C over night. After this incubation, the epidermis 
was removed from the skin by using the tweezers. The dermis pieces were put to tissue 
culture flasks (25 cm3), 5-6 pieces per flask. 3 mL of FM were added to each flask and all 
flasks were put into the incubator. The media was changed every 3 days. Microscopic 
observations were done regularly until the fibroblasts started to grow on the bottom of 
the flasks. Then the dermis pieces were discarded and the zero passage fibroblasts were 
incubated for the further usage. 
2.2.8.1.2 Basic culture of primary normal human dermal fibroblasts (pNHDF) 
Primary normal human dermal fibroblasts (pNHDF) were incubated at 37°C under 5 % 
CO2 at 95% humidity. Normal fibroblasts growing media: FM, the test media: FM + SerEx 
®. Proper numbers of cells were seeded into the 75 cm2 tissue culture flask. FM was 
changed twice a week. When the cell confluence got to 80%, cell passage was done to 
continue the growing of the cells. The first 3 passages have not been used for any tests. 
2.2.8.1.3 Basic culture of HaCaT cells 
HaCaT cells were cultured in cell growth media (HM) in the incubator at 37°C under 8 % 
CO2 at 95 % humidity. For functional testing, the media was changed to MCDB and the 
cells were shifted to the cultural conditions at 37 °C under 5 % CO2 at 95 % humidity. 
The HM medium was changed twice a week and when the confluence of cells got to 80%, 
cells were passaged.  
2.2.8.1.4 Cell passage and CASY cell counting 
Both HaCaT and pNHDF were passaged when the confluence got to 80 %. The 
procedures were similar and are described as following. The cells were cultured inside 
tissue culture flasks (75 cm2) with 10 mL growing media. The media were removed and 
PBS was used to rinse the rest media and were removed, too. 5 mL trypsin (1×) was 
added to the cells and the flask was put into the incubator at 37°C to digest the 
connection between cells and the bottom of the flask (HaCaT: ca. 10 min, pNHDF: 3 to 5 
min). When most cells floated in the media (observed under the microscope), the 
digestion from trypsin was stopped with 3 mL of cell growth media. Cells were mixed 
well in media with glass pipette and were removed to a 15 mL sterile centrifuge tube. 
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The cells were centrifuged (HaCaT: RCF= 1852; pNHDF: RCF= 2494) for 5 min. The rest 
of the media was discarded and the cell pellet was dispersed with 3-5 mL cell growth 
media. 10 µL or 100 µL (according to the different program used) of the well-mixed 
media was taken and was given to the 10 mL casyton solution and the solution was 
measured with correlative program by CASY. The number of living cells was read and 
according to the willing seed-cell number, the volume of the needed medium (with cells 
inside) was calculated and was in the end dispensed in the big tissue flask with 10 mL 
cell culture medium. The new passage number, date and cell type were written down 
and the flask was put into the incubator for further incubation. 
2.2.8.1.5 Freezing and thawing cells 
Freezing cells  
Freezing media: culture media plus 10 % DMSO, total volume: < 1.8 mL; cells were 
trypsinized and suspended in fresh culture medium. 10 % (v/v) DMSO was added and 
the well-mixed medium was transferred to a cell freeze tube (2 mL). The freeze tube was 
put to -80°C over night and then put to liquid nitrogen for long term storage. 
Thawing cells 
The frozen cells were thawed immediately after taken out from liquid nitrogen in the 
laminar flow at 37°C. Then the cells were transferred to a 75 cm2 tissue culture flask and 
diluted with 10 mL pre-warmed culture medium. The flask was put into the incubator 
immediately and was incubated over night. The cells would attach to the bottom of the 
flask on the second day. Old medium would then be replaced with fresh culture medium.  
2.2.8.2 Cell testing methods 
2.2.8.2.1 DAPI test 
No mycoplasm contamination is a pre-condition for cell culture and tests. DAPI tests 
(Grossgebauer et al., 1977) were regularly done to make sure the cleaness of the cell lab. 
pNHDF (in FM) were seeded to 24-well-plate which had one round cover glass in each 
well at different concentrations: 2.5 × 103 / well, 5 × 103/well, 1 × 104/well, 1.5 × 
104/well, 2 × 104/well. The plate was incubated till the cells grew firmly on the cover 
glass. The FM medium was discarded and 400 µL/well -20°C methanol was added to 
wells. The plate was put to 4°C for 10 min to fix the cells. DAPI solution was diluted with 
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1: 1000 in PBS/BSA [2% bovine serum albumin (m/v) in PBS] buffer.  Methanol was 
removed and 400 µL/ well DAPI staining solution was given to all wells staining for 45 
min at 4°C. DAPI staining solution was pipetted away and all wells were washed with 
PBS/BSA for 3 times, then they were washed 2 times with 4°C sterile Aqua Millipore. 
The round cover glasses were taken out and dried carefully on a absorbent paper. After 
that, the cover glasses were glued by nail polish oil onto the microscope slides with cells-
side upwards. 2 drops 2.5% Dabco solution (DakoCytomation) was dropped onto the 
round cover glasses to embed the section. The new cover glasses were put onto the 
round cover glasses with cells (avoid air bubbles). The sides of edge of the cover glasses 
were fixed with nail polish oil and the finished DAPI microscope sample slides were put 
to 4°C to store. The observation has been done by doctoral student Andrea Derksen in 
the institute of virology, University of Muenster. 
2.2.8.2.2. Preparation of plant fractions for subsequent in vitro testing 
PE fraction: PE fraction was dissolved in Aqua Millipore at 1 mg / mL. The fraction was 
put to ultrasonic bath for 15 min to get the mostly dissolved. The solution was filtrated 
with sterile cellulose acetate membrane-filter (0.2 µm) and the clear filtrate was used 
for further cell tests. 
Other plant fractions / substances: all fractions were dissolved in the correlative pre-
warmed (37°C) test media and diluted to 1 mg / mL. The solutions were then filtered 
with sterile cellulose acetate membrane-filter (0.2 µm) and the filtrates were used for 
further cell tests. All samples for cell testing were made fresh before the tests. 
2.2.8.2.3 Incubation of cells with test samples 
The cells were trypsinized and seeded at proper concentration into 96-well plate with 
culturing medium (100 µL/well). The plate was incubated for 24 hours to make sure the 
cells were attached to the bottom of the plate. Then the culture medium was replaced 
with testing medium (100 µL/well), which contained no serum in order to reduce 
growing speed of the cells (starving the cells). The plate was again incubated for at least 
24 hours. When the confluence of the cells got to 60 %, the test samples were diluted 
with test medium to designed concentrations such as 0.1 µg/mL , 1 µg/mL, 10 µg/mL etc. 
As soon as the cells were fed with the test plant samples media with different 
concentrations, 96-well plates, both with HaCaT cells and pNHDF, were put into the 
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incubator at 37°C under 5 % CO2 at 95 % humidity for 3 days. For each plate, there were 
always one line only with cell test medium was untreated control and one line with FBS 
(5 % FBS for HaCaT and 1 % FBS for fibroblasts) as positive control. Cell tests were 
performed after the respective incubation time. 
2.2.8.2 MTT assay  
MTT test was performed according to the method from Mosmann (1983). MTT (3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) reagent was dissolved in PBS 
at the concentration of 2.5 mg/mL and the solution was filtered over a sterile filter (0.2 
µm). After the incubation of cells with test sample, the culture media were removed and 
cells were washed once with PBS (100 µL/well). MTT solution (50 µL/well) was added 
to the 96-well plate and the plate was further incubated for at least 3 hours. The MTT 
solution was removed. The plate was knocked on some absorbent papers on the desk to 
remove the MTT solution completely. At the end, DMSO (50 µL/well) was added to each 
well and the plate was shaken for a while to get the reaction complete. The absorbance 
of the color in each well was measured by microtiter plate reader at MTT mode: ɉ595 
nm against reference wavelength ɉ 690 nm. 
2.2.8.3 XTT assay 
For XTT assay (Scudiero, P.A. et al, 1988; instruction from supplier Roche), 5 mL of XTT 
labeling reagent and 50 µL electrocoupling reagent were mixed and immediately added 
to the 96-well plate which has been finished incubating with test fractions/substances 
for 50 µL/well. The plate was further incubated for 4 to 8 hours for the reaction. The 
final color absorbent was measured by microtiter plate reader at ɉ 490 nm against ɉ690 nm.  
2.2.8.4 Neutral red uptake assay 
For the Neutral red uptake assay (Kull, F.C. et al., 1981), after the cell incubation with 
samples, the respective media were removed and cells were once washed with pre-
warmed PBS 200 µL/well. Neutral red fresh made medium was added to cells 100 
µL/well and the plate was further incubated for 2 hours to allow for the uptake of the 
dye. After that, the medium was removed and cells were washed with pre-warmed PBS 
200 µL/well for 2-3 times. After the removal of the PBS, the plate was knocked slightly 
on drying paper to get dry. NR desorb solution 100 µL/well were added to the plate and 
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the plate was incubated on plate shaker at RT for 30 min. The color absorbance was read 
by microtiter plate reader ɉ595 nm against ɉ 690 nm. 
2.2.8.5 BrdU cell proliferation assay 
For BrdU cell proliferation assay (Gratzner, H.G., 1982; instruction from supplier Roche), 
the fresh made BrdU labeling solution 10 µL/well was added to the plate 2 to 24 hours 
before the end of the cell incubation with correlative test sample media in 96-well plate. 
After that, the medium was removed and the plate was able to be stored at 4°C up to one 
week. fixDenat solution 100 mL/well were added to the plate and the plate was 
incubated at RT for 30 min. The fixDenat solution was abandoned and antibody dilution 
solution (50 µL/well) mixed with Anti-BrdU-POD (monoclonal antibody from mouse-
mouse hybrid cells conjugated with peroxidase) was added to the plate for 90 min's 
incubation. The reaction solution was removed and the plate was washed 3 times with 
100 µL/well diluted Washing buffer (3 mL Washing buffer + 27 mL Aqua Millipore for 
one plate). Then Substrate component A solution (50 µL/well) was added to each well 
and the plate was incubated at RT for 5-30 min until the color could be clearly seen. To 
stop the color reaction, 1 M H2SO4 (12.5 µL/well) was added to the plate. The color 
absorbance of each well was then measured by microtiter plate reader  ɉ 450 nm 
against ɉ690 nm. 
2.2.8.6 LDH assay 
LDH assay was performed according to the method from Porstmann et al. (1985) and 
the instruction from kit supplier Roche. After the cell incubation (2 wells each 
concentration were without cells as the control wells) with test plant samples (100 
µL/well), 25 µL medium from each well were pipetted to a new 96-well plate in the 
same order. The rest of the medium was discarded. LDH cell lyse buffer (10% Triton X-
100 in PBS, m/v) 25 mL/well were added to each well of 96-well plate with cells inside. 
The two plates were put at RT for 1 to 2 hours to complete the cell lysis. 25 µL was 
added to each well of both plates and the plates were incubated at RT for 10-30 min in 
the darkness. The reaction was stopped then by adding 1 N HCl (10 µL/well) to both 
plates. EtOH (5 µL/well) was added to each well to remove all disturbing bubbles. Both 
plates were measured by plate reader ɉ 490 nm against reference ɉ 690 
nm and calculated with : 
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Cytotoxicity (%)=஺(supernatant)ି஺(௦௨௣௘௥௡௔௧௔௡௧ ௎஼)஺(௟௬௦௘ௗ)ି஺(௦௨௣௘௥௡௔௧௔௡௧ ௎஼) × 100% 
A: absorption; Supernatant: the media pippeted into the other plate after the incubation 
with test substances; Lysed: the media with lysed cells. 
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3 Results 
This chapter is written in the order according to the bio-assay guided experiments. Cell 
experiments are the guides leading to the chemical isolations and respective 
phytochemical analyses.  
3.1 Definitions of skin disorders and wound healing concerned conceptions 
TCM plants survey was performed with PPRC 2005 according to several conceptions of 
frequently happening skin disorders. Definitions of the skin disorders below were listed 
below. 
Ulcer: Ulcers are irregularly-sized and shaped excavations of the integument due to 
injury or disease (Sutton et al., 1939). 
Edema (swelling): Edema belongs to the changes of the epidermis. Intercellular edema, 
or spongiosis, is shown by widening of bridges, the result is an intraepidermal vesicle. 
Intracellular edema takes several forms. In reticulierende collaquation, vacuoles develop 
in bursting, and multiocular vesicles are formed. In ballonierte degeneration, young 
epithelial cells balloon up and become loosened one from another, so forming a vesicle. 
In alteration cavitaire, the protplasm becomes homogeneous and stainless, and 
perinuclear edema appears, which may increase till the cell ruptures, a third method of 
intraepidermal vesicle formation (Sutton et al., 1939). 
Trauma: The skin is exposed to lacerations and bruises, excoriations and bites as is no 
other organ (Sutton et al., 1939) 
Aphthae: These lesions, commonly called canker sores, are acute, circumscribed, 
inflammatory lesions which may be recurrent and which occur transiently either singly 
or in small numbers. The earliest stage is a tiny vesicle, which enlarges a little and 
becomes eroded. The resulting flat, shallow ulcer is rarely wider than a few millimeters. 
Its floor is grayish white and fibrinous, and its narrow areola is brightly inflammed. The 
lesion is soft, lacking palpable induration (Sutton et al., 1939).  
Eczema: Eczema has been a sort of dermatologic scrap heap out of which, from time to 
time, certain diseases which possess a characteristic and definite nature are extracted. 
Scabies was was probaly the earlies and of these rescued dermatoses, infectious 
eczematoid dermatitis another, and the trichophytids, epidermophytids, and moniliids 
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among the most recent. All cases of eczuma are, to the pathologist, dermatitis. So are 
most other skin diseases. Eczema implies chronicity, a tendency to recurrence, and an 
element of idiosyncrasy. While somre cases are probably in reality dermatitis venenata, 
and others are dermatomycoses, yet other still defy satisfactory analysis (Sutton et al., 
1939). 
Hemorrhoids: Haemorrhoids or piles are varicosities in the anal canal caused by local 
pressure. Sometimes they prolapse. Symptoms may include itching, discomfort, pain and 
bleeding (Sinclair, A., 1995). 
Bites: The wounds on skin caused by bitten of snakes, animals or some insects.                                                   
Burns: According to the International Society for Burn Injuries (ISBI), a burn occurs 
when some or all of the different layers of cells in the skin are destroyed by a hot liquid 
(scald), a hot solid (contact burns) or a flame (flame burns). Skin injuries due to 
ultraviolet radiation, radioactivity, electricity or chemicals, as well as respiratory 
damage resulting from smoke inhalation, are also considered to be burns (World Health 
Organization, Violence and Injury Prevention and Disability, 
http://www.who.int/violence_injury_prevention/other_injury/burns/en/, 19. 11. 2011). 
Hematoma: By definition, a hematoma is a collection of blood outside of a blood vessel. 
It occurs because the wall of a blood vessel wall, artery, vein or capillary, has been 
damaged and blood has leaked into tissues where it does not belong. The hematoma 
may be tiny, with just a dot of blood or it can be large and cause significant swelling 
(Benjamin Wedro, http://www.medicinenet.com/hematoma/article.htm#what, 19. 11. 
2011). 
Sores: A painful usually infected place on the body [Wu, T.Z. et al., Longman Dictionary 
of English Language & Culture (English-Chinese), The Commercial Press, 2004]. 
3.2 The surveys for selected TCM wound healing plants         
According to the description of Pharmacopoeia of People’s Republic of China (2005 
version), all monographic herbal materials were screened for the skin active functions 
(see Table 2.2). There were 160 TCM plants selected from the herbal materials' 
screening. After that, the literature survey (see Table 2.3) was performed with all 
plants selected for getting basic research information of selected herbal drugs. After the 
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survey, the plants have not yet been described in detail by scientific literature 
phytochemically and functionally were selected for a further experimental investigation. 
However, the purchase possibility of TCM herbal drugs was limited in Germany. For all 
the reasons above, 12 TCM plants listed below were finally decided for the research 
(Table 3.1). 
Table 3.1 Final selected TCM plants for skin active research: the drug name, Chinese 
name, species, family and the skin concerning usage were listed according to the 
Pharmacopoeia of People’s Republic of China (2005 version). 
Herbal Drug / 
Chinese name 
Species Family Use 
Angelicae sinensis 
radix / Dang Gui 
Angelica sinensis 
(Oliv.) Diels 
Apiaceae Ulcer, trauma, sores, 
skin infection, 
swelling and edema 
Archyranthis 
bidentatae rhizoma / 
Niu Xi 
Achyranthes bidentata 
Bl. 
Amaranthaceae Hematoma 
Cimicifugae rhizoma / 
Sheng Ma 
Cimicifuga 
heracleifolia Kom, 
cimicifuga dahurica 
(Turcy.) Maxim. or 
Cimicifuga foetida L. 
Ranunculaceae Aphthae 
Corydalis rhizoma / 
Yan Hu Suo 
Corydalis yanhusuo W. 
T. Wang 
Papaveraceae Hematoma, swelling 
and edema 
Gardeniae fructus / 
Zhi Zi 
Gardenia jasminoides 
Ellis 
Rubiaceae Ulcer, sores, skin 
infection, swelling 
and edema 
Houttuyniae herba / 
Yu Xing Cao 
Houttuynia cordata 
Thunb. 
Saururaceae Ulcer, sores, skin 
infection, swelling 
and edema 
Lonicerae japonicae 
caulis / Ren Dong 
Teng 
Lonicera japonica 
Thunb. 
Caprifoliaceae Ulcer, sores, skin 
infection, swelling 
and edema 
Lonicerae japonicae 
flos / Jin Yin Hua 
Lonicerae japonica 
Thunb. 
Caprifoliaceae Ulcer, sores, skin 
infection, swelling 
and edema 
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Moutan cortex / Mu 
Dan Pi 
Paeonia suffruticosa 
Andr. 
Paeoniaceae 
(still recorded as 
Ranunculaceae in  
PPRC 2005 & 2010 ) 
Ulcer, trauma, sores, 
hematoma, skin 
infection, swelling 
and edema 
Notoginseng radix et 
rhizoma / San Qi 
Panax notoginseng 
(Burk.) F. H. chen 
Araliaceae Trauma, hematoma, 
swelling and edema 
Paeoniae rubrae radix 
/ Chi Shao 
Paeonia lactiflora Pall. 
or Paeonia veitchii 
Lynch 
Ranunculaceae Ulcer, trauma, sores, 
haematoma, skin 
infection, swelling 
and edema 
Rehmanniae radix / 
Di Huang 
Rehmannia glutinosa 
Libosch. 
Scrophulariaceae Trauma  
 
According to the descriptions in the Pharmacopoeia of People’s Republic of China (2005 
version), the herbal materials above were recorded to be used on different skin aspects 
in TCM and thus were valuable for further skin research investigations. The research 
with western modern scientific methods would be performed for the skin active TCM 
plants' investigations.    
3.3 Morphological and microscopic identification of selected TCM plants 
In the following, morphological descriptions of all TCM herbal drugs from Table 3.1 are 
given. Additionally, microscopic identifications of some herbal materials are described 
as well. All 12 selected TCM herbal drugs went through these identifications as 
described below.  
3.3.1 Angelicae sinensis radix 
 Morphological description of Archyranthis bidentatae rhizome (ASR) in PPRC 2005: 
Angelicae sinensis radix is of cylindrical-like shape, the superficial color is yellow-brown 
or brown. The longitudinal folds and transverse lenticel-like enations can be observed. 
The surfaces of the taproots are unsmooth. The diameters of the rootlets are from 0.3 to 
1 cm and the rootlets are twisted. The cross-sections of this herbal material show the 
yellow-white color or light yellow-brown. The root bark is thick and there are some 
fissures and brown punctiform secretory cavities, which lead to the intensive smell of 
this herbal drug. 
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Microscopic identification in Pharmacopoeia of People's Republic of China (2005) of ASR: 
the secretory ducts or secretory cambers can be observed with the diameters from 25 to 
160 µm in phloem, and secretory cells are all around. 2 to 3 of vessels gather together or 
scatter singly. Scalariform vessels and reticulate vessels are frequently seen and the 
diameters could reach about to 80 µm. 
 
Fig. 3.1 The morphological and microscopic photos of Angelicae sinensis radix: (a): The 
herbal material of Angelicae sinensis radix; (b): Several vessels of Angelicae sinensis radix 
gathered together; (c): One secretory chamber / dust  with secrotary cells gathered 
around the opening in phloem. The microscopic section of (b) and (c) was prepared in 
chloral hydrate with heating. 
According to Fig. 3.1, the morphological and microscopic figures of Angelicae sinensis 
radix were in accordance with the descriptions in PPRC (2005). This herbal material 
fulfilled the descriptions from PPRC 2005 both morphologically and microscopically, it 
was proven to be ASR and would be further tested for its skin active functions. 
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3.3.2 Archyranthis bidentatae rhizoma                                                                                         
Morphological descriptions of Archyranthis bidentatae rhizoma (ABR) in PPRC 2005: 
This herbal material is of circular cylinder shape, straight or slightly curved, the 
diameters are normally from 0.4 to 1 cm. There are slightly curved folds, sparse scars of 
lateral roots and long lenticel-like enations on the surfaces. The color of the surface is 
gray-yellow or light brown, the color of the cross section is light brown. The surface of 
the cross section is flat and has the cutin-look. The xylem of the middle vascular bundle 
is relative big, yellow-white colored and there are 2 to 4 irregular distributed yellow-
white colored punctiform vascular bundles around the big middle vascular bundle.                                                              
Microscopic description of ABR in PPRC 2005: There are sand crystals of calcium oxalate 
in the parenchyma cells.  
 
Fig. 3.2 The morphological and microscopic photos of Archyranthis bidentatae rhizoma: 
(a): The herbal materials of Archyranthis bidentatae rhizoma; (b): Crystal sand of 
calcium oxalate in a parenchyma cell. The microscopic section was prepared with chloral 
hydrate with heating.     
According to Fig. 3.2, this herbal material was identical to both morphological and 
microscopic identifications in PPRC 2005. It was proven to be ABR and would be further 
tested for its skin active functions. 
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3.3.3 Cimicifugae rhizoma 
Morphological descriptions of Cimicifugae rhizoma (CR) in PPRC 2005: Herbal materials 
of Cimicifugae rhizoma are long-shaped pieces with many nodous branches. The color of 
the surface is pitchy or brown; the surface is scabrate and has many scars of caudexes in 
the form of round empty holes. 
 
Fig. 3.3 The plant materials of Cimicifugae rhizoma.               
According to Fig. 3.3, this herbal material was identical to the morphological 
identifications in PPRC 2005. It was proven to be CR and would be further tested for its 
skin active functions. 
3.3.4 Corydalis rhizoma 
Morphological descriptions of Corydalis rhizoma (CDR) in PPRC 2005: Plant material of 
CDR is of irregular round shapes. The diameters of the materials are from 0.5 to 1.5 cm. 
The color is yellow or yellow-brown and there are irregular reticular folds on the 
surfaces. The top of the plant materials has cavate stem scars. The bottom of the plant 
usually has knobbly enations. The cross sections are yellow, cutin-looking and have the 
wax-glossing.  
Microscopic description of CDR in PPRC 2005: There are gelatinized starch granules 
inside this herbal material. The sclerenchymatous cells of hypodermis of CDR are green-
yellow colored, the sclerenchymatous cells are polygonal, quadrate-like or long column-
shaped. The cell walls of the cells are slightly curved. 
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Fig. 3.4 The morphological and microscopic photos of Corydalis rhizoma:  (a): The 
herbal materials of Corydalis rhizoma; (b): The green-yellow colored sclerenchymatous 
cells of hypodermis, cell walls are slightly curved; the microscopic section was prepared 
in chloral hydrate with heating; (c): Starch granules; The microscopic section was 
prepared with chloral hydrate with heating and then iodine solution was added.                  
According to Fig. 3.4, this herbal material was identical to both morphological and 
microscopic identifications in PPRC 2005. It was proven to be CDR and would be further 
tested for its skin active functions. 
3.3.5 Gardeniae fructus 
Morphological descriptions of Gardeniae fructus (GF) in PPRC 2005: The plant materials 
of GF are of oval or long-oval shape. The lengths are normally 1.5 to 3.5 cm and the 
diameters are usually 1 to 1.5 cm. The surfaces are red-yellow or red-brown. The 
pericarps are thin, crumbly and slightly glossing. The color of the inner sides of 
pericarps are lighter and with gloss. There are 2 to 3 raised pseudoseptums. Many dark 
red or yellow-red colored seeds are inside which are of oblate-oval shape with many 
tiny verrucose enations on the surfaces.  
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Microscopic descriptions of GF in PPRC 2005: The shape of pericarpic stone cells is 
rectangular-like. The diameters of the threadlike shaped pericarpic fibers are around 10 
µm, the lengths of them are around 110 µm. They usually rank crossed with each other. 
The stone cells of the episperm are yellow or light brown. They are mostly of long 
polygonal-shape , brick-shape or irregular-shape. The diameters of them are normally 
around from 60 to 112 µm and the lengths of them can get to 230 µm. The cell walls are 
thick and have big pits. The color of cell lumen is red-brown. Calcium oxalate druse 
crystals inside can be observed which have the diameters  from 19 to 34 µm. 
According to Fig. 3.5 (see below), this herbal material was identical to both 
morphological and microscopic identifications in PPRC 2005. It was proven to be GF and 
would be further tested for its skin active functions. 
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Fig. 3.5 The morphological and microscopic photos of Gardeniae fructus: (a): The plant 
materials of Gardeniae fructus; (b): The rectangular-like shaped pericarpic stone cells; 
(c): The threadlike shaped pericarpic fibers, the diameters of these fibers are around 10 
µm, the lengths are around 110 µm, cross-ranked; (d): Calcium oxalate druse crystals 
with the diameters in the range of 19 to 34 µm; (e): Stone cells of the episperm, the 
diameters are in the range of 60 to 112 µm , the lengths are about 230 µm, thick cell 
walls with big pits, the cell lumens are red-brown colored. All microscopic pictures were 
taken with the microscopic section prepared with chloral hydrate with heating.     
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3.3.6 Houttuyniae herba 
Morphological descriptions of Houttuyniae herba  (HH) in PPRC 2005: The stems of dry 
HH are oblate columnar, twisted and the surfaces are yellow-brown with several 
longitudinal edges. They are very fragile. The leaves are wrinkled, the supine surfaces of 
the leaves have the color from dark yellow-green to dark brown, the other side of the 
leaves have the color of gray-green or gray-brown.  
 
 
 
 
 
 
 
Fig. 3.6 The herbal material of Houttuyniae herba.                                                                                                                            
According to Fig. 3.6, this herbal material was identical to the morphological 
identification in PPRC 2005. It was proven to be HH and would be further tested for its 
skin active functions. 
3.3.7 Lonicerae japonicae caulis 
Morphological descriptions of Lonicerae japonicae caulis (RDT) in PPRC 2005: The 
herbal materials of RDT are long cylindrical shaped and have many branches. The 
diameters are normally from 1.5 to 6 mm. The surfaces are from red-brown to dark 
brown colored, some are  gray-green.  The surfaces are smooth or covered with flosses. 
The nodes are dispersed on the stems. The cross sections are white-yellow colored and 
hollow.  
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Fig. 3.7 The herbal material of Lonicerae japonicae caulis.                                                                                                                      
According to Fig. 3.7, this herbal material was identical to the morphological 
identification in PPRC 2005. It was proven to be RDT and would be further tested for its 
skin active functions. 
3.3.8 Lonicerae japonicae flos 
Morphological descriptions of Lonicerae japonicae flos (LJF) in PPRC 2005: The herbal 
materials of LJF are of claviform and the surfaces are white-yellow or white-green (the 
color goes deeper with storage time) covered with short flosses. The tops are bigger 
than the ends and the length is normally from 2 to 3 cm. The diameters of the tops are 
normally 3 mm and the diameters of the ends are around 1.5 mm.  
 
Fig. 3.8 The herbal material of Lonicerae japonicae flos: (a): Plant materials purchased 
from China Medica GmbH; (b): Plant materials purchased from Caesar & Lorenz GmbH.        
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According to Fig. 3.8, this herbal material was identical to the morphological 
identifications in PPRC 2005. It was proven to be LJF and would be further tested for its 
skin active functions. 
3.3.9 Moutan cortex 
Morphological descriptions of Moutan cortex (MC) in PPRC 2005: The plant materials of 
MC are of tubular or semi-tubular shape; Diameters are about from 0.5 to 1.2 cm. The 
surfaces are gray-brown or yellow-brown. The places where the corks were taken off 
show pink color. The internal surface areas are light gray-yellow or light brown and 
have clear thin longitudinal striations. The cross sections are relative smooth and are 
light pink.   
Microscopic identifications of MC in PPRC 2005: Many starch granules can be observed. 
They are usually of round-like or polygonal. The diameters of the single starch granules 
are normally around from 3 to 16 µm. The complex starch granules are normally consist 
of 2 to 6 starch granules. The calcium oxalate druse crystals have the diameters around 
from 9 to 45 µm. Sometimes the crystal cells connect to each other, so the calcium 
oxalate druse crystals can be observed in line. One crystal cell can contain one or more 
calcium oxalate druse crystals. The cork cells of MC are of brick-shape and have thick 
cell walls in light red color. 
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Fig. 3.9 The morphological and microscopic photos of Moutan cortex:  (a): The plant 
materials of Moutan cortex; (b): Starch granules: round or polygonal, single or complex 
starch grains; The microscopic section was prepared in chloral hydrate with heating, 
then with iodine solution; (c): The lithocysts with calcium oxalate druse crystals; (d): 
The cork cells with light red-colored thick cell walls. Pictures (c) and (d) were taken 
from the microscopic section prepared with chloral hydrate with heating.            
According to Fig. 3.9, this herbal material was identical to both morphological and 
microscopic identifications in PPRC 2005. It was proven to be MC and would be further 
tested for its skin active functions. 
3.3.10 Notoginseng radix et  rhizoma 
Morphological descriptions of Notoginseng radix et rhizoma (NRR) in PPRC 2005: The 
herbal materials of NRR are of cylindrical shape, diameters are from 1 to 4 cm.  The 
surfaces are gray-brown or gray-yellow. Some longitudinal folds, tuberculate enations 
and scars of lateral roots can be observed. The colors of cross sections are gray-green, 
yellow-green or gray-white.         
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Microscopic identifications of NRR in PPRC 2005: Many starch granules can be observed. 
Single starch granules are of round, semicircular or polygonal shapes. The diameters of 
the starch granules are usually from 4 to 30 µm. The compound starch granules consist 
of 2 to 10 starch granules. The scalariform vessels, reticulate vessels and spiral vessels 
normally have the diameters from 15 to 55 µm. The calcium oxalate druse crystals are 
seldom to be observed which have the diameters from 50 to 80 µm. 
 
Fig. 3.10 The morphological and microscopic photos of Notoginseng radix rhizoma: (a): 
The herbal materials of Notoginseng radix et rhizoma; (b): Starch granules: Round, 
semicircular or polygonal, single or complex starch grains, this microscopic section was 
prepared in chloral hydrate with heating, then with iodine solution; (c): Vessels, the 
microscopic section was prepared in chloral hydrate.                                                                                                                                                      
According to Fig. 3.10, this herbal material was identical to both morphological and 
microscopic identifications in PPRC 2005, except the rare calcium oxalate druse crystals 
were not observed. It was proven to be NRR and would be further tested for its skin 
active functions. 
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3.3.11 Paeoniae rubrae radix 
Morphological descriptions of Paeoniae rubrae radix (PRR) in PPRC 2005: The herbal 
materials of PRR are of cylindrical-shape, a little curved. The diameters are about from 
0.5 to 3 cm. The surfaces are brown-colored, rough with longitudinal sulcuses and folds. 
The cross sections are white or pink. The radiating ranged striations in the xylem are 
obvious to be observed and some of them have slits. 
Microscopic identification of PRR in PPRC 2005: Some parenchyma cells contain calcium 
oxalate druse crystals. 
Fig. 3.11 The morphological and microscopic photos of Paeonicae rubrae radix: (a): The 
plant materials of Paeoniae rubrae radix; (b): Parenchyma cells with calcium oxalate 
druse crystals inside. Microscopic section was prepared with chloral hydrate with 
heating.      
According to Fig. 3.11, this herbal material was identical to both morphological and 
microscopic identifications in PPRC 2005. It was proven to be PRR and would be further 
tested for its skin active functions. 
3.3.12 Rehmanniae radix 
Morphological descriptions of Rehmanniae radix (RR) in PPRC 2005: The herbal 
materials of RR are lumps with irregular shapes or of long round shape. Some of them 
are oblate and curved. The surfaces are brown-black or brown-gray. The cross sections 
are of brown-black or sooty and have gloss.  
Microscopic identification of RR in PPRC 2005: The secretary cells have similar shape as 
the parenchyma cells'. There are many secretary cells contain yellow-orange or red-
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orange colored oil inside. RR contains both bordered pit vessels and reticulate vessels 
which the diameters can get to about 92 µm. 
 
 
 
 
 
 
Fig. 3.12 The morphological and microscopic photos of Rehmanniae radix: (a): The 
herbal materials of Rehmanniae radix; (b) Secretary cells with yellow-orange or red-
orange colored oil-drop shaping secretions, the picture was artificially taken with the 
depth composition; (c): Vessels which have diameters around 50 µm. The microscopic 
section was prepared in chloral hydrate with heating.         
According to Fig. 3.12, this herbal material was identical to both morphological and 
microscopic identifications in PPRC 2005. It was proven to be PRR and would be further 
tested for its skin active functions. 
3.4 The yield of crude TCM plants' extracts for in vitro cell test screening 
The 12 TCM herbal materials were further investigated by in vitro experiments on 
potential skin cell activity (Table 3.1). According to the principal of bioassay-guided 
research, these plants were initially extracted and then tested on different skin cells 
(keratinocytes, fibroblasts) to testify a potential wound healing. It was unknown which 
kind of compounds would be responsible for the cell test effect, so a mixture of ethanol 
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and water (6:4, v/v) was used to prepare suitable extracts in order to obtain both 
lipophilic and hydrophilic compounds in the extracts. After some tests with ethanol-
water (6:4, v/v) extracts of early purchased herbal materials, most showed ineffective 
results. Reconsideration was then made according to the results, since there was a 
possibility that the effective substances were more hydrophilic compounds and some 
might not be dissolved in ethanol-water (6:4, v/v) extracts. It was then decided to 
prepare also water extracts of the different herbal materials. Thus, the latter purchased 
herbal materials including Archyranthis bidentatae rhizoma, Corydalis rhizoma, 
Gardeniae fructus and Moutan cortex were also extracted with water and these water 
extracts were tested on the skin cells. The method of extraction is described in 2.2.5.  
Table 3.2 The yields (%), related to amount of starting material of selected herbal 
materials extracted with EtOH-water (6:4, v/v) and water; n.d. : not determined. 
Herbal Drug 
Yield (%) of EtOH-
water (6:4, v/v) 
extraction 
 
Yield (%) of water 
extraction 
Angelicae sinensis radix 61.5 n.d. 
Archyranthis bidentatae rhizoma 59.2 45.6 
Cimicifugae rhizoma 26.3 n.d. 
Corydalis rhizoma 9.9 14.9 
Gardeniae fructus 19.1 27.6 
Houttuyniae herba 20.7 n.d. 
Lonicerae japonicae caulis 12.6 n.d. 
Lonicerae japonicae flos 33.3 n.d. 
Moutan cortex 23.7 24.4 
Notoginseng radix et rhizoma 25.7 n.d. 
Paeoniae rubrae radix 21.3 n.d. 
Rehmanniae radix 78.3 n.d. 
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3.5 DAPI test for mycoplasma detection 
Cell contamination is always a serious problem happened during cell culture. Among all 
the infections with different kinds of organisms, mycoplasma contamination is one of 
the very frequently and severe contamination. Mycoplasma (diameter: from 0.3 to 0.8 
µm) is a genus of bacteria that lack a cell wall (Ryan et al., 2004). They can proliferate 
within the cell, tolerate antibiotics and their growth does not have any obvious 
phenomenological evidence like turbidity and pH changes of the media or cytopathic 
effects of the cells. Mycoplasma contamination also affects functions, chromosomal 
aberrations and many other properties of cell lines (Mirjalili et al., 2005). According to 
the 20,000 tests carried out recently by Food and Drug Administration (FDA) among 
1970's to 1990's, over 3000 (over 15%) test results were positive for mycoplasma 
contaminations. 
Thus, for insuring the clean cell culture conditions and the reliability of the cell test 
results, DAPI test was regularly performed to prove the uncontaminated working 
environment. DAPI (4',6-diamidino-2-phenylindole) is a DNA-specific probe which 
forms a fluorescent complex by attaching in the minor grove of A-T rich sequences of 
DNA (Kapuscinski, 1995).  Mycoplasmas can be stained by DAPI as well. So the cells we 
used were stained with DAPI and the observation was performed under microscope to 
make sure if the cells were free of mycoplasma.  
The method of DAPI test was described in 2.2.8.2.1. There was no camera available for 
this observation in our institute, so all microscope sample slides were observed by 
doctoral student Andrea Derksen in the Institute of Virology, University of Muenster. 
According to the observation, no mycroplasma contamination existed. 
3.6 In vitro cell test screening of the TCM plants' crude extracts  
Extracts from the 12 selected TCM herbal drugs (Table 3.1) were used for the skin 
active function screening with MTT assay which was used for detection of cell viability 
and cytotoxicity. In this test, a tetrazolium salt {3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide, MTT} is converted to a colored formazan product by 
enzymes active only in living cells. Previous investigators have shown that dead cells are 
unable to reduce MTT within 30 min of lysis (Cole, 1986). The formed formazan can be 
dissolved in DMSO and shows the color from blue to purple which can be quantified by a 
plate reader at wavelength of 595 nm against reference wavelength of 690 nm. 
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In each MTT assay 96-well microtiter plate, one vertical line of wells were set up as 
untreated control in which all cells were treated with appropriate medium to show the 
normal growth condition of the cells. Another vertical line of the wells were set as 
positive control which were treated with fetal bovine serum in order to prove the cell 
viability of proliferated cells. These results were compared with measuring obtained 
values from treated cells with extracts or test substances. For a valid test, the cell 
viability of the positive control had to be increased by at least 10% related to the 
untreated control. Also, 10% increase of cell viability was required as the lowest border 
line to judge if the testing extracts or substances were positive for the cell viability.  
For in vitro cell test for skin active plants' screening, HaCaT keratinocytes and primary 
normal human dermal fibroblasts were used which represent epidermis and dermal 
layers of human skin. The pictures of two cell lines are shown in Fig 3.13. 
 
Fig. 3.13 Human adult low calcium high temperature keratinocytes (HaCaT 
keratinocytes) (a) and primary normal human dermal fibroblasts (pNHDF) (b). 
3.6.1 Archyranthis bidentatae rhizoma 
For in vitro investigation of the influence of the water extract (extract 2) and EtOH-water 
extract (6:4, v/v; extract 3) from Archyranthis bidentatae rhizoma (ABR), pNHDF and 
HaCaT keratinocytes were treated with the extracts at different concentrations. 
Evaluation of the experiments, which had been performed in 2 independent test series, 
was performed by MTT assay. Results are shown in Fig. 3.14. 
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Fig. 3.14 Dehydrogenase activity (MTT assay) of water extract (extract 2) and EtOH-
water extract (6:4, v/v; extract 3) from Archyranthis bidentatae rhizoma on primary 
normal human dermal fibroblasts (pNHDF) (a) and HaCaT keratinocytes (b) at doses of 
1, 10, 100 µg/mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=8 and the results replicate from 3 independent experiments 
with ** p < 0.01 compared to the untreated control group (UC); Positive control (PC): 1% 
FBS for (a) and 5% FBS for (b).  
The respective data (Fig. 3.14) indicated no activity of the extracts both on pNHDF and 
HaCaT keratinocytes. For that reason, no further functional experiments were 
performed on these extracts. 
3.6.2 Angelicae sinensis radix      
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract As) 
from Angelicae sinensis radix (ASR), pNHDF and HaCaT keratinocytes were treated with 
extract As at different concentrations. Evaluation of the experiments, which had been 
performed in 2 independent test series, was performed by MTT assay. Results are 
shown in Fig. 3.15. 
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Fig. 3.15 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 
As) from Angelicae sinensis radix on primary normal human dermal fibroblasts (pNHDF) 
(a) and HaCaT keratinocytes (b) at doses of 1, 10, 100 µg/ mL over an 48 h incubation 
period. Bars represent relative standard deviations (RSD) with n=8 and the results 
replicate from 3 independent experiments with ** p < 0.01 compared to the untreated 
control group (UC); Positive control (PC): 1% FBS for (a) and 5% FBS for (b). 
The respective data (Fig. 3.15) indicated no activity of the extract As on HaCaT 
keratinocytes while fibroblasts were stimulated only at high concentrations of 100 
µg/mL very significantly.  But ASR is one very popular TCM herbal drug which has been 
both functionally and structurally well investigated (Chen, Y.Z., 2001). For that reason 
no further experiments were performed on this extract.  
3.6.3 Cimicifugae rhizoma  
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract Ci) 
from Cimicifugae rhizoma (CR), pNHDF and HaCaT keratinocytes were treated with 
extract Ci at different concentrations. Evaluation of the experiments, which had been 
performed in 2 independent test series, was performed by MTT assay. Results are 
shown in Fig. 3.16. 
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Fig. 3.16 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 
CR) from Cimicifugae rhizoma on primary normal human dermal fibroblasts (pNHDF) (a) 
and HaCaT keratinocytes (b) at doses of 1, 10, 100 µg/mL over an 48 h incubation 
period. Bars represent relative standard deviations (RSD) with n=8 and the results 
replicate from 3 independent experiments with ** p < 0.01 compared to the untreated 
control group (UC); Positive control (PC): 1% FBS for (a) and 5% FBS for (b). 
The respective data (Fig. 3.16) indicated no activity of the extract on both pNHDF and 
HaCaT keratinocytes at all above concentrations. For that reason, no further functional 
experiments were performed on this extract. 
3.6.4 Corydalis rhizoma 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract 0) and 
water extract (extract 1) from Corydalis rhizoma (CDR), HaCaT keratinocytes were 
treated with extract 0 and extract 1 at different concentrations. Evaluation of the 
experiments, which had been performed in one test series, was performed by MTT assay. 
Results are shown in Fig. 3.17. 
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Fig. 3.17 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 0) 
and water extract (extract 1) from Corydalis rhizoma on HaCaT keratinocytes at doses of 
1, 10, 100 µg/mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=8 and the results replicate from 3 independent experiments 
with ** p < 0.01 compared to the untreated control group (UC); Positive control (PC) 
with 5% FBS. 
The respective data (Fig. 3.17) indicated no activity of the extract on HaCaT. The cell 
viability of HaCaT keratinocytes was inhibited by extract 1 at high concentrations of 100 
µg/mL.  For that reason, no further functional experiments were performed on these 
extracts. 
3.6.5 Gardeniae fructus 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract 4) and 
water extract (extract 5) from Gardeniae fructus (GF), HaCaT keratinocytes were treated 
with extract 4 and extract 5 at different concentrations. Evaluation of the experiments, 
which had been performed in one test series, was performed by MTT assay. Results are 
shown in Fig. 3.18. 
Fig. 3.18 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 4) 
and water extract (extract 5) from Gardeniae fructus on HaCaT keratinocytes at doses of 
1, 10, 100 µg/ mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=8 and the results replicate from 3 independent experiments 
with ** p < 0.01 compared to the untreated control group (UC); Positive control (PC) 
with 5% FBS. 
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The respective data (Fig. 3.18) indicated no activity of the extracts on HaCaT 
keratinocytes. The value of relative cell viability (%) was very significant after cells were 
treated with extract 5 at concentration of 100 µg / mL compared to untreated control 
group. But the increased cell viability percentages (4%) were not positive enough for 
one viability-stimulation. For that reason, no further functional experiments were 
performed on these extracts.  
3.6.6 Houttuyniae herba 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract Hu) 
from Houttuyniae herba (HH), pNHDF and HaCaT keratinocytes were treated with 
extract Hu at different concentrations. Evaluation of the experiments, which had been 
performed in 2 independent test series, was performed by MTT assay. Results are 
shown in Fig. 3.19. 
Fig. 3.19 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 
Hu) from Huttuyniae herba on primary normal human dermal fibroblasts (pNHDF) (a) 
and HaCaT keratinocytes (b) at doses of 1, 10, 100 µg/ mL over an 48 h incubation 
period. Bars represent relative standard deviations (RSD) with n=8 and the results 
replicate from 3 independent experiments with ** p < 0.01 and * p < 0.05 compared to 
the untreated control group (UC); Positive control (PC): 1% FBS for (a) and 5% FBS for 
(b). 
The respective data (Fig. 3.19) indicated no activity of the extract on both pNHDF and 
HaCaT keratinocytes at all above concentrations. For that reason, no further functional 
experiments were performed on this extract. 
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3.6.7 Lonicerae japonicae caulis 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract Lc) 
from Lonicerae japonicae caulis (RDT), pNHDF and HaCaT keratinocytes were treated 
with extract Lc at different concentrations. Evaluation of the experiments, which had 
been performed in 2 independent test series, was performed by MTT assay. Results are 
shown in Fig. 3.20. 
Fig. 3.20 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract Lc) 
from Lonicerae japonicae  Caulis on primary normal human dermal fibroblasts (pNHDF) 
(a) and HaCaT keratinocytes (b) at doses of 1, 10, 100 µg/mL over an 48 h incubation 
period. Bars represent relative standard deviations (RSD) with n=8 and the results 
replicate from 3 independent experiments with ** p < 0.01 and * p < 0.05 compared to 
the untreated control group (UC); Positive control (PC): 1% FBS for (a) and 5% FBS for 
(b). 
The respective data (Fig. 3.20) indicated extract Lc inhibited the cell viability of pNHDF 
at higher concentrations significantly while no activity of the extract on HaCaT 
keratinocytes  was observed. For that reason, no further functional experiments were 
performed on this extract. 
3.6.8 Lonicerae japonicae flos (Batch purchased from China Medica GmbH) 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract 6) from 
Lonicerae japonicae flos (LJF), pNHDF and HaCaT keratinocytes were treated with 
extract 6 at different concentrations. Evaluation of the experiments, which had been 
performed in 2 independent test series, was performed by MTT assay. Results are 
shown in Fig. 3.21. 
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Fig. 3.21 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 6) 
from Lonicerae japonicae flos (purchased from China Medica GmbH) on primary normal 
human dermal fibroblasts (pNHDF) (a) and HaCaT keratinocytes (b) at doses of 1, 10, 
100 µg/mL over an 48 h incubation period. Bars represent relative standard deviations 
(RSD) with n=8 and the results replicate from 3 independent experiments with ** p < 
0.01 compared to the untreated control group (UC); Positive control (PC): 1% FBS for (a) 
and 5% FBS for (b). 
The respective data (Fig. 3.21) indicated no activity of the extract 6 on HaCaT 
keratinocytes while fibroblasts were stimulated at high concentrations of 100 µg / mL 
very significantly. For that reason, further functional experiments were performed with 
LJF on pNHDF. 
3.6.9 Moutan cortex 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract 7) and 
water extract (extract 8) from Moutan cortex, pNHDF and HaCaT keratinocytes were 
treated with extract 7 and extract 8 at different concentrations. Evaluation of the 
experiments, which had been performed in 2 independent test series, was performed by 
MTT assay. Results are shown in Fig. 3.22. 
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Fig. 3.22 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 7) 
and water extract (extract 8) from Moutan  cortex on primary normal human dermal 
fibroblasts (pNHDF) (a) and HaCaT keratinocytes (b) at doses of 1, 10, 100 µg/mL over 
an 48 h incubation period. Bars represent relative standard deviations (RSD) with n=8 
and the results replicate from 3 independent experiments with * p < 0.05 and ** p < 0.01 
compared to the untreated control group (UC); Positive control (PC): 1% FBS for (a) and 
5% FBS for (b). 
The respective data (Fig. 3.22) indicated positive activity of the extract 7 and extract 8 
on pNHDF and HaCaT keratinocytes. The viabilities of pNHDF and HaCaT keratinocytes 
were stimulated by extract 7 at the concentration of 100 µg/mL very significantly. Also, 
cell viability of pNHDF was stimulated at the dose of 10 µg/mL very significantly. Also 
the viability of HaCaT keratinocytes was stimulated at the dose of 100 µg/mL very 
significantly compared to the untreated control group. Due to all above, further 
functional experiments were performed on these extracts. 
3.6.10 Notoginseng radix et rhizoma 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract No) 
from Notogingseng radix et rhizoma (NRR), primary normal human dermal fibroblasts 
(pNHDF) and HaCaT keratinocytes were treated with extract No at different 
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concentrations. Evaluation of the experiments, which had been performed in 2 
independent test series, was performed by MTT assay. Results are shown in Fig. 3.23. 
Fig. 3.23 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 
No) from Notoginseng radix et rhizoma on primary normal human dermal fibroblasts 
(pNHDF) (a) and HaCaT keratinocytes (b) at doses of 1, 10, 100 µg/mL over an 48 h 
incubation period. Bars represent relative standard deviations (RSD) with n=8 and the 
results replicate from 3 independent experiments with * p < 0.05 and  ** p < 0.01 
compared to the untreated control group (UC); Positive control (PC): 1% FBS for (a) and 
5% FBS for (b). 
The respective data (Fig. 3.23) indicated no activity of extract No on HaCaT 
keratinocytes while pNHDF were stimulated at concentration of 10 µg/mL very 
significantly. However, this herbal drug is very popular and have been well investigated 
both functionally and structurally. For that reason, no further functional experiments 
were performed. 
3.6.11 Paeoniae rubrae radix 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract Pa) 
from Paeoniae rubrae radix (PRR), primary normal human dermal fibroblasts (pNHDF) 
and HaCaT keratinocytes were treated with extract Pa at different concentrations. 
Evaluation of the experiments, which had been performed in 2 independent test series, 
was performed by MTT assay. Results are shown in Fig. 3.24. 
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Fig. 3.24 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 
Pa) from Paeoniae rubrae radix on primary normal human dermal fibroblasts (pNHDF) 
(a) and HaCaT keratinocytes (b) at doses of 10, 100 µg/mL over an 48 h incubation 
period. Bars represent relative standard deviations (RSD) with n=8 and the results 
replicate from 3 independent experiments with ** p < 0.01 compared to the untreated 
control group (UC); Positive control (PC): 1% FBS for (a) and 5% FBS for (b). 
The respective data (Fig. 3.24) indicated no activity of extract Pa on HaCaT 
keratinocytes and cell viability of pNHDF was inhibited at high concentration of 100 
µg/mL very significantly. For that reason, no further experiments were performed on 
this extract. 
3.6.12 Rehmanniae radix 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract Re) 
from Rehmanniae radix (RR), primary normal human dermal fibroblasts (pNHDF) and 
HaCaT keratinocytes were treated with extract Re at different concentrations. 
Evaluation of the experiments, which had been performed in 2 independent test series, 
was performed by MTT assay. Results are shown in Fig. 3.25. 
Fig. 3.25 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; extract 
Re) from Rehmanniae radix on primary normal human dermal fibroblasts (pNHDF) (a) 
and HaCaT keratinocytes (b) at doses of 10, 100 µg/mL over an 48 h incubation period. 
Bars represent relative standard deviations (RSD) with n=8 and the results replicate 
from 3 independent experiments with ** p < 0.01 compared to the untreated control 
group (UC); Positive control (PC): 1% FBS for (a) and 5% FBS for (b). 
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The respective data (Fig. 3.25) indicated no activity of extract RR on pNHDF and HaCaT 
keratinocytes. For that reason, no further experiments were performed on this extract. 
 
3.7 Skin active functional and phytochemical investigations of Lonicerae japonicae 
flos 
3.7.1 Fingerprinting of secondary compounds from Lonicerae japonicae flos by 
TLC   
Because of the positive activity of EtOH-water extract (6;4, v/v; extract 6) from 
Lonicerae japonicae flos (LJF) on pNHDF (3.5.8),  further investigations were performed 
on this herbal material. For a primary phytochemical fingerprinting, TLC investigation of 
EtOH extract from LJF was performed, the method was described in 2.2.7.3.  
 
Fig. 3.26 TLC investigation (EtOAc: formic acid: water= 90: 5: 5, v/v/v) of EtOH extract 
of Lonicerae japonicae flos(LJF). Detections were made after spraying with natural 
product reagent A solution at 366 nm. 1. chlorogenic acid; 2. quercitrin; 3. hyperosid; 4. 
caffeic acid; 5. EtOH extract of Lonicerae japonicae flos; 6. rutin. 
As shown in Fig. 3.26, the TLC investigation provided satisfactory fingerprinting; the 
presence of chlorogenic acid, caffeic acid may be reasonable. 
3.7.2 Extraction of Lonicerae japonicae flos and MTT assay results                                                                                                                      
According to MTT assay result in Fig. 3.21, viability of pNHDF was stimulated at the 
dose of 100 µg/mL by ethanol-water extract (6:4, v/v; extract 6) from LJF. For further 
investigations, herbal material of LJF was extracted with water, ethanol-water (1:1, v/v), 
ethanol and ethyl acetate separately which made differences by polarity of the yielding 
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products. These extracts were then further investigated by in vitro cell tests for skin 
active functions. 
3.7.2.1 Extractions of Lonicerae japonicae flos                                                         
Extracts with different polarity using water, ethanol-water (1:1, v/v), EtOH (96%, v/v) 
and ethyl acetate were prepared as shown in Fig. 3.27. 
Fig. 3.27 Four extractions and respective yields (%) from Lonicerae japonicae flos.  
As shown in Fig. 3.27, the yields (%) of the four extracts were: 35.2 % for extract V; 
33.8 % for extract S; 32.7 % for extract T; 21.3 % for extract K. 
3.7.2.2 MTT assay with extract 6, V, S, T and K  
For in vitro investigation of the influence of extract V, extract S, extract T and extract K 
from LJF on pNHDF and HaCaT keratinocytes, both cells lines were treated with these 
four extracts at different concentrations. Evaluation of the experiments, which had been 
performed in a test series, was performed by MTT assay. Results are shown in Fig. 3.21, 
Fig. 3.28, Fig. 3.29, Fig. 3.30 and Fig. 3.31.  
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MTT assay result with extract V  
Fig. 3.28 Dehydrogenase activity (MTT assay) of water extract (extract V) from 
Lonicerae japonicae flos on pNHDF at doses of 0.1, 1, 10, 100 µg / mL over an 48 h 
incubation period. Bars represent relative standard deviations (RSD) with n= 8. The 
result replicates from 2 independent experiment with * p < 0.05 and ** p < 0.01 
compared to the untreated control group (UC); Positive control (PC) with 1% FBS.  
The data (Fig. 3.28) indicated only moderate activity of extract V on pNHDF. For that 
reason, no further functional experiments were performed on this extract. 
MTT assay result with extract S 
Fig. 3.29 Dehydrogenase activity (MTT assay) of EtOH-water extract (1:1, v/v; extract S) 
from Lonicerae japonicae flos on pNHDF at doses of 0.1, 1, 10, 100 µg / mL over an 48 h 
incubation period. Bars represent relative standard deviations (RSD) with n= 8. The 
result replicates from 2 independent experiment with ** p < 0.01 compared to the 
untreated control group (UC); Positive control (PC) was treated with 1% FBS.  
The respective data (Fig. 3.29) indicated significant stimulation of cell activity after 
treatment with doses of 10 µg/mL of extract S. For that reason, this extract could be 
investigated further for its skin active function. 
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MTT assay result with extract T 
Fig. 3.30 Dehydrogenase activity (MTT assay) of EtOH extract (96%, v/v; extract T) 
from Lonicerae japonicae flos on pNHDF at doses of 0.1, 1, 10, 100 µg / mL over an 48 h 
incubation period. Bars represent relative standard deviations (RSD) with n= 8. The 
result replicates from 2 independent experiment with * p < 0.05 compared to the 
untreated control group (UC); Positive control (PC) with 1% FBS.  
The data (Fig. 3.30) indicated no positive activity of the extract T on pNHDF. At the dose 
of 100 µg / mL of extract T, the viability of pNHDF was inhibited very significantly. For 
that reason, no further functional experiments were performed on this extract. 
MTT assay result with extract K 
Fig. 3.31 Dehydrogenase activity (MTT assay) of EtOAc extract (extract K) from 
Lonicerae japonicae flos on pNHDF at doses of 0.1, 1, 10, 100 µg / mL over an 48 h 
incubation period. Bars represent relative standard deviations (RSD) with n= 8. The 
result replicates from 3 independent experiment with * p < 0.05 compared to the 
untreated control group (UC); Positive control (PC) with 1% FBS.  
The data (Fig. 3.31) showed stimulation of cell activity which was very significant of 
extract K from LJF on pNHDF at concentrations of 100 µg/ mL. For that reason, this 
extract could be investigated further for its positive function. 
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After MTT assay on pNHDF with different extracts from LJF, extract S (EtOH-water 
extract, 1:1, v/v) and extract K had positive cell activity. Further functional and chemical 
analytical experiments could be performed with them. 
3.7.3 FCPC fractionation with extract K            
Fast Centrifugal Partition Chromatography (FCPC) is based on the principal of liquid- 
liquid extraction. It can be used for comprehensive extraction, fractionation, separation 
and purification for natural products, proteins etc.(Marston et al., 1988). 
Extract K (EtOAc extract) from LJF was active on pNHDF at the concentration of 100 
µg/mL (Fig. 3.31). For investigation of the components of extract K, FCPC was 
performed. The method was described in detail in 2.2.7.4.   
The optimisation of the FCPC system                                                                                                     
For performing FCPC with extract K, it was important to choose the appropriate liquid- 
liquid partition system. For FCPC, most solvent mixtures which form two immiscible 
layers are acceptable (Marston et al., 1988). Thus, different liquid- liquid phases were 
mixed and were fractionated with extract K. The two phases were then separated and 
TLC was performed. The results were compared for the decision of the best partition 
system.                                                                   
Different partition systems were tested either according to experience or according to 
Arizona liquid system (Berthod et al., 2005) prior investigation.                                                                               
FCPC system I                                                                                                          
These two phases’ liquid-liquid partition systems were designed according to the 
experience and are listed in Table 2.4. 
Table 2.4 FCPC system I optimisation: The listed A to E systems were mixed. 10 mg of 
extract K were applied to these systems. After extraction, the different phases were 
separated and investigated by TLC. 
System I Stationary phase Mobile phase Additive (v/v) 
A Purified water 2 mL EtOAc 2 mL ------ 
B Purified water 2 mL EtOAc 2 mL 1% n-propanol 
C Purified water 2 mL EtOAc 2 mL 2% n-propanol 
D Purified water 2 mL EtOAc 2 mL 5% n-propanol 
E Purified water 2 mL EtOAc 2 mL 10% n-propanol 
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A to E systems, all upper phases were noted with number 1 while the lower phases were 
noted with number 2. TLC investigation was then performed. The result is shown in Fig. 
3.32.  
 
 
 
 
 
 
 
Fig. 3.32 TLC investigation (mobile phase: EtOAc: purified water: formic acid= 90: 5: 5, 
v/v/v) of fractions obtained from FCPC partition systems of extract K from LJF. 
Detection was made after spraying with natural product reagent A solution at 366 nm. 0: 
unfractionated extract K, A to E: fractions obtained from different FCPC partition 
systems (Table 2.4). 
FCPC system II              
For searching for the best liquid- liquid partition system, FCPC system II was shown in 
Table 2.5.  
Table 2.5 FCPC system II according to Arizona optimisation system (Berthod et al., 
2005): The listed F to J systems were mixed respectively. 10 mg extract K were applied 
to different systems. After extraction, different phases were separated and investigated 
by TLC. 
System II Heptane EtOAc Methanol Purified water 
F 1 19 1 19 
G 1 3 1 3 
H 1 1 1 1 
I 3 1 3 1 
J 9 1 9 1 
 
F to J systems, all upper phases were noted with number 1 and the lower phases were 
noted with number 2. TLC was then performed. The result is shown in Fig. 3.33.  
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Fig. 3.33 TLC investigation (mobile phase: EtOAc: purified water: formic acid= 90: 5: 5, 
v/v/v) of fractions obtained from FCPC partition systems of extract K from LJF. 
Detection was made after spraying with natural product reagent A solution at 366 nm. 0: 
unfractionated extract K, A to E: fractions obtained from different FCPC partition 
systems (Table 2.5). 
As shown in Fig. 3.32 and Fig. 3.33, system A (EtOAc with water) was finally chosen 
from system I because from the TLC result, phase A2 could probably fractionate one 
single compound which was suspected to be chlorogenic acid (Fig. 3.26). 
FCPC with extract K                                                                                                                                      
As EtOAc-water was decided as the partition phase, FCPC was performed. 1 g of extract 
K was fractionated with EtOAc-water liquid- liquid partition system. After TLC detection 
and fraction combination, 6 fractions were finally obtained from the ethyl acetate phase 
(fraction 1 to 6). Water phase fraction was obtained and named as fraction 7. TLC was 
then performed with all fractions. The results are shown in Fig. 3.34.  
 
Fig. 3.34 TLC investigation (mobile phase: EtOAc: purified water: formic acid= 90: 5: 5, 
v/v/v) of extract K (EtOAc extract from LJF) fractions obtained from FCPC. Detection 
was made after spraying with natural product A solution at 366 nm. 0: extract K; from 1 
to 6 are fractions from EtOAc phase; 7: water phase.  
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According to Fig. 3.34, fractions 2 to 6 showed still complicated patterns from TLC. A 
better method of fractionation needed to be performed for smaller fractions.  
All fractions were lyophilized and the weights were calculated. The results are listed in 
Table 3.3. 
Table 3.3 The weights and the yields of the fractions obtained by FCPC from extract K.  
Fraction number 
Weight of fraction 
(g) 
Yield (%) 
1 0.0013 0.13 
2 0.2426 24.26 
3 0.0370 3.70 
4 0.0093 0.93 
5 0.0082 0.82 
6 0.0098 0.98 
7 0.0063 0.63 
sum 0.3145 31.45 
 
As shown in Table 3.3, the sum yield (%) of extract K was only 31.45% which was 
against no sample loss principal of FCPC. The sample loss was however caused by 
sample injecting. 
3.7.4 UPLC with stationary phase from FCPC of extract K                                                                                     
As show in Fig. 3.34, fraction 7 contained probably only one single compound and it was 
doubted to be chlorogenic aicd (Fig. 3.26). UPLC was performed to prove the purity of 
fraction 7 and to identify the fraction against authentic reference of chlorogenic acid. 
Respective chromatograms are shown in Fig. 3.35.    
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Fig. 3.35 UPLC with fraction 7 (a) from FCPC with extract K (EtOAc extract from 
Lonicerae japonicae flos), chlorogenic acid reference (b) and fraction 7 mixed with 
chlorogenic acid reference (c). X axis: retention time (min); Y axis: absorbance (AU: 
absorbance units).  
According to Fig. 3.35, the main absorption peaks from fraction 7 and chlorogenic acid 
co-eluted (c). So fraction 7 was proven to be chlorogenic acid which had been already 
described for Lonicerae japonicae flos (Phan et al., 2005). With FCPC, chlorogenic acid 
was successfully isolated from the EtOAC extract (extract K) of Lonicerae japnicae flos. 
This could be a good investigated method for chlorogenic acid isolation. But according to 
Fig. 3.34, fractions 2 to 6 showed still complicated patterns by TLC. A better 
fractionation method had to be evaluated. 
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3.7.5 Fractionation of extract K with silica column PF-50SI/80G, PURIFLASHTM 
COLUMN-UPTIPREP                                                                                                                                                                 
For a better method for the fractionation of extract K, silica column PF-50SI/80G was 
used according to its weaker surface energy compared to other silica which ultimately 
facilitates narrow peaks  with basic compound. This column has also an homogeneous 
and dense chemistry which establishes very high loading capacities and stability. Thus, 
extract K was applied to silica column PF-50SI/80G in the hope of obtaining a suitable 
fractionation. The method was described in 2.2.7.6 and the gradient system is shown 
Table 2.6. 
Two runs were performed with the same gradient system. After each run, 20% of MeOH 
was used to wash the column and the elute was collected. Fractions  were combined 
according to the similar patterns of TLC investigation. The fractions from the first round 
were named according to the elution order as 1-1, 1-2, 1-3, 1-4, 1-5, 1-6, 1-7. 1-8 was 
named for the 20% of MeOH from the washing. The fractions from the second round 
were name according to the elution order as 2-1, 2-2, 2-3, 2-4, 2-5, 2-6, 2-7, 2-8. 2-9 was 
named for the 20% of MeOH from the washing. TLC was performed with all fractions. 
The results are shown in Fig. 3.36. 
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Fig. 3.36 TLC investigation (mobile phase: EtOAc: purified water: formic acid= 90: 5: 5, 
v/v/v) of fractions of extract K from silica column PF-50SI/80G of 1st (a) and 2nd (b) 
round. Detections were made after spraying with natural reagent A solution at 366nm.  
As shown in Fig. 3.36, extract K was fractionated into finer fractions by silica column PF-
50SI/80G compared to FCPC (Fig. 3.34). Fraction 1-8 and 2-9 were combined due to 
their similar TLC pattern and was named as fraction 9. All fractions were lyophilized and 
the weights were calculated. The result is shown in Table 3.4.                                                                     
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Table 3.4 The weights and yields of fractions of extract K with silica column PF-
50SI/80G, PURIFLASHTM COLUMN-UPTIPREP.  
Fractions 
Weights of fractions 
(mg) 
Yield (%) 
Round one   
1-1 706.4 18.6 
1-2 98.1 2.6 
1-3 80.8 2.1 
1-4 86.2 2.3 
1-5 52.6 1.4 
1-6 8.3 0.2 
1-7 3 0.1 
Round 2   
2-1 217.1 5.7 
2-2 446.7 11.8 
2-3 62.5 1.6 
2-4 9.7 0.3 
2-5 93.4 2.5 
2-6 121.5 3.2 
2-7 37.8 1.0 
2-8 32.9 0.9 
9 32.1 0.8 
Total  (2 rounds 
together) 
2089.1 55.1 
 
As shown in Table 3.4, although the column could achieve better separation efficiency, 
the yield was far not good as FCPC. 
3.7.6 Comparisons between Lonicerae japonicae flos purchased from China Medica 
GmbH and Caesar & Loretz GmbH                                                                                      
Lonicerae japonicae flos (LJF, from China Medica GmbH) has been proven to stimulate 
the cell viability of pNHDF (Fig. 3.21). Meanwhile, some primary chemical analyses 
were performed and chlorogenic acid was successfully fractionated with FCPC (Fig. 
3.35). For the further investigation of this herbal material, a great amount of LJF was 
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needed. Thus, 1 kg of Lonicerae japonicae flos was purchased from Caesar & Loretz 
GmbH which was the casual company for ordering plant materials for our institute.  
The new herbal material from Caesar & Loretz GmbH had morphological differences 
compared to the old LJF herbal material from China Medica GmbH (Fig. 3.8). So both 
chemical and cell in vitro functional investigations were performed with LJF herbal 
materials purchased from different companies in order to prove the equal identification.    
TLC comparison investigations                      
TLC investigation was performed with the LJF herbal materials from two different 
companies. The results are shown in Fig. 3.37.                                                                                                          
 
 
 
Fig. 3.37  TLC investigation of EtOH-water extracts (1:1, v/v) (a) and EtOAc extracts (b) 
of Lonicerae japonicae flos (LJF) purchased from China Medica GmbH and Caesar & 
Loretz GmbH. Detections were made after spraying with natural reagent A solution at 
366 nm. 1: hyperoside; 2: EtOH-water extract (1:1, v/v) of LJF from China Medica GmbH; 
3: EtOH-water extract (1:1, v/v) of LJF from Caesar & Loretz GmbH; 4: extract K from 
Caesar & Loretz GmbH; 5: caffeic acid; 6: quercitrin; 7: chlogenic acid; 8: EtOAc extract of 
LJF from China Medica GmbH; 9: EtOAc extract of LJF from Caesar & Loretz GmbH.             
As shown in Fig. 3.37, TLC patterns of both extracts of LJF from China Medica GmbH and 
Caesar & Loretz GmbH looked similarly. From TLC investigation, these two LJF herbal 
materials were identical. 
MTT assay comparison investigations                                                                                                                                   
MTT assays were performed with the herbal materials of LJF purchased from the two 
different suppliers to confirm the identical functional ability within the in vitro cell test 
system. EtOH-water extracts (6:4, v/v) of LJF from both suppliers were prepared. Test 
results are showed in Fig. 3.38. 
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Fig. 3.38 Dehydrogenase activity (MTT assay) of EtOH-water extracts (6:4, v/v) from 
Lonicarae japonicae flos (LJF) purchased from China Medica GmbH (extract 6) and 
Caesar & Loretz GmbH (extract 6c) on primary normal human dermal fibroblasts 
(pNHDF) at doses of 0.1, 1, 10, 100 µg/mL over an 48 h incubation period. Bars 
represent the relative standard deviation (RSD) with n= 8. The result replicates from 2 
independent experiments with * p < 0.05 and ** p < 0.01 compared to the untreated 
group (UC); positive control (PC) was with 1% FBS.  
The respective data (Fig. 3.38) indicated no activity of extract 6c (from Caesar & Loretz 
GmbH) on pNHDF while fibroblasts were stimulated at the concentrations of 1, 10, 100 
µg/mL significantly by extract 6 (from China Medica GmbH). For that reason, the in vitro 
cell test function of LJF herbal materials from different suppliers were not identical and 
the reason was unclear. 
The TLC investigation couldn't tell any differences of LJF herbal materials from different 
suppliers. These herbal materials from different suppliers might have different harvest 
places in China, might be stored under different conditions or might have the different 
storage time (according to the description in PPRC, the color of this herbal material 
turns from green to yellow with the running of the storage time).  
LC-MS comparison investigations 
LC-MS was performed with both materials of LJF purchased from the two different 
suppliers. Both EtOH-water extracts (6:4, v/v) were dissolved in MeOH-water (6:4, v/v) 
to 50 mg/mL. By comparing the results from two extracts, some differences were 
observed from the chromatograms. The peaks which were identifiable from the HPLC 
chromatograms existed differently in the two extracts were picked out and listed in 
Table 3.5. 
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Table 3.5 The different peaks observed after LC-MS of the EtOH-water (6:4, v/v) 
extracts from Lonicerae japonicae flos purchased from China Medica GmbH and Caesar & 
Loretz GmbH; Rt: retention time. 
Rt (min) Caesar & Loretz extract China Medica extract 
5.48  × (peak 1) 
12.76  × (peak 2) 
17.67 × (peak 3)  
17.93 × (peak 4)  
18.28 × (peak 5 )  
30.80  × (peak 6) 
36.41 × (peak 7)                                 
43.55   × (peak 8) 
48.19  × (peak 9) 
 
According to the result, 9 not identical peaks were observed by the liquid 
chromatography of these two LJF extracts. The ESI-MS spectra of the 9 peaks are listed 
in Fig. 3.39.  
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Fig. 3.39 The ESI-MS (ESI-MS/MS) spectra and UV absorptions (200-400 nm) of 9 
different peaks detected by liquid chromatography of EtOH-water (6:4, v/v) extracts of 
Lonicerae japonicae flos  purchased from from China Medica GmbH and Caesar & Loretz 
GmbH. 
As shown in Fig. 3.39, 9 compounds were found by comparing the two HPLC 
chromatograms. The differences of the components of LJF could be the reason which led 
to the different cell test results. 
In ESI-MS spectrum (a) obtained from peak 1 at Rt 5.48 min, the ion fragments (pseudo, 
positive mode) at m/z 405.1327 ([M+H]+), m/z 422.1585 ([M+NH4]+), m/z 427.1141 
([M+Na]+), m/z 443.0872 ([M+K]+) and m/z 831.2366 ([2M+Na]+) strongly indicated the 
molecular mass of 404 g/mol. Besides, the ion fragment m/z 243.0839 ([M+H]+) had the 
neutral fragment loss from 162.0498 u (theoretic 162.0528), which indicated the 
structure of a hexoside. By comparing the literature of LJF (Li, Xiao-qin et al., 2009), this 
result matched perfectly with the ESI-MS of scoxyloganin, which had the molecular mass 
of 404 g/mol. Thus, this substance could possibly be secoxyloganin. 
In ESI-MS spectrum (b) from peak 2, the ion fragments (pseudo, positive mode) at m/z 
389.1413 ([M+H]+), m/z 406.1666 ([M+NH4]+), m/z 411.1237 ([M+Na]+), m/z 427.0954 
([M+K]+) and m/z 799.2564 ([2M+Na]+) were obtained and strongly indicated the 
molecular mass of 388 g/mol. Besides, the ion fragment m/z 227.0898 ([M+H]+) had 
neutral fragment loss from 162.0523 u (theoretic 162.0528), which indicated the 
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existence of hexoside. By comparing the literature,  pseudo ion fragment mass at m/z 
411.1237 ([M+Na]+), m/z 389.1413 ([M+H]+) and m/z 799.2564 ([2M+Na]+) were in 
accordance with the MS data of epi-vogeloside reported in LJF (Li, X.Q. et al., 2009), and 
epi-vogeloside had the molecular mass of 388 g/mol which matched the MS spectrum of 
peak 2 very well. Thus, this substance could possibly be epi-vogeloside.  
The ESI-MS spectra (positive mode) of (c), (d) and (e) from peaks 3, 4 and 5 had many 
similar ion fragments.. In ESI-MS spectrum of (d), the ion fragment (pseudo) at m/z 
163.0585 ([M+H]+) and m/z 325.1107 ([M+H]+) indicated the sugar fragments. ESI-
MS/MS was performed with the ion fragment  at m/z 913.5132 ([M+Na]+) (peseudo ȌǤȟ/z between the m/z 913.5129 ([M+Na]+), m/z 781.4736 ([M+Na]+), m/z 
751.4617([M+Na]+), m/z 619.4239 ([M+Na]+), m/z 455.3464 ([M+Na]+) were typical 
sugar fragment mass. From m/z 455.3464 ([M+Na]+), there was no further sugar 
fragment loss. Thus, the ion fragment at m/z  455.3464 ([M+Na]+) was deduced to be the 
aglycon, so were the same in spectra (c) and (e). According to the analysis, the 
substances (peak3, peak 4 and peak 5) were identified to be triterpenoid saponin. 
In ESI-MS spectrum (f) from peak 6, the ion fragments (pseudo, positive mode) at m/z 
353.2678 ([M+H]+), m/z 375.2477 ([M+Na]+) and m/z 391.2309 ([M+K]+) suggested 
that molecular mass was 352 g/mol and the molecule was very stable.  
In ESI-MS spectra (g), (h) and (i) from peaks 7, 8 and 9, no conclusion or conjecture 
could be made due to the very less information. 
The componential differences between these two LJF EtOH-water extracts were briefly 
compared by LC-MS. However, the further investigations would be time-consuming. And 
the purpose of the work is to find one TCM plant which works stable on the skin cells, 
and it would be great that this plant works positively on both HaCaT keratinocytes and 
pNHDF. Thus, the further investigation with LJF was terminated. The investigations with 
Moutan cortex were then carried out due to its excellent in vitro cell tests (Fig. 3.22). 
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3.8 Skin active functional and phytochemical investigations of Moutan cortex 
3.8.1 MTT assay with crude extracts from Moutan cortex 
For in vitro investigation of the influence of EtOH-water extract (6:4, v/v; extract 7) and 
water extract (extract 8) from Moutan cortex, pNHDF and HaCaT keratinocytes were 
treated with extract 7 and extract 8 at different concentrations. Evaluation of the 
experiments, which had been performed in 2 independent test series, was performed by 
MTT assay. Results are shown in Fig. 3.22. 
Fig. 3.22 Dehydrogenase activity (MTT assay) of EtOH-water extract (6:4, v/v; Extract 7) 
and water extract (Extract 8) from Moutan  cortex on primary normal human dermal 
fibroblasts (pNHDF) (a) and HaCaT keratinocytes (b) at doses of 1, 10, 100 µg/mL over 
an 48 h incubation period. Bars represent relative standard deviations (RSD) with n=8. 
The results replicate from 3 independent experiments with * p < 0.05 and ** p < 0.01 
compared to the untreated control group (UC); Positive control (PC): 1% FBS for (a) and 
5% FBS for (b). 
As shown in Fig. 3.22, both ethanol-water (6:4, v/v; Extract 7) and water extract 
(Extract 8) had positive effects on the viability of pNHDF and HaCaT keratinocytes. For 
that reason, further investigations were performed. 
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3.8.2 Optimisation of the extracts from Moutan cortex 
For an optimal extraction of Moutan cortex (MC), four extractions with different solvent 
systems were performed: Extract M0 (water extract), extract M30 (EtOH-water, 3:7, 
v/v), extract M60 (EtOH-water, 6:4, v/v) and extract M96 (96% EtOH, v/v).  
1 g of milled Moutan cortex was extracted in 10 mL of purified water, EtOH-water (3:7, 
v/v), EtOH-water (6:4, v/v) and EtOH (96%, v/v). The suspension was mixed by vortex 
for 3 min. Centrifugation was then performed for 5 min at RCF 1852. Supernatants were 
filtrated with filter paper. TLC investigation (Fig. 3.40) was performed and the 
respective yields (%) were calculated (Table 3.6). 
Fig. 3.40  TLC investigation [Mobile phase I: EtOAc- water- formic acid= 90- 5- 5, v/v/v 
for (a), (b) and (e); Mobile phase II: cyclohexane- ethyl acetate, 3:1, v/v for (c) and (d)] 
of  extract M0 (water extract), extract M30 (EtOH-water extract, 3:7, v/v), extract M60 
(EtOH-water extract, 6: 4, v/v) and extract M96 (96% EtOH, v/v) from Moutan cortex. 
Detections were made: after development in the chamber at 254 nm (a & c), after 
spraying with natural reagent A solution at 366 nm (b), after spraying with FeCl3 
solution under daylight (d) and after spraying vanillin-HCl reagent under daylight (e). 1: 
Rutin; 2: Caffeic acid; 3: Quercitrine; 4: Chlorogenic acid; 5: Hyperosid; 0: water exract of 
MC; 30: EtOH-water (3:7, v/v) extract of MC; 60: EtOH-water (6:4, v/v) extract of MC; 96: 
EtOH (96%, v/v) extract of MC. 
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According to Fig. 3.40, more information of the content of MC was obtained with mobile 
phase I than with mobile phase II. Extract M30 and extract M60 had similar TLC patterns 
(a & b) and the amount of extracted components from these two extracts seemed to be 
greater than from extract M0 and extract M96. As shown in (d), spots of all four extracts 
turned to blue after spraying with FeCl3 solution, which indicats the existence of 
galloylated compounds. After spraying with vanillin-HCl, red spots were observed for 
the four extracts (e); this acidified vanillin reaction (Broadhurst, R.B. et al., 1978) 
indicated the existence possibility of flavan-3-ols, and condensed tannins in the ethanol-
water extracts from Moutan cortex. 
For all above, it was concluded that tannin-like and related galloylated compounds are 
parts of MC. Extraction with EtOH-water (3:7, v/v) and EtOH-water (6:4, v/v) yielded 
more components from MC than the other two extractions. 
Table 3.6 The weights and yields (%) of extract M0 (water extract), extract M30 (EtOH: 
water=3: 7, v/v), extract M60 (EtOH: water= 6: 4, v/v) and extract M96 (96% EtOH, v/v) 
from Moutan cortex, related to a 1 g weight in quantity of Moutan cortex. 
Extract Weight (g) Yield (%) 
M0 0.1907 19.7 
M30 0.1523 15.1 
M60 0.1539 15.4 
M96 0.0366 3.7 
 
According to Table 3.6, considering of quantitative extracting from MC, the extraction 
using 96% EtOH had the lowest yield (%). 
Taking into account the TLC investigations and the quantitative evaluation, the optimal 
extraction system for MC was supposed to be EtOH-water (3:7, v/v) or EtOH-water (6:4, 
v/v). Moreover, the cell based in vitro activity had been detected by using EtOH-water 
extract (6:4, v/v) from MC (3.6.9), so the best extraction system for MC was decided to 
be EtOH-water (6:4, v/v). 
3.8.3 Tannin content of Moutan cortex 
As shown in Fig. 3.40, tannin-like compounds were detected by TLC and subsequent 
spaying with vanillin-HCl reagent. The tannin content of MC was determined 
quantitatively (Glasl, 1983) by using the tannin-protein binding reaction (method 
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described in 2.2.7.2). The tannin content of MC was determined to be 2.75% which was a 
quite high content. Thus, subsequent investigations of tannins from MC had to be 
performed. 
3.8.4 Defatting of Moutan cortex                                                                                                                              
As a common sense, many lipophilic extracts from natural products are toxic for skin 
cells, so defatting was performed with Moutan cortex prior to further investigations. The 
method was described in 2.2.7.5. 1500.0 g of milled Moutan cortex was extracted with 
petroleum benzine and 33.0 g of lipophilc extract (extract PE) was obtained. The yield 
was 2.2%, related to the starting material.                                                                                                                                               
After extract PE was obtained, it was observed that many crystalls precipitated when 
extract PE was cooled down to RT. The picture of crystals' formation is shown in Fig. 
3.41.  
 
Fig. 3.41 Crystalline precipitates from extract PE (petroleum benzine extract) from 
Moutan cortex. 
As shown in Fig. 3.41, these crystals formed in extract PE were subsequently analyzed 
by GC-MS for identification or to obtain more information on this substance. 
3.8.5 GC-MS with extract PE and crystals inside 
The sample of extract PE was prepared in petroleum benzine at 1 mg/mL. Some white 
crystals obtained from extract PE were cleaned carefully with hexane. After drying, the 
crystals were dissolved in hexane to 1 mg/mL. Both samples were applied to GC-MS. The 
running conditions and method are described in 2.2.7.9. The result of GC-MS is shown in 
Fig. 3.42. 
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Fig. 3.42 GC-MS total ion chromatograms of extract PE (a) and crystalline precipitates 
obtained from extract PE (b); EI/MS spectrum of crystalline precipitates in extract PE (c) 
(TIC).  
According to Fig. 3.42, the crystals from extract PE appeared to be a single peak in GC 
which was also identical with the main peak shown in the GC from extract PE.  
For the MS, two main mass signals were focal for m/z 166 and 151. NIST database was 
used for the data evaluation. Paeonol was suggested to be the compound which was 
already known as the major phenolic compound in MC (Chun, S.C. et al., 2007). The 
chemical structure of paeonol is shown in Fig. 3.43. 
Fig. 3.43 The molecular structure of paeonol. 
The molecular weight of paeonol is 166.174 g/mol which matched the mass spectrum 
perfectly. The fragment of m/z 151 matched the molecular weight of paeonol minus one 
methyl group. For the unambiguous identification of the compound, 1H and 13C NMR 
analyses were performed. 
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3.8.6 1H and 13C NMR of crystal precipitate from extract PE 
After rinsed with hexane, the crystals from extract PE, which were doubted to be 
paeonol were brought into a vacuum drying oven over night. 5.4 mg of the dry crystals 
were dissolved in CDCl3; 1H NMR and 13C NMR measurements were performed. Results 
are shown in Fig. 3.44. 
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Fig. 3.44 1H NMR (a) and 13C NMR of paeonol, dissolved in CDCl3, 400 MHz for 1H (a) and 
100 MHz for 13C (b); ǣɁȋȌǤ 
As shown in Fig. 3.44, this white needle appeared in extract PE was identified to be 
paeonol (compound 1) by NMR analyses. All data obtained were consistent with 
published literature (Lee, S.C. et al., 2005) (for the detailed NMR analyses see appendix). 
3.8.7 In vitro skin function cell investigation with extract PE 
After extract PE was obtained, its effect on in vitro cell physiology was investigated with 
both pNHDF and HaCaT keratinocytes. For cell in vitro tests, Aqua Millipore was added 
to extract PE and the solution was dissolved with the help of 15 min ultrasonic bath at 
RT. The PE solution extract was then filtrated with sterile filter (0.2 µm) and was diluted 
to the final concentrations with appropriate medium required by cell culture. According 
to lab experience, pNHDF are more sensitive with XTT assay than with MTT assay. For 
this reason, XTT assay was performed with pNHDF instead of MTT assay. BrdU cell 
proliferation assay was made close behind with HaCaT keratinocytes. The results of in 
vitro cell tests are shown in Fig. 3.45 and Fig. 3.46. 
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Fig. 3.45 Dehydrogenase activity XTT assay of petroleum benzine extract from Moutan 
cortex on primary normal human dermal fibroblasts (pNHDF) at doses of 0.05, 0.1, 1, 10 
and 20 µg/mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=6. The result replicates from 2 independent experiments with 
**  p < 0.01compared to the untreated control group (UC); Positive control (PC) 1% FBS. 
According to Fig. 3.45, the respective data indicated no activity of extract PE on pNHDF.  
Fig. 3.46 Dehydrogenase activity [MTT assay; (a)] and cell proliferation assay [BrdU 
assay; (b)] of petroleum benzine extract from Moutan cortex on HaCaT keratinocytes at 
doses of 0.1, 1, 10, 20, 50 µg/mL over an 48 h incubation period. Bars represent relative 
standard deviations (RSD) with n=6 (a) and n=8 (b). The results replicate from 2 
independent experiments with * p < 0.05 and ** p < 0.01 compared to the untreated 
control group (UC); Positive control (PC) 5% FBS. 
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The respective data in Fig. 3.46 indicated no positive activity of extract PE on HaCaT 
keratinocytes. As shown in Fig. 3.46 (b), at the doses of 10, 20 and 50 µg/mL, the cell 
proliferation was inhibited.  
According to these results, no positive skin activity was observed. Thus, no further 
experiments were performed on this extract. 
3.8.8 The optimisation of quantitative and effective extracting method of Moutan 
cortex 
The EtOH-water (6:4, v/v) extract of defatted MC herbal material had to be fractionated 
for further bioassay-guided investigations. In the purpose to obtain high yields and 
effective extraction, two different extracting methods were experimentally performed 
prior to a large scale extraction. 
First extracting trial: 50.0 g of defatted MC were extracted with EtOH-water (6:4, v/v) 
for 15 min in ultrasonic bath; after centrifugation at RCF 1852 for 5 min, filtration with 
filter paper was performed.  Final extract was obtained and was named as extract US.  
Second extracting trial: 50.0 g of defatted Moutan cortex were extracted with EtOH-
water (6:4, v/v) using magnetic stir bar at maximum speed for about 19 h; after 
centrifugation at RCF 1852 for 5 min, filtration with filter paper was performed. Final 
extract was obtained and was named as extract MR. TLC investigation was performed 
for both extracts to compare the two extracts. The results are shown in Fig. 3.47.       
Fig. 3.47  TLC investigation (mobile phase: EtOAc-formic acid-water, 90: 5 : 5, v/v/v) for 
extract US and extract MR from defatted MC. Detections were made: after plate 
development at 254 nm (a); after spraying with vanillin-HCl (b) reagent under daylight.                                                                                               
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According to Fig. 3.47, the qualitative and quantitative composition of extract US and 
extract MR were similar. This vanillin-HCl assay indicated the existence of condensed 
tannins etc. in the EtOH-water extract (6:4, v/v) of defatted MC (Broadhurst et al, 1978). 
Table 3.7 The weights and yield (%) of extracts US and MR related to the 50.0 g starting 
material of defatted Moutan cortex. 
Extract Weight (g) Yield (%) 
US 3.73 7.5 
MR 4.55 9.1 
As shown in Table 3.7, the yield (%) of extraction by using magnetic stir bar was higher 
than extraction with ultrasonic bath. Moreover, the extracting method by stirring was 
preferred because of the gentleness and low heat production from this method. Thus, 
this method was decided for the further extraction and fractionation of defatted MC. 
3.8.9 Bioassay-guided fractionation with defatted Moutan cortex                                                                                
Ethanol-water (6:4, v/v) extraction of defatted Moutan cortex (extract 9)                                                   
After the optimisation of the extracting method of defatted MC (3.7.8), extraction with 1 
kg of defatted MC was performed. Due to the great amount of the material, extraction by 
magnetic stirring bar was not practical any more as the tool for this extraction. For that 
reason, extracting with a shaker was performed and the extraction was twice performed 
for obtaining a higher yield.  
The method is described in 2.2.7.15. After the extraction, 247.03 g of dry extract were 
obtained with a yield (%) of 24.7% related to 1.0 kg of defatted Moutan cortex, which 
was even better than two trial extractions in 3.7.8. The extract was named as extract 9. 
3.8.10 FCPC with extract 9                                                                                                                                           
For further phytochemical investigation, extract 9 (EtOH-water extract of defatted MC, 
6:4, v/v) was fractionated by FCPC. 1.0 g of extract 9 was applied to FCPC. The method 
used is described in 2.2.7.4. TLC was performed with 7 fractions obtained finally 
(fractions 1 to 6 were obtained from EtOAc phase, 7 was the water phase). TLC results 
are shown in Fig. 3.48. 
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Fig. 3.48 TLC investigation (mobile phase: EtOAc-formic acid-water, 90: 5: 5, 
v/v/v) of subfractions obtained from FCPC of extract 9 from Moutan cortex (MC). 
Detections were made: after chamber development at 254 nm (a); after spraying 
with natural product reagent A solution at 366 nm (b); after spraying with 
vanillin-HCl under daylight (c). 1 to 6: Fractions from EtOAc phase of FCPC; 7: 
Water phase from FCPC; 9: Extract 9.  
According to Fig. 3.48, the fractions obtained from FCPC were not pure, most of 
them showed complex TLC patterns. After spraying with vanillin-HCl reagent, 
red spots indicated the occurrence of flavan-3-ols and condensed tannins. 
According to the lab experience, the red spots at the top might be flavan-3-ols. 
Further investigation and identification had to be performed on this subject.     
So far, there were not so many scientific articles published about the 
investigation of tannins from MC. For that reason, this seemed to be a promising 
subject for the further investigations.  
The weights and yield (%) of fractions from FCPC are listed in Table 3.8. 
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Table 3.8 Weights and yields (%) of fractions obtained from FCPC related to 1.0 
g extract 9 as starting material.  
Fraction Weight (mg) Yield (%) 
1 2.5 0.3 
2 6.7 0.7 
3 111.1 11.1 
4 9.2 0.9 
5 23 2.3 
6 37.9 3.8 
7 748.8 74.9 
sum 936.7 94 
 
3.8.11 Fractionation of extract 9 with tap funnel 
After fractionation of extract 9 with FCPC, the idea of getting into the research 
direction of analyzing tannins was decided. For investigations, extract 9 needed 
to be further fractionated by partitioning of extracts between EtOAc and water 
phases. The method of using tap funnel was decided for this fractionation due to 
its advantages of easy operation, time saving and no sample loss through big 
amount extraction. The method is described in 2.2.7.15. 
With the two fractions 10 and 12 which were obtained, TLC investigations were 
performed. According to Fig. 3.48, the occurrence of condensed tannins was 
suspected. For that reason, some reference compounds, such as (+)-catechin and 
(-)-epicatechin were used. The results of TLC are shown in Fig. 3.49. 
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Fig. 3.49  TLC investigations (mobile phase: EtOAc-formic acid-water, 90: 5: 5, 
v/v/v) of fraction 10 (EtOAc fraction) and fraction 12 (water fraction) from 
extract 9; Detections were made:  directly after the chamber development at 254 
nm (a); after spraying with vanillin-HCl reagent under daylight (b); spraying 
with natural product reagent A solution at 366 nm (c). Epi: (-)-epicatechin, 5 
mg/mL; Cat: (+)-catechin, 5 mg/mL; 10: fraction 10; 12: fraction 12.                                                                                               
According to Fig. 3.49 (b), red spots from fractions 10 and 12 after spraying 
with vanillin-HCl reagent showed at similar Rf values with (+)-catechin and (-)-
epicatchin. This indicates that catechin and epicatechin might exist in both 
extracts. The weights and yields (%) of fractions 10 and 12 from this 
fractionation are shown in Table 3.9.  
Table 3.9 The weights and yields (%) of fractions 10 and 12 obtained from 
EtOAc-H2O partitioning fractionation related to 50.0 g extract 9 as starting 
material. 
Fraction Weight (g) Yield (%) 
10 7.32 14.6 
12 41.82 83.6 
Sum 49.14 98.2 
 
3.8.12 In vitro cell test with fractions 10 and 12 from Moutan cortex 
Fractions 10 (EtOAc fraction) and 12 (water fraction) were tested in vitro on 
pNHDF and HaCaT keratinocytes for the further functional experiments in the 
purpose of finding the skin active fraction from MC.  
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In vitro cell test with fraciton 10 from Moutan cortex 
For in vitro investigation of the influence of EtOAc fraction from defatted Moutan 
cortex (fraction 10), pNHDF and HaCaT keratinocytes were both treated with 
fraction 10 at different concentrations. Evaluation of the experiments, which had 
been performed in 2 different independent test series, was performed by XTT 
assay, neutral red uptake assay and BrdU cell proliferation assay. Results are 
shown in Fig. 3.50. 
Fig. 3.50 Dehydrogenase activity assay [XTT assay, (a)] and BrdU cell 
proliferation assay (b) of fraction 10 from defatted Moutan cortex (MC) on 
primary normal human dermal fibroblasts (pNHDF) at doses of 0.1, 1, 10,  20, 30 
and 50 µg/mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=8. The results replicate from 2 independent 
experiments with * p < 0.05 and ** p < 0.01 compared to the untreated control 
group (UC); Positive control (PC) 1% FBS. 
The respective data (Fig. 3.50) indicated that the dehydrogenase activity of 
pNHDF were stimulated by fraction 10 at low doses of 0.1, 1 and 10 µg/mL, while 
the proliferation of pNHDF was increased at the dose of 10 µg/mL. The cell 
viability was inhibited to a great extent at dose of 30 µg/mL and the cell 
proliferation was inhibited at the same concentration compared to the respective 
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untreated control groups. At the dose of 50 µg/mL, the cell proliferation was 
inhibited very significantly which indicated that cytotoxicity might be caused by 
fraction 10 at this concentration. 
 
Fig. 3.51 Cell viability assay [neutral red uptake assay, (a)] and cell proliferation 
assay (BrdU cell proliferation assay, (b)) of fraction 10 from defatted Moutan 
cortex (MC) on HaCaT keratinocytes at doses of 1, 10, 30, 50 and 100 µg/mL over 
an 48 h incubation period. Bars represent relative standard deviations (RSD) 
with n=6 for (a) and n=8 for (b). The results replicate from 3 independent 
experiments with * p < 0.05 and ** p < 0.01 compared to the untreated control 
group (UC); Positive control (PC) 5% FBS. 
The respective data (Fig. 3.51) indicated significant stimulation activity of 
fraction 10 on HaCaT keratinocytes at doses of 1 and 10µg/mL. Also cell 
proliferation was stimulated at the concentration of 1 µg/mL.  
According to Fig. 3.50 and Fig. 3.51, fraction 10 from defatted MC stimulated 
cell viability of pNHDF and HaCaT keratinocytes at low concentrations as well as 
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the cell proliferation. For that reason, further functional investigation and 
phytochemical analyses were performed with fraction 10.  
In vitro cell test with fraction 12 from Moutan cortex 
For in vitro investigation of the influence of fraction 12 from defatted Moutan 
cortex on pNHDF and HaCaT keratinocytes were both treated with fraction 12 at 
different concentrations. Evaluation of the experiments, which had been 
performed in 2 different independent test series, was performed by XTT assay, 
neutral red uptake assay and BrdU cell proliferation assay. Results are shown in 
Fig. 3.52. 
Fig. 3.52 Dehydrogenase activity assay [XTT assay, (a)] and cell proliferation 
assay [BrdU cell proliferation assay, (b)] of  fraction 12 from defatted Moutan 
cortex (MC) on primary normal human dermal fibroblasts (pNHDF) at doses of 
0.1, 1, 10,  20, 30 and 50 µg/mL over an 48 h incubation period. Bars represent 
relative standard deviations (RSD) with n=8. The results replicate from 3 
independent experiments with * p < 0.05 and ** p < 0.01 compared to the 
untreated control group (UC); Positive control (PC) 1% FBS. 
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The respective data (Fig. 3.52) indicated that the cell viability of pNHDF was 
significantly stimulated by fraction 12 at low doses of 0.1 and 1  µg/mL, while the 
proliferation rates of pNHDF increased at the dose of 1 µg/mL. The cell viability 
was inhibited at higher dose of 30 µg/mL and cell proliferation was inhibited to a 
great extend at the dose of 50 µg/mL compared to untreated control which 
indicated that cytotoxicity might be caused at this concentration. 
Fig. 3.53 Cell viability assay [neutral red uptake assay, (a)] and cell proliferation 
assay (BrdU cell proliferation assay, (b)) of water fraction 12 from defatted 
Moutan cortex (MC) on HaCaT keratinocytes at doses of 0.1, 1, 10, 30, 50 and 100 
µg/mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=6 for (a) and n=8 for (b). The results replicate from 3 
independent experiments with ** p < 0.01 compared to the untreated control 
group (UC); Positive control (PC) 5% FBS. 
According to Fig. 3.52 and Fig. 3.53, fraction 12 from defatted MC stimulated 
cell viability of pNHDF and HaCaT keratinocytes at low concentrations and the 
same time the cell proliferation was increased. For that reason, further 
functional investigation and phytochemical analyses had to be performed with 
fraction 12.  
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By in vitro cell investigation, stimulating activity on pNHDF and HaCaT 
keratinocytes was obtained from both fraction 10 and fraction 12 from Moutan 
cortex. Thus, both would be further investigated functionally and 
phytochemically. 
3.8.13 Fractionation of fraction 12 by Sephadex® LH-20         
As fraction 12 was proven to have positive influence on both pNHDF and HaCaT 
keratinocytes, further fractionation was performed. By TLC investigations, 
tannins had been detected in this fraction (Fig. 3.48), for that,  Sephadex®LH-20 
was chosen for the further fractionation. It is known that this stationary phase 
can be well used for the separation of proanthocyanidins. While flavan-3-ols and 
oligomeric proanthocyanidins can be separated by the use of methanol and 
ethanol as mobile phases, polymeric proanthocyanidins can be eluted by 
acetone-H2O mixture (Hagerman, 2011).  
The fractionation method used for the separation of fraction 12 is described in 
2.2.7.6. Fraction 12 (1.4 g) was applied to Sephadex® LH-20 column. The MeOH-
water eluate (1:1, v/v) was named as fraction 121 and the resulting acetone-
water (7:3, v/v) eluate was named as fraction 122.  TLC investigation of both 
fractions was performed and the respective results are shown in Fig. 3.54.                                                                                                                                          
Fig. 3.54  TLC investigation (EtOAc: formic acid: water= 90: 5: 5, v/v/v)  of 
MeOH-water (1:1, v/v) fraction 121 and 70% acetone fraction 122 obtained from 
Sephadex®LH-20 from fraction 12 from Moutan cortex (MC). Detections were 
made: directly after chamber development at 254 nm (a); after spraying with 
natural product reagent A solution at 366 nm (b); after spraying with vanillin-
H2SO4 reagent under daylight (c).  
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As shown in Fig. 3.54, the polymeric and other high molecular 
proanthocyanidins were fractionated (fraction 122) with acetone-water (7:3, v/v) 
and shown as the dark red spot at the bottom line. 
Table 3.10 The weights and yields (%) of fractions obtained from fractionation 
of Moutan cortex by Sephadex® LH-20 related to 1.4 g of fraction 12 as the 
starting material.  
Fraction Weight (g) Yield (%) 
121 0.51 36.7 
122 0.10 7.4 
Sum 0.62 44.1 
 
3.8.14 In vitro cell tests with fractions 121 and 122   
For in vitro investigation on the influence of fractions 121 and 122 on skin cells, 
pNHDF and HaCaT keratinocytes were treated with the fractions at different 
concentrations. Evaluation of the experiments, which had been performed in 2 
independent test series, was performed by XTT assay and BrdU cell proliferation 
assay. Respective results are shown in Fig. 3.55,  Fig. 3.56 and Table 3.11. 
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In vitro cell assays with fraction 121  
 
Fig. 3.55 Dehydrogenase activity [XTT assay, (a)] and cell proliferation assay 
(BrdU cell proliferation assay) of fraction 121 from Moutan cortex on primary 
normal human dermal fibroblasts (pNHDF) at doses of 0.05, 0.1, 1, 10 and 30 
µg/mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=8. The results rep mlicate from 3 independent 
experiments with * p < 0.05 and ** p < 0.01 compared to the untreated control 
group (UC); Positive control (PC) 1% FBS. 
The respective data (Fig. 3.55) indicated that the cell viability of pNHDF was 
stimulated significantly by fraction 121 at low doses of 0.05, 0.1 and 1 µg/mL, 
while the proliferation of pNHDF was increased at the dose of 0.05, 0.1 and 1 
µg/mL. At all test concentrations, no cytotoxicity was observed. 
For in vitro cell investigation with fraction 122, neutral red uptake assay and 
BrdU cell proliferation assay were performed. The results are shown in Fig. 3.56. 
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Fig. 3.56 Cell viability assay [neutral red uptake assay, (a)] and cell proliferation 
assay [BrdU cell proliferation assay, (b)] of fraction 121 from Moutan cortex (MC) 
on HaCaT keratinocytes at doses of 0.1, 1, 10, 20, 30, 50 and 100 µg/mL over an 
48 h incubation period. Bars represent relative standard deviations (RSD) with 
n=6 for (a) and n=8 for (b). The results replicate from 3 independent 
experiments with ** p < 0.01 compared to the untreated control group (UC); 
Positive control (PC) 5% FBS. 
The respective data (Fig. 3.56) indicated that the cell viability of HaCaT 
keratinocytes was stimulated by fraction 121 at doses of 1, 10, 20 and 30 µg/mL, 
while the proliferation of HaCaT keratinocytes was increased at the dose of 1 and 
10 µg/mL. As shown in BrdU cell proliferation assay, the cell proliferation was 
reduced to a great extend at the dose of 100 µg/mL compared to untreated 
control. 
For the investigation of the cytotoxicity of fraction 121, LDH cytotoxicity assay 
was performed on both pNHDF an HaCaT keratinoytes. Lactate dehydrogenase 
(LDH) is an a typical necrosis marker and an indicator for the integrity of cell 
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membranes. LDH content in the cell culture media was quantified by this assay 
for the determination of necrotic cytotoxicity. The method of this assay was 
described in 2.2.8.6. 
Table 3.11 LDH cytotoxicity investigation with fraction 121 on both pNHDF and 
HaCaT keratinocytes. Positive control (PC) was treated with 1% FBS for pNHDF 
and 5% FBS for HaCaT keratinocytes. The LDH value (%) is related to LDH 
release level of the untreated control group. n.d.: not determined. 
Cell 
type 
Concentrations (µg/mL) 
PC 0.1 1 10 20 30 50 100  
pNHDF 2.0 0.6 0.1 0.5 0.7 0.7 n.d. n.d. LDH 
(%) HaCaT 1.7 n.d. -0.8 -1.4 -1.6 n.d. -3.2 -3.3 
 
As shown in Table 3.11, there was no necrotic cytotoxicity observed according 
to all the low relative LHD release values. Compared with the low proliferation 
value caused by fraction 121 at 100 µg/mL on HaCaT kerationcytes (Fig. 3.54), it 
is concluded that fraction 121 could decrease the proliferation of HaCaT 
keratinocytes at this concentration without causing cell necrosis. 
According to Fig. 3.5, Fig. 3.56 and Table 3.11, 50% MeOH fraction (fraction 
121) from fraction 12 through Sephadex® LH-20 column could stimulate cell 
viability of pNHDF and HaCaT keratinocytes at low concentrations and the same 
time the cell proliferation was influenced. For that reason, further functional 
investigation and phytochemical analyses had to be performed with fraction 121.  
In vitro cell assays with fraction 122  
For in vitro cell investigation of the influence of fraction 122 on pNHDF and 
HaCaT keratinocytes, both cell lines were treated at different concentrations. 
Evaluation of the experiments, which had been performed in 2 different 
independent test series, was performed by XTT assay, neutral red uptake assay 
and cell BrdU proliferation assay. Results are shown in Fig. 3.57,  Fig. 3.58 and 
Table 3.12. 
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Fig. 3.57 Dehydrogenase activity assay [XTT assay, (a)] and cell proliferation 
assay (BrdU cell proliferation assay) of fraction 122 from Moutan cortex on 
primary normal human dermal fibroblasts (pNHDF) at doses of 0.05, 0.1, 1, 10 
and 30 µg/mL over an 48 h incubation period. Bars represent relative standard 
deviations (RSD) with n=8. The results replicate from 3 independent 
experiments with * p < 0.05 and ** p < 0.01 compared to the untreated control 
group (UC); Positive control (PC) 1% FBS. 
The respective data (Fig. 3.57) indicated that the cell viability of pNHDF was 
stimulated significantly by fraction 122 at low doses of 0.05, 0.1 and 1 µg/mL, 
while the proliferation of pNHDF was increased. The viability of pNHDF was 
started to be inhibited at the dose of 10 µg/mL, at the dose of 30 µg/mL the cell 
viability was only about the half compared to the untreated control, from which 
the cytotoxicitiy might be caused. Accordingly, the proliferation of the cells was 
also inhibited to a great extent at the dose of 10 µg/mL. 
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Fig. 3.58 Cell viability assay [neutral red uptake assay, (a)] and cell proliferation 
assay [BrdU cell proliferation assay, (b)] of fraction 122 from Moutan cortex (MC) 
on HaCaT keratinocytes at doses of 0.1, 1, 10, 20 and 30 µg/mL over an 48 h 
incubation period. Bars represent relative standard deviations (RSD) with n=6 
for (a) and n=8 for (b). The results replicate from 3 independent experiments 
with ** p < 0.01 compared to the untreated control group (UC); Positive control 
(PC) 5% FBS. 
The respective data (Fig 3.58) indicated that the cell viability of HaCaT 
keratinocytes was stimulated significantly by fraction 122 at doses of 0.1, 1 and 
10 µg/mL, while the proliferation of HaCaT keratinocytes was increased at the 
dose of 0.1 and 10 µg/mL. The viability of HaCaT keratinocytes was started to be 
inhibited at the dose of 20 µg/mL, the cell viability was only about 24% 
compared to the untreated control at the dose of 30 µg/mL, from which the 
cytotoxicitiy might be caused. Accordingly, the proliferation of the cells was also 
inhibited to a great extent at the dose of 30 µg/mL. 
For the investigation of the cytotoxicity of fraction 122, LDH cytotoxicity assay 
was performed on both pNHDF on HaCaT keratinoytes. Results are shown below. 
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Table 3.12 LDH cytotoxicity results from fraction 122 on both pNHDF and 
HaCaT keratinocytes. Positive control (PC) was treated with 1% FBS for pNHDF 
and 5% FBS for HaCaT keratinocytes. The LDH value (%) is the relative LDH 
release related to the untreated control group. n.d.: not determined. 
Cell 
type 
Concentrations (µg/mL) 
PC 0.1 1 10 20 30 50 
LDH 
(%) 
pNHDF 0.6 0.2 -0.7 -0.8 6.0 16.2 n.d. 
HaCaT 1.7 n.d. -0.1 -3.0 6.6 n.d. 11.0 
  
As shown in Table 3.12, at the doses of 30 and 50 µg/mL, the LDH values (%) 
increased to 16.2% and 11.0%, which indicated necrosis of the cells. The result 
matched also well to cell viability and proliferation assays. 
For all above in vitro cell test results from fractions 121 and 122 indicated that, 
they had both active functions on cell viability and cell proliferation. But fraction 
122 could cause necrotic cytotoxicity at the higher concentration of 30 µg/mL. 
3.8.15 Fractionation of fraction 10 with Sephadex® LH-20                                                                                                                              
As fraction 10 was proven to have positive influence on both pNHDF and HaCaT 
keratinocytes (Fig. 3.50 and Fig. 3.51), further fractionation was performed. 
Due to the positive vanillin-HCl reagent detection (Fig. 3.49) of fraction 10, 
Sephadex®LH-20 was used for the further fractionation in the purpose of 
obtaining a good separation of these phenolic compounds. 
The method used is described in 2.2.7.6. 6.0 g of fraction 10 were applied to the 
column (65 cm × 3 cm) and ethanol (96%, v/v; for fractionation of flavonoids, 
flavan-3-ols and oligomeric proanthocyanidins), methanol (for fractionating 
oligomeric proanthocyanidins) and acetone (70%; for fractionating polymeric 
proanthocyanidins) were used to elute different fractions. Ethanol-eluted  
fractions were combined according to the similar patterns of TLC plates. There 
were 11 final fractions obtained and named as 10A to 10K. Methanolic fraction 
was collected and was named as fraction 101. Finally, the column was eluted 
with acetone (70%),  the fraction was collected and named as fraction 102.  
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TLC investigation was performed with all fractions obtained. Results are shown 
in Fig. 3.59. 
 
Fig. 3.59 TLC investigation (mobile phase: EtOAc- formic acid- water= 90- 5- 5, 
v/v/v) of fractions obtained from Sephadex® LH-20 of fraction 10 from Moutan 
cortex. Detections were made: under daylight (a); after spraying with vanillin-
HCl reagent under daylight (b) & (e); after spraying with FeCl3 reagent under 
daylight (c) & (d). A to K: Ethanolic fractions from fraction 10; 101: methanol 
fraction; 102: 70% acetone fraction.  
As shown in Fig. 3.59 (b), ethanolic fractions A to K had been well fractionated. 
Fraction 10A showed neither reaction with vanillin-HCl reagent, nor reaction 
with FeCl3 reagent, so no further investigation was performed. After spraying 
with FeCl3 reagent,  fractions D, F, G, I, J, K and 101 showed blue color spots, this 
indicated the existence of galloylated structures. Fractions could contain both 
condensed tannins and compounds with galloylated structure. Also, 
proanthocyanidins can be galloylated. From these data, the existence of 
condencsed or hydrolyzable tannins is possible. With all interesting information, 
further phytochemical and compounds isolation were performed. 
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All obtained fractions were freed of organic solvents and lyophilized. The 
weights and yields (%) were calculated and shown in Table 3.13. 
Table 3.13 The weights and yields (%) of Sephadex® LH-20 fractions related to 
6.0 g of fraction 10 as the starting material.                                                                                                                             
Fraction Weight (mg) Yield (%) 
10A 87.7 1.5 
10B 2190.6 36.5 
10C 179.5 3.0 
10D 84.4 1.4 
10E 25.7 0.4 
10F 39.9 0.7 
10G 31.6 0.5 
10H 42.4 0.7 
10I 359.8 6.0 
10J 614.5 10.2 
10K 454.7 7.6 
101 737.0 12.3 
102 30.8 0.5 
Sum 4878.6 81.3 
 
3.8.16 Further fractionation of fraction 10 by MCI gel® ChP-20P  
As shown in Fig. 3.59 (b), fractionation of fraction 10 by Sephadex® LH-20 with 
ethanol as mobile phase led to a isolation of subfractions 10A to 10K. Due to the 
positive reaction with vanillin/HCl reagent, it can be hypothesized that the 
respective compounds may be condensed tannins or flavan-3-ols. In the purpose 
of obtaining purified substances for unambiguous identification, further 
fractionation was done by MCI gel® ChP-20P column. 
The method of fractionation was described in 2.2.7.6. Fractions 10C, 10D, 10E, 
10F, 10G, 10I, 10J, 10K were applied to MCI gel® ChP-20P column using MeOH-
water gradient.  
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3.8.16.1 MCI gel® ChP-20P column fractionation of fraction 10C                                                          
179.5 mg of fraction 10C were applied to MCI gel® ChP-20P column and 
fractionated by MeOH-water with gradient from 20% to 70%. Fractions were 
collected and TLC investigation was performed. According to this, one fraction 
(10C1) was finally obtained and lyophilized. The weight of fraction 10C1 was 
96.2 mg, the yield was 53.6%, related to the 10C fraction used for MCI gel® 
fractionation. 
3.8.16.2 MCI gel® ChP-20P column fractionation of fraction 10D                                                             
84.4 mg of fraction 10D were applied to MCI gel® ChP-20P column and 
fractionated by MeOH-water with gradient from 20% to 70%. Fractions were 
collected and TLC investigation was performed. According to this, 2 fractions 
were finally obtained and lyophilized. The fractions were named 10D1 and 10D2. 
The weight of 10D1 was 35.0 mg with a yield of 41.5% related to the 10D 
fraction used for MCI gel® fractionation; the weight of fraction 10D2 was 23.3 mg 
with a yield of 27.6%, related to the 10D fraction used for MCI gel® fractionation, 
the total yield was 69.1%. 
3.8.16.3 MCI gel® ChP-20P column fractionation of fraction 10E                              
25.7 mg of fraction 10E were applied to MCI gel® ChP-20P column and 
fractionated by MeOH-water with gradient from 20% to 70%. Fractions were 
collected. No spots could be detected by TLC. The column was then washed with 
methanol and the complete elute was combined with all fractions obtained 
before in order to get the complete fraction 10E back. Methanol was then 
removed by rotary evaporator at temperature less than 40°C and the fraction 
was lyophilized. The weight of the regained fraction 10E was 68.5 mg which was 
more than the original weight. The fraction was planned to be fractionated with 
preparative HPLC at a later stage.  
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3.8.16.4 MCI gel® ChP-20P column fractionation of fraction 10F                                      
39.9 mg of fraction F were applied to MCI gel® ChP-20P column and fractionated 
by MeOH-water with a gradient from 20% to 70%. Fractions were collected and 
TLC investigation was performed. According to this, two fractions were obtained 
and lyophilized. The fractions were named 10F1 and 10F2. The weight of 
fraction 10F1 was 14.0 mg with a yield of 35.1%, related to the 10F fraction used 
for MCI gel® fractionation. The weight of fraction 10F2 was 8.2 mg with a yield of 
20.6%, related to the 10F fraction used for MCI gel® fractionation. The total yield 
was 55.7%.  
3.8.16.5 MCI gel® ChP-20P column fractionation of fraction 10G                                                 
31.6 mg of fraction 10G were applied to MCI gel® ChP-20P column and 
fractionated by MeOH-water with a gradient from 20% to 70%. Fractions were 
collected and TLC investigation was performed. According to this, 2 fractions 
were obtained and lyophilized. The fractions were named 10G1 and 10G2. The 
weight of fraction 10G1 was 14.2 mg with a yield of 44.9%, related to the 10G 
fraction used for MCI gel® fractionation. The weight of fraction 10G2 was 5.0 mg 
with a yield of 15.8%, related to the 10G fraction used for MCI gel® fractionation. 
The total yield was 60.7%. 
3.8.16.6 MCI gel® ChP-20P column fractionation of fraction 10I                                         
359.8 mg of fraction 10I were applied to MCI gel® ChP-20P column and 
fractionated by MeOH-water with a gradient from 20% to 70%. Fractions were 
collected and TLC investigation was performed. According to this, 3 fractions 
were obtained and lyophilized.  The fractions were named as 10I1, 10I2 and 10I3 
respectively. The weight of fraction 10I1 was 23.6 mg with a yield of 6.6% 
related to the 10I fraction used for MCI gel® fractionation. The weight of fraction 
10I2 was 150.0 mg with a yield of 41.7%, related to the 10I fraction used for MCI 
gel® fractionation. The weight of fraction 10I3 was 114.4 mg with a yield of 
31.8 %, related to 10I fraction used for MCI gel® fractionation. The total yield of 
both was 80.1%. 
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3.8.16.7 MCI gel® ChP-20P column fractionation of fraction 10J                                                   
614.5 of fraction 10J were applied to MCI gel® ChP-20P column and fractionated 
by MeOH-water with gradient from 20% to 70%. Fractions were collected and  
TLC investigation was performed. According to this, 2 fractions were obtained 
and lyophilized. The fractions were named 10J1 and 10J2 respectively. The 
weight of fraction 10J1 was 311.1 mg with a yield of 50.6%, related to the 10J 
fraction used for MCI gel® fractionation. The weight of fraction 10J2 was 211.7 
mg with a yield of 34.5%, related to the 10J fraction used for MCI gel® 
fractionation. The total yield was 85.1%.  
3.8.16.8 MCI gel® ChP-20P column fractionation of fraction 10K                                       
454.7 mg of fraction 10K were applied to MCI gel® ChP-20P column and 
fractionated by MeOH-water with gradient from 20% to 70%. Fractions were 
collected and TLC investigation was performed. According to this, one fraction 
was finally obtained and lyophilized. The fractions remained to be called 10K1. 
The weight of fraction 10K was 328.5 mg and the yield was 72.2%, related to the 
10K fraction used for MCI gel® fractionation. 
The TLC investigations with all fractions from MCI gel® ChP-20P column are 
shown in Fig. 3.60.  
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Fig. 3.60  TLC investigation (mobile phase: EtOAc -formic acid- water= 90: 5: 5, 
v/v/v) of subfractions obtained from 10C, 10D, 10E, 10I, 10K after 
chromatography on MCI® gel. Detections were performed at 254 nm (a); after 
spraying with vanillin-HCl reagent under daylight (b, e, g); under daylight (c); 
after spraying with vanillin-HCl and FeCl3 reagents under daylight (d, f, h). C to I: 
methanolic subfractions from MCI gel® ChP-20P column. 
As shown in 3.60 (b), the fraction 10C1 was suspected to be a flavan-3-ol: 
catechin or epicatechin. Further investigation would be performed to identify 
this compound.   
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As shown in Fig. 3.60 (b), fraction 10D had been separated into two subfractions 
10D1 and 10D2. Each of them contained one main substance which turned to red 
with vanillin-HCl reagent. With FeCl3 reagent, the red spot of fraction 10D1 
showed also blue color in Fig. 3.60 (d). This TLC information suggested the main 
substance in 10D1 to be a flavan-3-ol with a galloyl structure. 
Fraction 10E had not been successfully fractionated by this method (3.8.16.3). 
Therefore preparative HPLC had to be performed to separate it further. As 
shown in Fig. 3.60 (b, c & e), one yellow spot occured in this fraction which 
indicated the presence of a flavonoid. After spraying with vanillin-HCl reagent, 
the yellow spot didn't turn to red, this indicated that it probably had one double 
bond at the C-2, C-3 position which was against the essential requirement for a 
positive reaction of vanillin-HCl assay (Sarkar et al., 1976). As shown in Fig. 3.60 
(c), there was the columnar dark colored area which turned blue after spraying 
with FeCl3 reagent [Fig 3.60 (d)]. This indicated that fraction 10E contained 
galloylated structural compound(s). 
As shown in Fig. 3.60 (b) & (d), fraction 10F had been separated into 2 
subfractions and each of them contained one main substance which was turned 
to red after spraying with vanillin-HCl reagent. With FeCl3 reagent, the blue color 
showed in fraction 10F1 around the red spot obtained from vanillin-HCl reaction, 
this indicated that the main substance in 10F1 might be a dimer or trimer of 
flavan-3-ols connected with the structure of gallic acid. Fraction 10F2 had the 
columnar blue area far below the red spot, which additionally suggested that 
fraction 10F2 had both monomeric or oligomeric flavan-3-ols of condensed 
tannins and compound(s) with galloyl structure. 
As shown in Fig. 3.60 (b), (c) & (d), fraction 10G had been separated into 2 
subfractions 10G1 and 10G2. Each of them gave a positive reaction with vanillin-
HCl reagent which indicated that both of them contained flavan-3-ols or 
oligomeric proanthocyanidins. By FeCl3 reagent, some blue spots were shown, 
which indicated the existence of galloylated compounds. 
As shown in Fig. 3.60 (a), (c) & (d), fraction 10J had been separated into 2 
subfractions 10J1 and 10J2 which showed similar TLC patterns. According to the 
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vanillin-HCl reaction, both fractions were assessed to be oligomeric 
proanthocyanidins. After the reaction with FeCl3 reagent, strong blue color 
occured in both fractions which indicated the existence of galloylated structures. 
As shown in Fig. 3.60 (e) & (f), fraction 10K had both reaction with vanillin-HCl 
reagent and with ferric chloride reagent. This indicated that fraction 10K might 
exist of oligomeric proanthocyanidin(s) and galloyl structural compound(s).  
As shown in Fig. 3.60 (g) & (h), fraction 10I was separated into 3 fractions. 
Fraction 10I1 and 10I2 had reaction with vanillin-HCl reagent and fraction 10I2 
and 10I3 gave reaction with ferric chloride. This indicats that fraction 10I1 and 
fraction 10I2 contained oligomeric proanthocyanidins whilst fraction 10I2 and 
10I3 contained galloylated structures.  
3.8.17 Further analytical studies of fractions    
To obtain more information on the purity and structural features of compounds 
obtained after fractionation on MCI gel®, analytical HPLC was performed for 
single-compound fractions followed by NMR studies (see 2.2.7.12). Complex 
fractions were subjected to further preparative HPLC to obtain pure compounds. 
Therefore, a MeOH-water gradient was used (see 2.2.7.7). The gradient of MeOH-
water (0.1% TFA in Aqua millipore) was used. The results are shown below.  
3.8.17.1 Analytical investigations of  fraction 10C1 
Fraction 10C1 consisted of a single compound and it was doubted to be catechin 
or epicatechin. To make proof of that,  analytical HPLC was performed firstly 
with fraction 10C1 and then with a spiked mixture of fraction 10C and (+)-
catechin reference compound. Results are shown in Fig. 3.61. 
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Fig. 3.61 Analytical HPLC chromatograms of fraction 10C1 (a) and mixture of 
fraction 10C1 and (+)-catechin (b); ɉmax: 280 nm. 
As shown in Fig. 3.61, fraction 10C1 contained only one compound which was in 
accordance with TLC result. After (+)-catechin was added to fraction 10C, only 
one peak was observed. For the identificatin, 1H NMR investigation was 
performed. The result is shown in Fig. 3.62. 
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Fig. 3.62 1H NMR of catechin, in CD3COD, 400 MHz; ǣɁȋȌǤ  
By proton NMR (for the detailed analysis see appendix), fraction 10C1 was 
identified to be catechin.   
164  Results 
The optical rotation degree was then measured by polarimetry (method see 
2.2.7.13):  ȏȽȐ20ܦ   = +1.7° (c=0.0151 g/mL, MeOH). Additionally, CD spectra are 
recorded and the result is shown in Fig. 3.63.  
Fig. 3.63 Circular dichroism spectrum of fraction 10C1 (catechin), c=0.1 mg/mL, 
in MeOH, 20°C.  
As shown in Fig. 3.63, CD spectrumǣɉȋȟɂȌǣʹͲͺȋ-0.0143), 210 nm (-0.003), 
223 nm (-0.0089), 242 nm (0.0013), 279 nm (-0.0024). This CD spectrum was in 
accordance with the literature for (+)-catechin (Korver, et al., 1971). LC-MS 
determination was then performed with fraction 10C1. The result is shown in 
Fig. 3.64. 
Fig. 3.64  The ESI-MS spectrum of fraction 10C1.  
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As shown in Fig. 3.64, the ESI-MS pseudomolecular ion peak (positive mode) 
m/z 291 ([M+H]+) was identical with the theoretical pseudomolecular mass m/z 
[M+H]+ of catechin (290.26 g/mol) of catechin (C15H14O6).  
With all above analytical measurements, the colorless powder- fraction 10C1 
was identified to be (+)-catechin (compound 2). 
3.8.17.2 Analytical investigations of fraction 10D1 
For the purity investigation of fraction 10D1, analytical HPLC was performed. 
The results are shown in Fig. 3.65. 
Fig. 3.65 Analysis of fraction 10D1 by analytical HPLC; ɉmax: 280 nm. 
As shown in Fig. 3.65, fraction 10D1 was a mixture.  At the retention time of  
29.4 min, the signal peak of the main compound was observed. For further 
fractionation, fraction 10D1 was subjected to preparative HPLC. However, the 
separation was not successful. Thus, peracetylation was performed with fraction 
10D1 and the side compounds would not contribute to the main signals. The 
peracetylated sample of 10D1 was measured by proton NMR. The result of 1H 
NMR is shown in Fig. 3.66. 
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Fig. 3.66 1H NMR of peracetylated fraction 10D1 (main content: epicatechin-3-O-
gallate),  in acetone-D6, 400 MHz; ǣɁȋȌǤ 
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The molecular structure of (-)-epicatechin-3-O-gallate in its peracetylated form is 
shown in Fig. 3.67. 
Fig 3.67 The molecular structure of  peracetylated (-)-epicatechin-3-O-gallate. 
According to 1H NMR of peracetylated fraction 10D1 (Fig. 3.66) (for the detailed 
NMR analysis see appendix), the signals of epicatechin-3-O-gallate were strong 
enough for the identification. The main compound was identified to be 
epicatechin-3-O-gallate. Because of the interrupting signals, the signal from H3 
could be not clearly observed and described. Also the signal from H6' was not 
strong enough and had some part overlapping with the signal from H2'. Besides, 
two small signals elsewhere appeared between the doublet signal from H5'. But 
other proton signals were well exhibited and matched to literatures (Davis, et al., 
1996; Kumar, et al., 2005). The optical rotation degree was then measured by 
polarimetry ȋʹǤʹǤ͹Ǥͳ͵Ȍǣ ȏȽȐ20ܦ  = -45.4° (c=0.0076 g/mL, MeOH). LC-
MS determination was also performed with peracetylated fraction 10D1. The 
result is shown Fig. 3.68. 
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Fig. 3.68  ESI-MS spectrum of peracetylated fraction 10D1. 
As shown in Fig. 3.68, the ESI-MS pseudomolecular ion peak (positive mode) 
m/z 737 ([M+H]+) of fraction 10D1 is in accordance with the theoretical 
pseudomolecular mass m/z [M+H]+ of peracetylated (-)-epicatechin-3-O-gallate 
(C36H32O17, 736 g/mol).  
With all above analytical measurements, fraction 10D1 was identified to be (-)-
epicatechin-3-O-gallate (compound 3). 
3.8.17.3 Analytical investigations of fraction 10D2 
Fraction 10D2 was a subfraction obtained from fraction 10D after MCI gel®. For 
purity investigation, analytical HPLC was performed. The result is shown in Fig. 
3.69. 
Fig. 3.69 Analysis of fraction 10D2 by analytical HPLC; ɉmax: 280 nm. 
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Fraction 10D2 turned out to be a mixture of 4 compounds. Further separation of 
10D2 was performed by preparative HPLC and the main compound was 
successfully isolated. 5.8 mg of this compound were obtained. Analytical HPLC 
was then performed to prove the purity. The result is shown in Fig.3.70. 
Fig. 3.70 Analysis of substance 10D21 by analytical HPLCǢɉmax: 280 nm. 
As shown in Fig. 3.70, fraction 10D21 contained one compound. After that, 
peracetylation was performed and 1H NMR was recorded. The results are shown 
in below.  
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Fig. 3.71 1H NMR of peracetylated fraction 10D21 [epicatechin-ȋͶ՜ͺȌ-catechin], 
in CDCl3, 400 MHz; ǣɁȋȌǤ 
The molecular structure of peracetylated (-)-epicatechin-ȋͶȾ՜ͺȌ-catechin is 
shown in Fig. 3.72. 
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Fig. 3.72 The molecular structure of peracetylated (-)-epicatechin-ȋͶȾ՜ͺȌ-
catechin (procyanidin B1). 
By the proton NMR (for the detailed NMR analysis see appendix), this 
peracetylated compound was identified to be epicatechin-ȋͶ՜ͺȌ-catechin. The 
optical rotation degree was determined by polarimetry (method see 2.2.7.13):  ȏȽȐ20ܦ  = +25.5° (c=0.0076 g/mL, MeOH). CD was also performed to obtain the 
configuration information at C-4, the result is shown in Fig. 3.73. 
Fig. 3.73 Circular dichroism spectrum of fraction 10D21, c=0.1 mg/mL, in MeOH, 
20°C.  
As shown above, CD spectrumǣɉȋȟɂȌǣʹͲͲȋͲǤͲͲͻͷȌǢʹͳͲȋͲǤͲ͵ͻͺ); 254 
nm (0.0005). A positive cotton effect at 200-ʹʹͲǡͶȾ-
configuration (Barrett, et al., 1979). Due to the big coupling between the H-ͶȽȋ
ring) and H-3 (C ring), the H-3 (C rȌȾ-position, so 
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the upper part epicatechin was turned out to be (-)-epicatechin. After that, the 
LC-MS determination was performed. The result is shown in Fig. 3.74: 
Fig. 3.74 ESI-MS spectrum of peracetylated fraction 10D21.  
As shown in Fig. 3.74, the ESI-MS pseudomolecular ion peak (positive mode) 
m/z 1021 ([M+Na]+) is identical with the theoretical pseudomolecular mass of  
peracetylated (-)-epicatechin-(4Ⱦ՜ͺȌ-catechin (C50H46O22, 998 g/mol). 
With all above analytical measurements, the brown powder-fraction 10D21 was 
identified to be (-)-epicatechin-ȋͶȾ՜ͺȌ-catechin (procyanidin B1, compound 4). 
3.8.17.4 Analytical investigations of fraction 10E 
Fraction 10E was a mixture. For the purity investigation, analytical HPLC was 
performed. The result is shown in Fig. 3.75. 
Fig. 3.75 Analysis of fraction 10E by analytical HPLCǢɉmax: 254 nm. 
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As shown in Fig. 3.75, two compounds were detected. A further purification was 
performed by preparative HPLC. The isolation was successful and isolated 
compound was named as 10E1 (7.9 mg). The purity investigation of this 
compound was investigated by analytical HPLC. The result is shown in Fig. 3.76. 
Fig. 3.76 Analysis of substance 10E1 by analytical HPLCǢɉmax: 280 nm. 
As shown above, the substance had satisfying purity. So it was peracetylated and 
subjected to 1H NMR for identification. However, the amount of compound 10E1 
was too less, so due to the unclear and weak signals from the NMR result, this 
compound could not be identified.  
The LC-MS was investigation was then performed with peracetylated fraction 
10E1. The result is shown in Fig. 3.77.  
Fig. 3.77 ESI-MS spectrum of peracetylated fraction 10E1.  
As shown in Fig. 3.77, The ESI-MS spectrum (positive mode) of fraction 10E1 
obtained weak signals. One peak showed at m/z 303.0147. It is unclear if this is 
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the pseudomolecular mass peak. According to the positive vanillin-HCl reaction 
of fraction 10E, fraction 10E1 could be one compound containing galloyl 
structure. But due to the very less information, no further structure elucidation 
was possible.  
3.8.17.5 Analytical investigations of fraction 10F1 
Fraction 10F1 was a mixture. For the purity investigation, analytical HPLC was 
performed. The result is shown in Fig. 3.78. 
Fig. 3.78  Analysis of fraction 10F1 by analytical HPLC. ɉmax: 280 nm.  
As shown in Fig. 3.78, fraction 10F1 consisted of 3 compounds. They had similar 
Rt at 25.3 min, 26.6 min and 28.2 min respectively. Preparative HPLC was 
performed for isolation of pure compounds. However, this fractionation failed. 
Therefore, fraction 10F1 was peracetylated and subjected to 1H NMR in the hope 
that some compound could be identified. The result is shown in Fig. 3.79. 
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Fig. 3.79 1H NMR of peracetylated fraction 10F1(mixture) from Moutan cortex,  
in CDCl3, 400 MHz; ǣɁȋȌǡǣfrom other components in fraction 
F1.  
176  Results 
The molecular structure of peracetylated (-)-epicatechin-3-O-gallate-ȋͶ՜ͺȌ-
catechin is shown in Fig. 3.80.  
Fig. 3.80 The molecular structure of peracetylated (-)-epicatechin-3-O-gallate-
(4՜ͺȌ-catechin. 
As shown in Fig. 3.80 (for the detailed NMR analysis see appendix), among many 
disturbing signals from other components, the main proton signals of 
epicatechin-3-O-gallate-(4՜ͺȌ-catechin could be identified. Comparing with the 
proton NMR with peracetylated procyanidin B1 (Fig. 3.71), the signal of H-3 (F) 
was found with the ȏɁȋ-3 (F) (peracetylated procyanidin 
B1]ǣ ͷǤͲͶ ȋȌǢ  ͳͲ	ͳǣ Ɂ-3 (F): 5.00 ppm (ddd)]. 
Thus, at H-3 (F) position, it was impossible to have a peracetylated galloyl group. 
Therefore, the galloyl group was deduced to be at H-3 (C) position. However, the 
proton signals from H-2 (C), H-3 (C), H-4 (C) and the proton signals on B and E 
rings could not be clearly determined due to the disturbing signals. By the 
distinguishable signals, the main component in this fraction is possibly 
epicatechin-3-O-gallate-(4՜ͺȌ-catechin. The LC-MS determination of exact 
compound mass was performed, too. The result is shown in Fig. 3.81. 
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Fig. 3.81 The ESI-MS spectrum of peracetylated fraction 10F1. 
As shown in Fig. 3.81, the ESI-MS pseudomolecular ion peak (positive mode) 
m/z 1235 ([M+H]+) was identical with the theoretical pseudomolecular mass 
m/z [M+H]+ of peracetylated epicatechin-3-O-gallate-ȋͶ՜ͺȌ-catechin (C61H54O28, 
1234 g/mol).  
However, because fraction 10F1 was a mixture, the optical rotation and the 
circular dichroism determination were not performed, so the steric configuration 
could not be established. Thus, fraction 10F1 contained epicatechin-3-O-gallate-ȋͶ՜ͺȌ-catechin (compound 5). 
                                                                                                                                                                                                                                                          
3.8.17.6 Analytical investigations of fraction 10F2    
Fraction 10F2 was a mixture. For the purity investigation, analytical HPLC was 
performed. The result is shown in Fig. 3.82. 
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Fig. 3.82 Analysis of fraction 10F2 by analytical HPLCǢɉmax: 240 nm. 
As shown in Fig. 3.82, two compounds were detected at 240 nm by analytical 
HPLC. Preparative HPLC was then performed to separate these two compounds. 
The so obtained compound from peak 1 was isolated and named as 10F21. For 
purity determination, analytical HPLC was performed. The result is shown in Fig. 
3.83.  
Fig. 3.83 Analysis of fraction 10F21 by analytical HPLCǢɉmax: 240 nm.  
As shown in Fig. 3.83, 10F21 was isolated by preparative HPLC. For the 
identification, it was peracetylated and 1H NMR recorded. But due to the very 
less amount of it, the signals from 1H NMR were too weak to be identified. The 
LC-MS determination was then performed. The result is shown in Fig. 3.84. 
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Fig. 3.84 The ESI-MS spectrum of peracetylated fraction 10F21. 
As shown in Fig. 3.84, the ESI-MS (positive mode) of this peracetylated fraction 
obtained weak signals. The spectrum obtained similar fragment peak m/z 1021 
([M+Na]+) as the peracetylated fraction 10D21 (Fig. 3.74) which was identified 
as procyanidin B1. So a further comparison was performed. The result is shown 
in Fig. 3.85. 
Fig. 3.85 The comparison between the ESI-MS spectra of peracetylated fraction 
10D21 and peracetylated fraction 10F21. 
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As shown in Fig. 3.85, the difference between the two spectra was the fragment 
m/z 1157.2147 from peracetylated fraction 10D21 and the fragment m/z 
1116.2493 from peracetylated fraction 10F21 (very weak peak). Thus, deduced 
from the mass spectrum, fraction 10F21 could contain a compound which has 
similar structure as proyanidin B1.  
3.8.17.7 Analytical investigations of fraction 10G1 
Fraction 10G1 was a mixture. For the purity determination, analytical HPLC was 
performed. The result is shown in Fig. 3.86. 
Fig. 3.86 Analysis of fraction 10G1 by analytical HPLCǢɉmax: 280 nm.  
As shown in Fig. 3.86, this fraction was a mixture. Due to the time limitation, this 
fraction was peracetylated directly and the proton NMR was performed. The 
result is shown in Fig. 3.87. 
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Fig. 3.87 1H NMR of peracetylated fraction 10G1(mixture) from Moutan cortex, 
in CDCl3ǡͶͲͲǢǣɁȋȌ; unnoted signals from other compound(s). 
As shown in Fig. 3.87, the peracetate of fraction 10G1 was a mixture (for the 
detailed NMR analysis see appendix). However, the proton signals from 
hydrolyzable tannin were relative dominant and clear. The three proton signals 
from the galloyls (2H) were clearly observed. By comparing this peracetylated 
proton NMR with peracetylated 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose [see Fig. 
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3.95 (b)], signals of H-1, H-5, H6 (2H) were identified. But the rest signals for H-
2, H-2, H-4 were not able to be identified because the positions of the galloyls 
could not be identified. For further identification, 2-dimensional NMR could be 
performed. However, due to the time limitation, it was not accomplished. 
The LC-MS determination of peracetylated fraction 10G1 was performed. The 
result is shown in Fig. 3.88. 
Fig. 3.88 The ESI-MS spectrum of peracetylated fraction 10G1. 
As shown in Fig. 3.88, the ESI-MS pseudomolecular ion peak (positive mode) 
m/z 1099 ([M+H]+) was identical with the theoretical pseudomolecular mass 
m/z [M+H]+ of peracetylated tri-galloyl glucose (C49H46O29, 1098 g/mol). 
Thus, a major component of fraction 10G1 was identified to be tri-galloyl glucose 
(compound 6), and three different tri-galloyl glucose (for the detailed NMR 
analysis see appendix) were already reported from Moutan cortex: 1,2,6-tri-O-GG, 
1,3,6-tri-O-GG, 3,4,6-tri-O-GG (Wu, Y. et al., 2003).    
3.8.17.8 Analytical investigations of fraction 10G2 
Fraction 10G2 was a mixture. But the amount of fraction 10G2 was too less for 
any analytical method. For that reason, no further investigations were performed. 
3.8.17.9 Analytical investigations of fraction 10H 
Fraction 10H was a mixture. For the purity investigation, analytical HPLC was 
performed. The result is shown in Fig. 3.89. 
Results  183 
Fig. 3.89 Analysis of fraction 10H by analytical HPLCǢɉmax: 240 nm.  
As shown in Fig. 3.89, a compound had dominant absorption at 240 nm. Thus, 
preparative HPLC was performed. However, the compound was not successfully 
isolated. So fraction 10H was then peracetylated and 1H NMR was performed. 
But the proton signals obtained from 1H NMR were so complicated that no 
compound could be clearly identified. Due to the time limitation, no experiments 
were further performed with this fraction. 
3.8.17.10 Analytical investigations of fraction 10I1 
Fraction 10I1 was a mixture. For the purity determination, analytical HPLC was 
performed. The result is shown in Fig. 3.90. 
Fig. 3.90 Analysis of fraction 10I1 by analytical HPLC; ɉmax: 280 nm.  
As shown in Fig. 3.90, further fractionation could be performed. But due to the 
limitation of the time, no further investigations were  performed with fraction 
10I1. 
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3.8.17.11 Analytical investigations of fraction 10I2 
Fraction 10I2 was a mixture. For the purity investigation, analytical HPLC was 
performed. The result is shown in Fig. 3.91. 
Fig. 3.91 Analysis of fraction 10I2 by analytical HPLCǢɉmax: 280 nm. 
As shown in Fig. 3.91, further fractionation is necessary. But due to the 
limitation of time, no further investigations were performed with fraction 10I2. 
3.8.17.12 Analytical investigations of fraction 10I3 
Fraction 10I3 was a mixture. For the purity investigation, analytical HPLC was 
performed. The result is shown in Fig. 3.92. 
 
Fig. 3.92 Analysis of fraction 10I3 by analytical HPLC; X axis: Rt (min); Y axis: 
absorbance unit; detecting wavelength: 280 nm. 
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As shown in Fig. 3.92, fraction 10I3 was a mixture, and all compounds had 
similar retention time. Better analytical HPLC conditions should be investigated 
to separate these peaks optimally. However, due to the time limitation, no 
further investigations were performed.   
3.8.17.11 Analytical investigations of fraction 10J1, fraction 10J2 and 
fraction 10K1 
Analytical HPLC were performed with fractions 10J1 and 10J2. Due to the 
chromatograms, both of them showed one single peaks at Rt 29 min with 
satisfactory purity. The results are shown in Fig. 3.93. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.93 Analysis of fractions 10J1 and 10J2 by analytical HPLC; (a): fraction 
10J1; (b): fraction 10J2; ɉmax: 280 nm. 
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With the followed 1H NMR (Fig. 3.94), fractions 10J1, 10J2 and 10K1 showed 
exactly the same proton signals. The result is shown in Fig. 3.94. 
 
Fig. 3.94 Comparison of the proton NMR of fractions 10J1, 10J2 and 10K1 [in 
CD3ǡͶͲͲǢǣɁȋȌ].       
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As shown in Fig. 3.94, the three substances had the same proton NMR spectrum, 
the analyses of the proton NMR (both free phenolic and peracetylated) was 
performed and were shown in Fig. 3.95 [free phenolic: fraction 10J1 (a); 
peracetylated: fraction 10J2 (b)].  
 
188  Results 
 
Fig. 3.95 1H NMR of: (a) 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose (fraction 10J1) in 
CD3OD and (b) peracetylated 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose (fraction 
10J2) in CDCl3 from Moutan cortex; ͶͲͲǢǣɁȋȌ; x: proton signals 
from other component (s) in fraction 10J2.    
As shown in Fig. 3.95, the peracetylated compound showed clear signals in 
proton NMR (for the detailed NMR analysis see appendix). For example, the 
signals from H-5 and H-6, signals from H-2 and H-4 were all clearly separated. 
The proton signals from H-2 and H-4 (both free phenolic and peracetate) were 
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identified by comparison with data from the literature (Tanaka et al., 2003; 
Haddock et al., 1982).  
The molecular structure of 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose is shown in Fig. 
3.96. 
 
Fig. 3.96 The molecular structure of 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose. 
As shown in Fig. 3.96, fraction 10J1and 10J2 were identified to be 1,2,3,4,6-
penta-O-galloyl-Ⱦ-D-glucose (for the detailed analysis see appendix), so was 
fraction 10K1. The optical rotation degree of fraction 10J1 was measured:  ȏȽȐ20ܦ  
= + 27.4 (c= 0.0189 g/mL, MeOH). Then the circular dichroism determination 
was performed. The result is shown in Fig. 3.97. 
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Fig. 3.97 Circular dichroism spectrum of 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose 
(fraction 10J2), c=0.1 mg/mL, in MeOH, 20°C.  
As shown in Fig. 3.97, CD spectrumǣɉȋȟɂȌǣ225 nm (0.0070), 239 nm (0.0001), 
272 nm (0.0078). The result was in accordance with data from the literature 
(Okuda, T. et al., 1982). The LC-MS determination was then performed with . The 
result is shown in Fig. 3.98. 
Fig. 3.98 The ESI-MS spectrum of fraction 10J1. 
As shown in Fig. 3.98, the ESI-MS spectrum (positive mode), the pseudo mass 
molecular signal m/z=963 [M+Na]+ was obtained, which was consistent to the 
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mass of 1,2,3,4,6- penta-O-galloyl-Ⱦ-D-glucose (C41H32O26, 940.67 g/mol).  
According to the above analytical investigations, fraction 10J1, fraction 10J2 and 
fraction K1 were identified to be the same substance because of the same proton 
NMR results (all in CDCl3). Thus, the white colored powder- fraction 10J1, 10J2 
and 10K1 were identified to be 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose 
(compound 7).  
3.8.17.14 Analytical investigations of fraction 101 
Fraction 101 is the methanolic fraction obtained from the Sephadex® LH-20 from 
fraction 10 (EtOAc fraction from defatted Moutan cortex). Analytical HPLC was 
performed. The result is shown in Fig. 3.99. 
 
Fig. 3.99 Analysis of fraction 101 by analytical HPLCǢɉmax: 280 nm. 
As shown in Fig. 3.99, fraction 101 was a mixture. Due to the limitation of the 
time, no further fractionation was performed. 
3.8.17.15 Analytical investigations of fraction 102 
Fraction 102 is the 70% acetone fraction obtained from Sephadex® LH-20 from 
fraction 10 (EtOAc fraction from defatted Moutan cortex) and it was supposed to 
be a mixture of polymeric proanthocyanidins and other high molecular 
compounds. About 50 mg of fraction 102 were dissolved in CDCl3 for long term 
13C NMR measurement. However, the amount was not enough for obtaining 
sufficient spectroscopic data. Due to the limitation of the time, no further 
investigations were performed.  
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3.8.18 In vitro cell test with subfractions from fraction 10 (Moutan cortex) 
Fraction 10 had been further fractionated into subfractions, consisting mainly of 
flavan-3-ols, oligomeric proanthocyanidins and hydrolyzable tannins. Due to the 
time limitation, only some of them were tested on the HaCaT keratincytes in vitro 
influence on cell physiology.  
In vitro cell test with fraction 100 
For in vitro investigation the influence of fraction 100 from Moutan cortex, on 
HaCaT keratinocytes at different concentrations were investigated. Evaluation of 
the experiments was performed by MTT assay and BrdU cell proliferation assay. 
Results are shown in Fig. 3.100. 
 
 
Fig. 3.100 Dehydrogenase activity assay [MTT assay, (a)] and BrdU cell 
proliferation assay (b) of fraction 100 from Moutan cortex on HaCaT 
keratinocytes at doses of 0.1, 1, 10, 20, 50 µg/mL over an 48 h incubation period. 
Bars represent relative standard deviations (RSD) with n=6. The results replicate 
from 3 independent experiments with * p < 0.05 and ** p < 0.01 compared to the 
untreated control group (UC); Positive control (PC) 5% FBS. 
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The respective data (Fig. 3.100) indicated significant stimulation activity of 
fraction 100 on HaCaT keratinocytes at doses of 10 µg/mL. At the doses of 0.1, 1, 
20 µg/mL, the tendency of the stimulation tendency was shown. Cell 
proliferation was stimulated at the concentration of 1 and 10 µg/mL.  
Therefore, fraction 100 from MC stimulated cell viability of HaCaT keratinocytes 
at low concentrations as well as the respective proliferation rate. At the test 
concentration of 1 µg/mL, the results from viability and proliferation test didn't 
match perfectly. It could due to the different growth conditions or the small 
experimental errors happened during the seeding or feeding of the cells.  
In vitro cell test with fraction 10J2 (PGG) 
Fraction 10J2, a component of fraction 100, was identified to be 1,2,3,4,6-penta-
galloyl-Ⱦ-D-glucose (PGG) (3.10.7.11). Since fraction 100 was proven to stimulate 
the cell viability and proliferation of HaCaT keratinocytes, further cell 
investigations were performed with fraction 10J2. HaCaT keratinocytes were 
tested with this fraction at different concentrations. Evaluation of the 
experiments was performed by MTT assay and BrdU cell proliferation assay. 
Results are shown in Fig. 3.101.  
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Fig. 3.101 Dehydrogenase activity assay [MTT assay, (a)] and BrdU cell 
proliferation assay (b) of 1,2,3,4,6-penta-galloyl-Ⱦ-D-glucose (PGG, fraction 10J2) 
from Moutan cortex on HaCaT keratinocytes at doses of 0.1 µg/mL (1.1×10-4 
mol/L), 1 µg/mL (1.1×10-3 mol/L), 10 µg/mL (1.1×10-2 mol/L), 20 µg/mL 
(2.1×10-2 mol/L) over an 48 h incubation period. Bars represent relative 
standard deviations (RSD) with n=6. The results replicate from 2 independent 
experiments with * p < 0.05 and ** p < 0.01 compared to the untreated control 
group (UC); Positive control (PC) 5% FBS. 
The respective data (Fig. 3.101) indicated significant stimulation activity of PGG 
on HaCaT keratinocytes at the concentration of 0.1 µg/mL (1.1×10-4 mol/L). Also, 
cell proliferation was stimulated at the same concentration. At the higher 
concentrations as 10 µg/mL (1.1×10-2 mol/L) and 20 µg/mL (2.1×10-2 mol/L), 
PGG reduced the cell viability and the cell proliferation of HaCaT keratinocytes to 
a great extent. It might lead to the cytotoxicity. Therefore, PGG stimulated cell 
viability of HaCaT keratinocytes at low concentration as well as the cell 
proliferation.  
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In vitro cell test with fraction 101 
For in vitro investigation of the influence of fraction 101 from Moutan cortex, 
HaCaT keratinocytes were tested with fraction 101 at different concentrations. 
Evaluation of the experiments was performed by MTT assay and BrdU cell 
proliferation assay. Results are shown in Fig. 3.102. 
Fig. 3.102 Dehydrogenase activity assay [MTT assay, (a)] and BrdU cell 
proliferation assay (b) of fraction 101 from Moutan cortex on HaCaT 
keratinocytes at doses of 0.1, 1, 10, 20, 50 µg/mL over an 48 h incubation period. 
Bars represent relative standard deviations (RSD) with n=6. The results replicate 
from 3 independent experiments of MTT assay and 2 independent experiments 
of BrdU proliferation assay with * p < 0.05 and ** p < 0.01 compared to the 
untreated control group (UC); Positive control (PC) 5% FBS. 
The respective data (Fig. 3.102) showed significant stimulation activity of 
fraction 101 on HaCaT keratinocytes at doses of 10 µg/mL. Also, cell 
proliferation was stimulated at the same concentration.  
According to the results, fraction 101 stimulated cell viability of HaCaT 
keratinocytes at low concentration (10 µg/mL) as well as the cell proliferation.  
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In vitro cell test with fraction 102 
For in vitro investigation of the influence of fraction 102 from Moutan cortex, 
HaCaT keratinocytes were tested with fraction 102 at different concentrations. 
Evaluation of the experiments was performed by MTT assay and BrdU cell 
proliferation assay. Results are shown in Fig. 3.103. 
Fig. 3.103 Dehydrogenase activity assay [MTT assay, (a)] and BrdU cell 
proliferation assay (b) of fraction 102 from Moutan cortex on HaCaT 
keratinocytes at doses of 0.1, 1, 10, 20, 50 µg/mL over an 48 h incubation period. 
Bars represent relative standard deviations (RSD) with n=6. The results replicate 
from 2 independent experiments with ** p < 0.01 compared to the untreated 
control group (UC); Positive control (PC) 5% FBS. 
The respective data (Fig. 3.103) indicated no stimulation of fraction 102 on 
HaCaT keratinocytes both for cell viability and proliferation. However, at the 
concentration of 50 µg/mL, this fraction inhibited cell viability and proliferation 
significantly. It might lead to the cytotoxicity at this concentration. Thus, fraction 
102 had no positive effect on the growth of HaCaT keratinocytes. 
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Summary of the bioassays performed in this work 
Table 3.14 The bioassays used in this work for different purposes of detecting 
different cells. 
 
Bio-assays Tested cell types Detection purposes 
MTT assay 
pNHDF/HaCaT 
keratinocytes 
Cell viability, cytotoxicity 
XTT assay pNHDF Cell viability, cytotoxicity 
Neutral red uptake assay HaCaT kerationcytes Cell viability, cytotoxicity 
BrdU cell proliferation 
assay 
pNHDF/HaCaT 
keratinocytes 
Cell proliferation 
LDH cytotoxicity assay 
pNHDF/HaCaT 
keratinocytes 
cytotoxicity 
 
MTT and XTT assay were both used to detect the cell viability. XTT assay is 
considered to be better than MTT assay, more accurate, safer, faster and easier. 
Comparing these two assays, MTT assay generates a more stable color which 
could last for days than the hours of the XTT assay (Berridge, M. V. et al., 1996). 
MTT assay generates the insoluble formazan, so more manipulative steps are 
required and thus more errors could be brought to the assay. In this work, the 
results of cell viabilities (%) from both assays were in fact very similar, but XTT 
assay worked better with pNHDF than MTT assay did. pNHDF are more sensitive 
with XTT tetrazolium salt, the results are very reproducible and the values from 
the spectrophotometric reading are higher than MTT assay.  
The reaction between MTT tetrazolium salt and HaCaT keratinocytes is not very 
sensitive, so neutral red uptake assay was performed. For this assay, the 
background color should be noticed due to the hours culturing with the neutral 
red. Results obtained from neutral red uptake assay all had very small relative 
standard deviation. However, because the background absorption values 
(without cells) have been subtracted from the measured substance values, so the 
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cell viabilities (%) show greater comparison with each other. To this problem, the 
comparison with the cell viability of positive control is important, also, the 
Student's t-test could also show directly the significance of the value. In this work, 
using neutral red up-take assay could reproduce the results from the MTT assay. 
This assay was also tried to perform with pNHDF due to its cheap price. But it 
turned out that this cell line was not sensitive with this assay, the red dye taken 
by pNHDF was not much and it caused low reading values.  
With the positive cell viability assay results, the cell proliferation could happen. 
For the determination, BrdU cell proliferation assay was performed. And for 
more specific information about the cytotoxicity, LDH assay was also performed.  
This in vitro bioassay test system worked well and the results from different 
assays were reasonable and all in accordance with each other. 
 
Structure of the extraction/fractionation of MC and the influence of the 
extracts/fractions on skin cells 
Beside in vitro cell assays, another big part of this work was analytical 
investigations. As a visualized summary of the fractionation of Moutan cortex, 
the fractionating structure is represented in Fig. 3.104.  
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Fig. 3.104 The fractionation scene of Moutan cortex and the overview of the 
outcome from in vitro cell viability assays; Frac.: abbrevation of fraction; marked 
in green: positive influence on cell physiology; marked in pink: no positive 
influence on cell phsiology; Frac. : fraction. 
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4 Discussion 
4.1 TCM plants survey 
Traditional Chinese Medicine (TCM) is one huge medical system with over 2000 
years' history. During the time, many classics came out and gave us great 
resources from the nature. This work is the investigation with skin active plants 
in TCM. Thus, to find a suitable TCM plant for further research is very important. 
As the investigation was taken out in Germany, thus, there were several objective 
restrictions. The important one was how to proceed the survey for skin active 
plants. There were several problems existing: 
1. There are too many TCM classics from the history, most of them were 
written in Classical Chinese. Thus, they are hard to be understood. And 
due to the different time, different locations and different local languages 
in China, the same name could refer to different resources, or one 
resource had several different names. Taking Moutan cortex as one 
example, the standard Chinese name was called Mu Dan Pi (⢑ѩⳞ) which 
was also called differently in other books, as Dan Gen (ѩṩ), Fen Dan Pi 
(㊹ѩⳞ) and Tiao Dan Pi (ᶑѩⳞ). Even the plant name of Moutan cortex 
(Paeonia suffruticosa Andr.) was called differently in the past, as Mu Dan 
(⢑ѩ), Dan Gen (ѩṩ), Dan Pi (ѩⳞ),  Lu Jiu (咯丝), Shu Gu (啐ခ), Bai 
Shu (ⲭᵟ), Bai Liang Jin (ⲭє䠁), Wu Mu Dan (੤ѩⳞ), Mu Shao Yao (ᵘ
㢽㦟), Hua Wang (㣡⦻), Luo Yang Hua (⍋䱣㣡) and Yun Nan Mu Dan (Ӂ
ই⢑ѩ) (Zhu, Jianping et al., ZHONGYAOMING KAOZHENG YU GUIFAN, 
P1251, 01.03.2007, Press of Zhongyi Guji). Also, the access to these books 
is not so easy in Germany. 
2. Lacking of the experienced TCM doctors in Germany. The modern TCM 
plants researches which are running in China, mostly, for selecting the 
TCM plants, the researchers make inquiry and obtain the herbal 
information from the experienced TCM doctors. Or they ask the local 
people who are experienced or dealing with TCM herbal drugs.  
Facing these problems, the TCM survey in this work was performed by screening 
through the Pharmacopoeia of People's Republic of China (PPRC, version 2005), 
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which is the only standard of TCM plants in China. In PPRC, single plants are 
described by the modern scientific methods. The Latin names, family and the 
species of the herbal drugs are given. Also, for most herbal drugs, there are 
morphological and chemical identifications. Beside, the processing (Paozhi) of 
the herbal materials, nature and flavour, meridian entry, function and indication 
in TCM are given.  
By going through PPRC, 160 herbal drugs were found being recorded for skin 
activity. However, by using the PPRC, some shortcomings of it came into the sight: 
1. As described in introduction of this work, in a formula, the plants play 
different roles, such as principal drug, associate drug, adjuvant drug and 
messenger drug. The roles give some information of the function of each 
herbal drug in the formula. But there are also no descriptions in the PPRC 
for the formula drugs; 
2. Not for all herbal drugs PPRC gives unambiguous microscopic 
identification and clear chemical identification. For example, among all 
TCM plants in this work, the microscopic identifications of Cimicifugae 
rhizoma, Houttuyniae herba, Lonicerae japonicae caulis, Lonicerae 
japonicae flos are not given in PPRC; 
3. Imperfection and mistakes in the nomenclature and families. Beside 
Chinese names, the universal botanical nomenclature is given. But the 
writing form is wrong. For example, Moutan cortex is written as CORTEX 
MOUTAN. Besides, among all my herbal drugs, one mistake about the 
plant family has been found. Moutan cortex belongs to the family 
Paeoniaceae internationally, but in PPRC, the family is written as 
Ranunculaceae. There are some debates about the family of this herbal 
drug, but still, in the newest PPRC 2010, the plant family has not been 
changed;  
4. By comparing the European Pharmacopoeia and PPRC, it is easy to see 
that in PPRC, the main chemical components of TCM single herbal drugs  
have not been well described, some are even without this content. For 
example, Viticis negundo folium is one of those plants which have no 
componential descriptions. It is not changed in the newest PPRC 2010; 
Discussion  203 
5. The small covering range of the TCM medicines: 1146 resources of TCM 
are recorded in PPRC 2005 and 2136 resources of TCM are recorded in 
PPRC 2010 (including meteria medica and Chinese patent medicine). 
However, there are over 100,000 recipes recored in the ancient books of 
TCM. And according to a nationwide natural resource survey, there are 
about 12807 kinds of traditional Chinese medicines and botanical 
medicines in China (Chen, K. et al., 1999).  
For all above, PPRC still has many limitations which are expected to be changed. 
Especially, as mentioned in the introduction, modernization of TCM has been 
made as the main goal of the TCM development, and several achievements have 
been made and active components were nowadays identified . So, in addition to 
the ancient function of the TCM herbal drugs, the new breakthroughs which have 
been proven with modern research could also be considered to be written in 
PPRC, such as the active constituent ephedrine isolated from Ephedrae herba 
against asthma.  
But so far, although PPRC still has many aspects to improve, it did help the survey 
for skin active plants, and it enabled 160 skin active TCM plants to be selected in 
the shortest time at the beginning of the research.  
However, there are not so many TCM herbals drugs for sale in Germany. The 
available ones are all well-known in China. So it was hard to find any plant which 
still had so much unexploited space for the research. But this situation could not 
be changed. 
By the literature research, the available scientific literature was investigated to 
make sure the plants for research were not investigated in the same aspect as the 
direction of this work and for the phytochmical aspect, they shall not be totally 
investigated. 
Finally, 12 of the TCM plants were purchased and tested. No reports were 
published on the in vitro cell testing of these plants on human skin cells. However, 
about Angelicae sinensis, similar research has been performed. This 
polysaccharide rich TCM herbal drug has a direct mucosal healing effect on 
gastric epithelial cells by increasing ornithine decarboxylase and c-Myc 
expression (Sen et al., 2002). For that reason, no further investigations with this 
herbal drug were performed, although with active in vitro cell test results. 
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By the later work, some of these selected herbal drugs were proven to be skin 
active, some interesting results were obtained. Thus, the skin active TCM herbal 
selecting system fits the whole situation and is advisable.  
 
4.2 Investigations of the influence of Moutan cortex on skin 
Moutan cortex is one of the most widely used TCM herbal drugs in China. It is one 
of the most important crude drugs known as an analgesic, a sedative, an anti-
inflammatory agent, and remedy for female diseases in Chinese traditional 
medicine, and it is prescribed particularly in various Chinese preparations used 
for treatment of Oketsu syndrome (blood stagnation) (Yoshikawa, M. et al., 1992). 
Besides, MC is recorded in the PPRC (2005, 2010) for various skin and wound 
care applications, as cooling the blood, healing traumatic injuries. In the part of 
Chinese patent medicines (PPRC 2005), MC was contained in Fengliaoxing 
Fengshi Dieda Yaojiu (a patent medicine, process: 2 hours' evaporation with 
water, accompanying with 30-40 days' immersion in Chinese distilled liquor) 
with the other 26 TCM drugs, which can be either taken orally or used externally 
on the skin for traumatic injuries, swelling, hematoma and blood stasis.  
In recent years, many literatures have been published about the structural and 
functional studies about MC. The main components of MC are paeonol, 
paeonoside, paeonolide, paeoniflorin, some water soluble tannins (pentagaolloyl 
glucose, trigalloyl glucose etc.) etc. Among them, paeonol is considered as the 
main active component in MC, which has not been proven by the presented 
investigations. 
Until now, many pharmacological developments have been obtained with MC. 
The water extract of MC and paeonol have been proven to have the 
antiaggregatory effect in vitro and in animal test (Hirai, A. et al., 1983); the 
extracts and components of MC have strong antimicrobial effect against 
Staphylococcus aureus, Pneumococcus, Shigella dysenteriae, Streptococcus 
hemolyticus etc. (Hou, J. et al., 2006; Kwon, O.G. et al., 1999); the anti-
inflammatory effect of MC has been extensively studied and in in vitro tests and 
in animal models (Oh, G.S. et al., 2003; Lee, S. et al., 2003; Chung, H.S. et al., 2007; 
Wu, M. et al., 2007; Kim, H.S. et al., 2011); MC also has protective effect on liver 
cells (Shon, Y.H. et al., 2002; Liu, H.X. et al., 2009); anti-diabetic effect from MC in 
Discussion  205 
in vitro test and in animal test (Hong, H. et al., 2003; Lau, C.H. et al., 2007);  the 
inhibitory effects of MC on allergic reaction has been studied in animal model 
and in vitro cell tests (Jiang, S.S. et al., 2007; Kim, Jinju et al., 2007; Hong, M.H. et 
al., 2010; Kim, S.H. et al., 2003); the anti-oxidant activity supported by 
polysaccharides and polyphenolic contents of MC was studied (Xing, G.Q. et al., 
2010); the antitumor effect of MC was also reported (Xing, G.Q. et al., 2009; 
Zhang, C.H. et al., 2008; Lee, H.J. et al., 2010). Besides, the antidepressant-like 
effect of paeonol was also reported (Zhu, W. et al., 2006) and lately, paeonol was 
reported  to improve the behavior in a rat model of Alzheimer's disease (Zhou, J. 
et al., 2011). 
However, no pharmaceutical investigations of the physiological effects on the 
human skin of MC were reported. Only one publication reported something in 
similar direction about one TCM formula (Hokoei-to, in Chinese: Pu Gong Ying 
Tang, components: Taraxaci radix, Angelicae Radix, Cyperi rhizoma, Moutan 
cortex, Dioscoreae rhizoma) containing MC, the decoction of boiling water of all 5 
TCM drugs together resulted in the increasing proliferation of endothelial cells 
isolated from bovine aorta and in the suppressed proliferation of smooth muscle 
cells. And with the single test of the decoction of MC, it also caused cell 
proliferation of the endothelial cells. However, proliferation of smooth muscle 
cells isolated from bovine aorta was slightly depressed by MC decoction 
(Yokozawa et al., 1996). This article could be regarded as a reference, but it could 
not explain anything to our work. Especially, with the different extracting method, 
the result could be totally different. With the 60 min's water extracting of MC in 
this article, many componential changes could happen. 
In this work, with the crude EtOH-water extract (extract 7) and water extract 
(extract 8) of MC, the mitochondrial activity of both pNHDF and HaCaT 
keratinocytes was enhanced greatly (20-39%) at the concentration of 100 µg/mL, 
the influence of extract 7 worked more effective than extract 8. For the 
investigation of the corresponding component (s), further fractionations were 
performed. By the positive reaction with vanillin-HCl and with methanolic FeCl3  
solution, tannins were found to be one main class compounds existing in MC. 
This result is very exciting and promising, because several publications have 
reported tannins to have the positive influence on human skin' physiology and 
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for the wound healing (Deters, A. et al., 2001; Sen, C.K. et al., 2002). Besides, for 
the analytical investigations, analyzing of condensed tannins and flavan-3-ols are 
not so far fully described. The well-known flavan-3-ol and tannins from MC are 
(+)-catechin, some hydrolyzable tannins as 4,6-di-O-galloyl-D-glucose, 3,6-di-O-
GG, 1,2,3,6-tetra-O-GG, 1,2,3,4,6-penta-O-GG, 1,3,4,6-tetra-O-GG, 3,4,6-tri-O-GG, 
1,3,6-tri-O-GG, 1,2,6-tri-O-GG (Wu, Y.T. et al., 2003).  
With this background, bioassay guided investigations were further performed. 
Significant increase of mitochondrial activity of the cells was obtained with 
fraction 10 (EtOAc extract of defatted MC), fraction 100 (EtOH fraction of fraction 
10 by Sephadex® LH-20), fraction 101 (MeOH fraction of fraction 10 by 
Sephadex® LH-20), fraction 12 (water extract of defatted MC), fraction 
121(MeOH fraction of fraction 12 by Sephadex® LH-20), fraction 122 (70% 
acetone fraction of fraction 12 by Sephadex® LH-20) and isolated 1,2,3,4,6-penta-
O-galloyl-Ⱦ-D-glucose. 
For testing the influence of the herbal extracts/fraction/compound, HaCaT 
keratinocytes and pNHDF were used. As we know, skin is mainly consisted by 
two big layers: epidermis and dermis. The epidermis is stratified squamous 
epithelium. The main cells of the epidermis are the keratinocytes, which 
synthesis the protein keratin (Bensouilah, J. et al., 2006). As epidermal cells 
migrate upward from the basal layer, they lose their mitotic potential to a great 
extent and begin to synthesize such specific constituents as fibrillar, amorphous 
proteins, keratohyalin, and membrane-coating granules. Their surface becomes 
modified, and finally their nuclei and cytoplasmic organelles are lost. At the end 
of differentiation, epidermal cells become constituents of the horny layer. 
However, the dermis is laying between the epidermis and the subcutaneous 
panniculus (Montagna, W. et al., 1974). It is made up of fibroblasts, which 
produce collagen, elastin and structural proteoglycans, together with immuno-
competent mast cells and macrophages. Collagen fibres make up 70% of the 
dermis (Bensouilah, J. et al., 2006). Thus, with higher cell viability, HaCaT 
keratinocytes can proceed either proliferation or differentiation. As to pNHDF, 
with the stimulated mitochondrial activity, cell proliferation and the protein 
(mostly collagen) production could occur.  
For that reason, BrdU cell proliferation assay was performed to explain the 
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activity happening in the cells after fed and incubated with herbal extracts 
(fractions). Among all tests, significant cell proliferation was observed while the 
cell viability was enhanced. This indicated these exogenous test 
extracts/fractions/compound had the influence on the proliferation of both cell 
types. Followed by the cell proliferation, differentiation could happen on 
keratinocytes, the differentiation test could be performed by quantitive 
determination of keratin produced by cells (Deters, A. et al., 2001). For pNHDF, 
collagen determination could still be performed in the future, to see if the test 
substances also have influence on the stimulating effect on producing of collagen. 
Both the differentiation detection of keratinocytes and the collagen producing of 
pNHDF were not performed due to the limitation of time.  This could be a good 
further investigation aspect. 
With the analytical investigation, paeonol, (+)-catechin, (-)-epicatechin-ȋͶȾ՜ͺ)-
catechin, (-)-epicatechin-3-O-gallate, epicatechin-3-O-gallate-ȋͶ՜ͺȌ-catechin, tri-
galloyl-glucose, 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose were isolated and 
identified. 1,2,3,4,6-penta-O-galloyl-Ⱦ-D-glucose was tested as single compound 
on HaCaT keratinocytes, and 11% significant enhancement of the cell viability 
with 35% significant increasing of the cell proliferation were observed at the 
testing dose of 1.1×10-4 mol/L. 
However, as described in introduction, wound healing is a very long and 
complicated procedure. Before the cell proliferation happens, the wound firstly 
would process the hemostasis phase and inflammatory phase, and after the 
proliferative phase, remodeling phase would perform to terminate wound 
healing. With the happening of the wound, many aspects are not less important 
as cell proliferation, for example, anti-microbial, anti-inflammation etc. As 
mentioned before, MC has been reported for its strong antimicrobial functional 
components, such as benzoic acid, methyl gallate, p-hydroxybenzoic acid, gallic 
acid, p-hydroxybenzoic acid and PGG are all active contents (Kwon, O.G. et al., 
1999). Besides, anti-inflammatory effect is one of the most popular functions 
proven from MC, and the testing extracts were mostly ethanolic, aqueous extracts 
and EtOAc extract, which were similar as the extraction and fractionation method 
in this work. It indicated the effective anti-inflammatory components from MC 
were also contained in the tested extracts and fractions of this work. Moreover, 
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PGG was also reported to have the anti-inflammatory effect (Lee, S. et al., 2003).  
However, MC was reported to have antiaggregatory effect from its water extract 
and paeonol (Hirai, A. et al., 1983). Paeonol was extracted with petroleum ether  
as defatting step in this work, and this extract (PE) was not effective on skin cells. 
So no further worries should be made with it. But the water extract showed 
stimulating mitochondrial activity and proliferative effect on both type cells. As 
mentioned before, the hemostasis phase is important for wound healing. It stops 
the bleeding and offers a closed environment for the further process of the 
wound healing. Therefore, the using of MC on the bleeding wound should be 
avoided.  
This work used bioassay guided investigations to analyze a traditional skin active 
TCM herbal drug - Moutan cortex. Water extract and EtOH-water (6:4, v/v) 
extract of MC caused the enhancement of the cell viability both on HaCaT 
keratinocytes and pNHDF. With further fractionation, the cell viability 
stimulation and the cell proliferation were both obtained in the followed 
subfractions. Additionally, seven compounds were isolated and identified from 
MC, and 3 were firstly reported. Isolated PGG was also tested on HaCaT 
keratinocytes and significant proliferative effect was obtained. Together with the 
literature studying and comparing, it is strongly indicated that Moutan cortex is a 
very potential TCM plant for wound healing with multi-functions. And PGG also 
turns out to be one of the active compounds which is responsible for promoting 
the proliferation of HaCaT keratinocytes. 
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5 Appendix 
Table 5.1  1H and 13C NMR spectral data for paeonol in CDCl3 (not deuterated 
solvent: proton NMR: Ɂ͹Ǥʹ͸ ppm, locked; 13C NMR: Ɂ͹͹Ǥͳ͸ ppm, locked). 
No. 
Chemical shifts (ppm) 
1 H 1H (literature) 13C 
13 C 
(literature) 
1   113.97 117.43 
2   165.33 164.70 
3 6.42 (d, J= 2.5 Hz) 
6.38 (d, J=2.4 
Hz) 100.90 100.23 
4   166.21 165.56 
5 
6.44 (dd, J= 8.8 Hz, 
J= 2.5 Hz ) 
6.42 (dd, J=8.8 
Hz, J=2.4 Hz) 
107.67 107.02 
6 
7.63 (d, J= 8.8 Hz) 
7.61 (d, J=8.8 
Hz) 
132.40 131.75 
7   202.68 202.03 
8 2.56 (s) 2.52 (s) 26.33 25.52 
9 3.84 (s) 3.82 (s) 55.60 54.92 
 
Literature: Lee, S.C. et al., 2005  
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Table 5.2 1H NMR spectral data for fraction 10C (+)-catechin in MeOD (not 
deuterated solvent: Ɂ 4.87 ppm, locked). 
No. 
Chemical shifts 
                                                          1 H                                                        
2 4.56 (d, 7.7 Hz) 
3 3.97 (ddd, 8.1 Hz, 7.7 Hz, 5.5 Hz) 
4Ƚ 2.84 (dd, 16.2 Hz, 5.5 Hz) 
4Ⱦ 2.51 (dd, 16.2 Hz, 8.1 Hz) 
6 5.93 (d, 2.2 Hz) 
8 5.86 (d, 2.2 Hz) 
2’ 6.84 (d, 2.0 Hz) 
5’ 6.76 (d, 8.2 Hz) 
6’ 6.72 (dd, 8.2 Hz, 2.0 Hz) 
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Table 5.3 1H NMR spectral data for fraction 10D1: peracetate of (-)-epicatechin-
3-O-gallate in acetone-D6 (not deuterated solvent: Ɂ 2.05 ppm, locked). 
No. 
Chemical shifts 
                                                          1 H                                                        
2 5.52 (s) 
3 5.75-5.77 (m; theoretical ddd) 
ͶȽ 3.22 (dd, 18.2 Hz, 4.6 Hz) 
ͶȾ 3.07 (dd, 18.2 Hz, 2.6 Hz) 
6 6.73 (d, 2.2 Hz) 
8 6.60 (d, 2.2 Hz) 
2’ (B) 7.49 (s) 
5’ (B) 7.25 (d, 9.0 Hz) 
6’ (B) 7.48 (dd, 9.0 Hz, 2.1 Hz) 
2''/6'' (D) 7.62 (2s) 
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Table 5.4 1H spectral data for peracetylated procyanidin B1 (fraction D21 from 
Moutan cortex) in CDCl3 (not deuterated solvent: Ɂ7.26 ppm, locked). 
No. 
Chemical shifts (ppm) 
1 H 
2 (C) 5.44 (s), R: 5.28/5.33 
3 (C) 5.14 (2s); R: 5.20 
4 (C) 4.41 (s); R: 4.54 
6 (A) 6.29 (d, J=2.2 Hz) 
8 (A) 5.98 (d, J=2.2 Hz) 
2' (B) 7.08 (d, J=8.1 Hz) 
5' (B) 7.30 (d, J=8.83 Hz) 
6`(B) 7.16 (m) 
2 (F) 4.33 (d, J=9.7 Hz) 
3 (F) 5.04 (ddd, J=9.5 Hz, J=7.0 Hz, J=2.9 Hz) 
4Ƚ (F) 3.21 (dd, J=16.6 Hz, J=7.0 Hz; R: 3.06 (m) 
4Ⱦȋ	Ȍ 2.55 (dd, J=16.6 Hz, J=9.5 Hz) R: 2.73 (m) 
6 (D) 6.67 (s), R: 6.59 
2' (E) 6.87 (d, J=1.1 Hz) 
5' (E) 6.93 (d, J=8.8 Hz) 
6' (E) 6.72 (m) 
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Table 5.5 1H NMR spectral data for peracetylated fraction 10F1 [a mixture: 
contains probably epicatechin-3-O-gallate-(4՜8)-catechin] in CDCl3 (not 
deuterated solvent: Ɂ 7.26 ppm, locked). 
No. 
Chemical shifts (ppm) 
1 H 
2 (C), 3(C) ca. 5.27-5.50 
4 (C), 2(F) ca. 4.24-4.43 
6 (A) 5.99 (d, J=2.5 Hz) 
8 (A) 6.26 (d, J=2.5 Hz) 
3 (F) 5.00 (ddd, J=9.5 Hz, J=7.0 Hz, J=2.8 Hz) 
4Ƚ (F) 3.15 (dd, J=16.7 Hz, J=7.0 Hz) 
4Ⱦ (F) 2.51 (dd, J=16.7 Hz, J=9.0 Hz) 
6 (D) 6.63 (s) 
B, E 6.83-7.24 (m) 
Gallate (G) 7.47 (2s) 
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Table 5.6 1H NMR spectral data of peracetylated fraction 10G1 (trigalloyl 
glucose) in CDCl3 ȋǣɁ͹Ǥʹ͸ǡȌǤ 
No. 
Chemical shifts 
1 H 
1 5.96 (d, 8.4 Hz) 
2, 3, 4 5.34-5.56 (m, unable to distinguish and identify) 
5 4.11-4.15 (m) 
6 
4.33 (dd, 12.7 Hz, 5.2 Hz) 
4.57 (dd, 12.7 Hz, 1.9 Hz) 
Galloyl (A, B, C) 7.80, 7.79, 7.74 (all 2H, s) 
-OAc 1.99-2.31 (m) 
 
 
Table 5.7 1H NMR spectral data of fraction 10J1 (1,2,3,4,6-penta-O-galloyl-Ⱦ-D-ȌȋǣɁͶǤͺ͹ǡȌǤ 
No. 
Chemical shifts 
                                                          1 H                                                        
1 6.09 (d, 8.5 Hz) 
2 5.44 (t, 9.3 Hz) 
3 5.76 (t, 9.5 Hz) 
4 5.47 (t, 9.5 Hz) 
5/6 (2H) 4.21-4.38 (m) 
Galloyls (A-E) 6.75, 6.80, 6.83, 6.90, 6.96 (all 2H, s) 
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Table 5.8 1H NMR spectral data of peracetylated fraction 10J2 (1,2,3,4,6-penta-
O-galloyl-Ⱦ-D-glucose) in CDCl3 (not ǣɁ͹Ǥʹ͸ǡȌǤ 
No. 
Chemical shifts 
1 H 
Measured data Literature data 
1 6.13 (d, 8.5 Hz) 6.12 (d, 9.5 Hz) 
2 5.72 (t, 9.0 Hz) 5.70 (t, 9.5 Hz) 
3 5.90 (t, 9.5 Hz) 5.89 (t, 9.5 Hz) 
4 5.59 (t, 9.8 Hz) 5.58 (t, 9.0, 9.5 Hz) 
5 4.25-4.29 (m) 4.26 (m) 
6 
4.40 (dd, 12.6 Hz, 5.0 Hz) 4.38 (dd, 12.0 Hz, 5.0 Hz) 
4.60 (dd, 12.6 Hz, 1.8 Hz) 4.58 (br. d, 12.0 Hz) 
Galloyls (A-E) 
7.67, 7.69, 7.72, 7.78, 7.82 
(all 2H, s) 
7.66, 7.68, 7.71, 7.78, 7.81 
(all 2H, s) 
-OAc 2.24-2.31 (m) 2.20-2.28 (m) 
 
Literature: Haddock, E. A. et al., 1982. 
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Corrigenda 
 
April, 2012; Author: Ruxi Wang; Dissertation topic: Bioassays Guided in vitro 
Investigations on skin-active Plants from Traditional Chinese Medicine. 
The following corrigenda should be made due to the errors in this dissertation: 
The first sentence of the last paragraph at page 148 should be corrected as ''For 
in vitro cell investigation with fraction 121...''. 
The Fig. 3.56 (b) at page 149 should be replaced with: 
 
The positions of H-6 (A) and H-8 (A) in Fig. 3.79 at page 175 should be 
exchanged. 
The first sentence of the last paragraph at page 195 should be corrected as 
''According to the results, fraction 101 stimulated cell viability of HaCaT 
keratinocytes...''. 
The word ''HaCaT'' at page 207 in line 5 and line 10 should be deleted. 
The chemical shifts of 6 (A) and 8 (A) in Table 5.5 should be exchanged with each 
other. 
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